<SEC-DOCUMENT>0001214659-21-000742.txt : 20210125
<SEC-HEADER>0001214659-21-000742.hdr.sgml : 20210125
<ACCEPTANCE-DATETIME>20210125064545
ACCESSION NUMBER:		0001214659-21-000742
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		7
FILED AS OF DATE:		20210125
DATE AS OF CHANGE:		20210125

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Ault Global Holdings, Inc.
		CENTRAL INDEX KEY:			0000896493
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTRONIC COMPONENTS, NEC [3679]
		IRS NUMBER:				941721931
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-251995
		FILM NUMBER:		21547811

	BUSINESS ADDRESS:	
		STREET 1:		11411 SOUTHERN HIGHLANDS PARKWAY
		STREET 2:		SUITE 240
		CITY:			LAS VEGAS
		STATE:			NV
		ZIP:			89141
		BUSINESS PHONE:		(949) 444-5464 3679

	MAIL ADDRESS:	
		STREET 1:		11411 SOUTHERN HIGHLANDS PARKWAY
		STREET 2:		SUITE 240
		CITY:			LAS VEGAS
		STATE:			NV
		ZIP:			89141

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DPW Holdings, Inc.
		DATE OF NAME CHANGE:	20171229

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DIGITAL POWER CORP
		DATE OF NAME CHANGE:	19960823
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>p122211424b5.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; background-color: white"><B>Filed Pursuant
to Rule&nbsp;424(b)(5)<BR>
Registration No.&nbsp;333-251995</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>PROSPECTUS SUPPLEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>(To Prospectus
dated January 20, 2021)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">Up to $50,000,000</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;<IMG SRC="aultglobal_biglogo.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">Ault Global Holdings,
Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">(formerly known
as DPW Holdings, Inc.)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">Shares of Common
Stock</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have entered into
an At-The-Market Issuance Sales Agreement, or the sales agreement, with Ascendiant Capital Markets, LLC, or ACM, relating to shares
of our common stock offered by this prospectus supplement and the accompanying prospectus. In accordance with the terms of the
sales agreement, we may offer and sell shares of our common stock, par value $0.001 per share, having an aggregate offering price
of up to $50,000,000 from time to time through ACM, acting as sales agent, at our discretion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our common stock is
traded on the NYSE American, or the Exchange, under the symbol &ldquo;DPW.&rdquo; The closing price of our common stock on January
21, 2021 was $5.00 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of January 21, 2021,
the aggregate market value of our outstanding common stock held by non-affiliates, or the public float, was $133,345,395, which
was calculated based on 26,669,079 shares of our outstanding common stock held by non-affiliates at a price of $5.00 per share,
the closing price of our common stock on January 21, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Sales of our common
stock, if any, under this prospectus supplement and accompanying prospectus may be made in sales deemed to be &ldquo;at the market
offerings&rdquo; as defined in Rule 415 under the Securities Act of 1933, as amended, or the Securities Act. ACM is not required
to sell any specific number or dollar amount of securities, but will act as a sales agent using commercially reasonable efforts
consistent with its normal trading and sales practices, on terms mutually agreed to by ACM and us. There is no arrangement for
funds to be received in any escrow, trust or similar arrangement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The compensation to
ACM for sales of common stock sold pursuant to the sales agreement will be an amount equal to 3.25% of the gross proceeds of any
shares of common stock sold under the sales agreement. In connection with the sale of the common stock on our behalf, ACM may be
deemed to be an &ldquo;underwriter&rdquo; within the meaning of the Securities Act and the compensation of ACM may be deemed to
be underwriting commissions or discounts. We have also agreed to provide indemnification and contribution to ACM with respect to
certain liabilities, including liabilities under the Securities Act or the Securities Exchange Act of 1934, as amended, or the
Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 139.2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><B><I>Investing
in our common stock involves a high degree of risk. See &ldquo;Risk Factors&rdquo; beginning on page&nbsp;S-6 of this prospectus
supplement, on page 6 of the accompanying prospectus and under similar headings in the other documents that are incorporated by
reference into this prospectus supplement and the accompanying prospectus.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Neither the Securities
and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this
prospectus supplement or the prospectus to which it relates is truthful or complete. Any representation to the contrary is a criminal
offense.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="acmsm_smlogo.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>January 25,
2021</B>&nbsp;</P>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>TABLE OF CONTENTS</B></P>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>PROSPECTUS SUPPLEMENT</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="width: 96%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 3%; border-bottom: black 1.5pt solid">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Page</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top">About this Prospectus Supplement</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">ii</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top">Cautionary Statement Regarding Forward-Looking Statements</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">ii</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top">Prospectus Supplement Summary</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">S-1</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top">Risk Factors</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">S-6</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top">Use of Proceeds</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">S-29</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top">Dilution</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">S-30</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top">Dividend Policy</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">S-30</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top">Plan of Distribution</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">S-31</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top">Legal Matters</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">S-32</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; text-align: justify">Experts</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">S-32</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top">Where You Can Find More Information</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">S-32</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top">Incorporation of Documents by Reference</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">S-32</TD></TR>
</TABLE>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="white-space: nowrap; width: 93%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 6%; border-bottom: black 1pt solid">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Page</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; vertical-align: top">About this Prospectus</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">1</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="white-space: nowrap; vertical-align: top">Disclosure Regarding Forward-Looking Statements</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">1</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; vertical-align: top">About the Company</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">2</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="white-space: nowrap; vertical-align: top">Risk Factors</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">7</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; vertical-align: top">Use of Proceeds</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">30</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="white-space: nowrap; vertical-align: top">The Securities We May Offer</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">30</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; vertical-align: top">Description of Capital Stock</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">31</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="white-space: nowrap; vertical-align: top">Description of Debt Securities</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">32</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; vertical-align: top">Description of Warrants</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">39</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="white-space: nowrap; vertical-align: top">Description of Rights</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">41</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; vertical-align: top">Description of Units</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">42</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="white-space: nowrap; vertical-align: top">Plan of Distribution</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">42</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; vertical-align: top">Legal Matters</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">44</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: justify">Experts</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">44</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; vertical-align: top">Where you can find more Information</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">44</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="white-space: nowrap; vertical-align: top">Incorporation of Documents by Reference</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">44</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: NewSection -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>ABOUT THIS PROSPECTUS
SUPPLEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">This
document is in two parts. The first part is this prospectus supplement, which describes the specific terms of this offering and
also adds to and updates information contained in the accompanying prospectus and the documents incorporated by reference into
this prospectus supplement and the accompanying prospectus. The second part, the accompanying prospectus, gives more general information
about securities we may offer from time to time, some of which does not apply to this offering. Generally, when we refer to this
prospectus, we are referring to both parts of this document combined together with all documents incorporated by reference. If
the description of the offering varies between this prospectus supplement and the accompanying prospectus, you should rely on the
information contained in this prospectus supplement. However, if any statement in one of these documents is inconsistent with a
statement in another document having a later date&mdash;for example, a document incorporated by reference into this prospectus
supplement or the accompanying prospectus&mdash;the statement in the document having the later date modifies or supersedes the
earlier statement. You should rely only on the information contained in or incorporated by reference into this prospectus supplement
or contained in or incorporated by reference into the accompanying prospectus to which we have referred you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Neither
we nor ACM have authorized anyone to provide you with information that is different. If anyone provides you with different or inconsistent
information, you should not rely on it. We do not, and ACM does not, take responsibility for, and can provide no assurances as
to, the reliability of any information that others provide you. The information contained in, or incorporated by reference into,
this prospectus supplement and contained in, or incorporated by reference into, the accompanying prospectus is accurate only as
of the respective dates thereof, regardless of the time of delivery of this prospectus supplement and the accompanying prospectus
or of any sale of securities. It is important for you to read and consider all information contained in this prospectus supplement
and the accompanying prospectus, including the documents incorporated by reference herein and therein, in making your investment
decision. You should also read and consider the information in the documents to which we have referred you under the captions &ldquo;Where
You Can Find More Information&rdquo; and &ldquo;Incorporation of Documents by Reference&rdquo; in this prospectus supplement and
in the accompanying prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We
are offering to sell, and are seeking offers to buy, the shares only in jurisdictions where such offers and sales are permitted.
The distribution of this prospectus supplement and the accompanying prospectus and the offering of the shares in certain jurisdictions
or to certain persons within such jurisdictions may be restricted by law. Persons outside the United States who come into possession
of this prospectus supplement and the accompanying prospectus must inform themselves about and observe any restrictions relating
to the offering of the shares and the distribution of this prospectus supplement and the accompanying prospectus outside the United
States. This prospectus supplement and the accompanying prospectus do not constitute, and may not be used in connection with, an
offer to sell, or a solicitation of an offer to buy, any securities offered by this prospectus supplement and the accompanying
prospectus by any person in any jurisdiction in which it is unlawful for such person to make such an offer or solicitation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We own or have rights
to various trademarks, service marks and trade names that we use in connection with the operation of our business. This prospectus
supplement, the accompanying prospectus and the information incorporated herein and thereby by reference may also contain trademarks,
service marks and trade names of third parties, which are the property of their respective owners. Our use or display of third
parties&rsquo; trademarks, service marks, trade names or products in this prospectus supplement or the accompanying prospectus
is not intended to, and does not imply a relationship with, or endorsement or sponsorship by us. Solely for convenience, the trademarks,
service marks and trade names referred to in this prospectus may appear without the&nbsp;<SUP>&reg;</SUP>, <SUP>TM</SUP> or <SUP>SM</SUP>
symbols, but such references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable
law, our rights or the right of the applicable licensor to these trademarks, service marks and trade names.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless otherwise stated
or the context requires otherwise, references to &ldquo;AGH,&rdquo; the &ldquo;Company,&rdquo; &ldquo;we,&rdquo; &ldquo;us&rdquo;
or &ldquo;our&rdquo; are to Alt Global Holdings, Inc.&nbsp;and its subsidiaries.<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>CAUTIONARY STATEMENT
REGARDING FORWARD-LOOKING STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">This
prospectus supplement and accompanying prospectus, including the documents that we incorporate by reference, contain forward-looking
statements within the meaning of Section&nbsp;27A of the Securities Act and Section&nbsp;21E of the Exchange Act. Such forward-looking
statements include those that express plans, anticipation, intent, contingency, goals, targets or future development and/or otherwise
are not statements of historical fact.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">These
forward-looking statements are based on our current expectations and projections about future events and they are subject to risks
and uncertainties known and unknown to us that could cause actual results and developments to differ materially from those expressed
or implied in such statements, including the risks described under &ldquo;Risk Factors&rdquo; in this prospectus supplement, and
the other information in this prospectus supplement, the accompanying prospectus and our Annual Report on Form&nbsp;10-K/A for
the year ended December&nbsp;31, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">In
some cases, you can identify forward-looking statements by terminology, such as &ldquo;expects,&rdquo; &ldquo;anticipates,&rdquo;
&ldquo;intends,&rdquo; &ldquo;estimates,&rdquo; &ldquo;plans,&rdquo; &ldquo;believes,&rdquo; &ldquo;seeks,&rdquo; &ldquo;may,&rdquo;
&ldquo;should&rdquo;, &ldquo;could&rdquo; or the negative of such terms or other similar expressions. Accordingly, these statements
involve estimates, assumptions and uncertainties that could cause actual results to differ materially from those expressed in them.
Any forward-looking statements are qualified in their entirety by reference to the factors discussed throughout this prospectus
supplement and the accompanying prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">You
should read this prospectus supplement, the accompanying prospectus and the documents that we reference herein and therein completely
and with the understanding that our actual future results may be materially different from what we expect. You should assume that
the information appearing in this prospectus supplement, the accompanying prospectus and the documents incorporated by reference
is accurate as of their respective dates. Our business, financial condition, results of operations and prospects may change. We
may not update these forward-looking statements, even though our situation may change in the future, unless required by U.S. federal
securities laws to update and disclose material developments related to previously disclosed information. We qualify all of the
information presented in this prospectus supplement and the accompanying prospectus, and particularly our forward-looking statements,
by these cautionary statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<DIV STYLE="padding-right: 2%; padding-left: 2%; border: Black 1pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PROSPECTUS SUPPLEMENT SUMMARY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>&nbsp;</I>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>This summary highlights
selected information contained in other parts of this prospectus supplement. Because it is a summary, it does not contain all of
the information that you should consider in making your investment decision. Before investing in our securities, you should read
the entire prospectus carefully, including the information set forth under the heading &ldquo;Risk Factors.&rdquo;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;Company Overview</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1pt; text-align: justify; text-indent: 35.9pt">Ault Global
Holdings, Inc., or AGH, is a diversified holding company that owns operating subsidiaries and divisions engaged in a number of
diversified business operations including the defense, aerospace, commercial, health/medical, finance and commercial lending sectors.
Our largest subsidiary is Gresham Worldwide, which provides advanced bespoke military and commercial applications. We began implementing
our strategy in late 2016 led by our Executive Chairman Milton &ldquo;Todd&rdquo; Ault, III and Vice Chairman and Chief Executive
Officer William B. Horne. AGH is presently led by an Executive Committee, the members of which are Messrs. Ault and Horne and Henry
Nisser, our President and General Counsel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We operate as a holding
company with operations conducted primarily through our subsidiaries. We conduct our activities in a manner so as not to be deemed
an investment company under the Investment Company Act of 1940, as amended (the &ldquo;Investment Company Act&rdquo;). Generally,
this means that we do not invest or intend to invest in securities as our primary business and that no more than 40% of our total
assets will be invested in investment securities as such term is defined in the Investment Company Act. Pursuant to the Investment
Company Act, companies such as our subsidiary Digital Power Lending, LLC (&ldquo;DP Lending&rdquo;) are excluded from the definition
of an investment company since its business consists of making small loans and industrial banking. We also maintain a large investment
in Avalanche International, Corp., <FONT STYLE="color: #231F20">which does business as MTIX International.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Originally, we were
primarily a solution-driven organization that designed, developed, manufactured and sold high-grade customized and flexible power
system solutions for the medical, military, telecom and industrial markets. Although we are actively seeking growth through acquisitions,
we will continue to focus on high-grade and custom product designs for the commercial, medical and military/defense markets, where
customers demand high density, high efficiency and ruggedized products to meet the harshest and/or military mission critical operating
conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have operations
located in Europe through our wholly-owned subsidiary, Gresham Power Electronics (formerly Digital Power Limited) (&ldquo;Gresham
Power&rdquo;), located in Salisbury, England. Gresham Power designs, manufactures and sells power products and system solutions
mainly for the European marketplace, including power conversion, power distribution equipment, DC/AC (direct current/active current)
inverters and UPS (uninterrupted power supply) products. Gresham Power is specialized in the field of naval power distribution
products, as well as our wholly owned subsidiary Relec Electronics (&ldquo;Relec&rdquo;) located in Dorset, England. Relec was
established in 1978 with the aim of providing specialist power conversion and display products to support professionals in the
electronics industry. Relec&rsquo;s aerospace background means it consistently and meticulously delivers high performance and robust
power and display solutions. Relec exerts its utmost effort to customize a product or a feature to achieve optimum performance
and service delivery. Relec continues to be guided by this philosophy and currently operates in specific fields, specializing in
AC-DC Power Supplies, DC-DC Converters, Displays and EMC Filters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;<B>Recent Events</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Reorganization
of Our Corporate Structure</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Commencing in October
2019 and continuing through July 2020, we reorganized our corporate structure pursuant to a series of transactions among our company
and our directly and indirectly-owned subsidiaries. The purpose of the reorganization was to align our various businesses by the
products and services that constitute the majority of each subsidiaries&rsquo; revenues. As a result of the foregoing transactions,
our corporate structure is as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 5; Options: NewSection -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<DIV STYLE="padding-right: 2%; padding-left: 2%; border: Black 1pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="chart_s2.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On January 7, 2020,
we formed Coolisys Technologies Corp. (&ldquo;CTC&rdquo;) in order to hold Digital Power Corporation. Coolisys is presently owned
by GWW and owns Microphase Corporation, Gresham Power Electronics, Relec and Enertec Systems. We may dispose of Coolisys in the
future, leaving GWW as the direct owner of the four foregoing subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Other Matters</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">In
January 2018, we formed Super Crypto Mining, Inc., a wholly-owned subsidiary, which recently changed its name to Digital Farms,
Inc. (&ldquo;DFI&rdquo;). DFI was established to operate our newly formed cryptocurrency business, which mined a variety of digital
currency for our own account. These cryptocurrencies include Bitcoin, Litecoin and Ethereum.&nbsp;We made the decision to discontinue
DFI&rsquo;s operations in the first quarter of 2020.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">On
May 23, 2018, DP Lending entered into and closed a securities purchase agreement with I. AM, Inc. (&ldquo;I. AM&rdquo;). <FONT STYLE="background-color: white">I.
AM&rsquo;s operations were discontinued in the first quarter of 2020 and it is currently in bankruptcy proceedings.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On October 2, 2020,
we entered into an At-The-Market Issuance Sales Agreement (the &ldquo;Sales Agreement&rdquo;) with Ascendiant Capital Markets,
LLC to sell shares of common stock having an aggregate offering price of up to $8,975,000 from time to time, through an &ldquo;at
the market offering&rdquo; program (the &ldquo;2020 ATM Offering&rdquo;). On December 1, 2020, we filed an amendment to the prospectus
supplement with the SEC to increase the amount of common stock that may be offered and sold in the ATM Offering, as amended under
the Sales Agreement to $40,000,000 in the aggregate, inclusive of the up to $8,975,000 in shares of common stock previously sold
in the 2020 ATM Offering. The offer and sale of shares of common stock from the 2020 ATM Offering was made pursuant to our effective
&ldquo;shelf&rdquo; registration statement on Form&nbsp;S-3 and an accompanying base prospectus contained therein (Registration
Statement No.&nbsp;333-222132) which became effective on January 11, 2018. Through December 31, 2020, we had received gross proceeds
of $39,978,350 through the sale of 12,582,000 shares of common stock from the 2020 ATM Offering. The 2020 ATM Offering was terminated
on December 31, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August 5, 2020,
we received $2,000,000 from Esousa Holdings, LLC (&ldquo;Esousa&rdquo;) and on October 22, 2020, we issued to Esousa a promissory
note in the principal face amount of $2,000,000, with an interest rate of 13%. The outstanding principal face amount, plus any
accrued and unpaid interest, is due by November 3, 2020, or as otherwise provided in accordance with the terms set forth therein.
In connection therewith, we delivered to Esousa a warrant to purchase 729,927 shares of common stock at an exercise price of $3.01.
The exercise of the warrant is subject to approval of the NYSE American. The foregoing debt was paid off in December of 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On October 27, 2020,
we issued to Esousa two unsecured promissory notes in the aggregate principal face amount of $1,200,000, of which $850,000 was
received prior to September 30, 2020. The principal amount of $850,000 of the first note dated October 27, 2020, together with
all accrued unpaid interest at an annual rate of 14%, was due and payable on December 28, 2020. The principal amount of $350,000
of the second note dated October 27, 2020, together with all accrued unpaid interest at an annual rate of 14%, was due and payable
on January 7, 2021. Both unsecured promissory notes were repaid on December 14, 2020. In connection with the two promissory notes,
we delivered to the Esousa (i) a warrant dated October 27, 2020, to purchase 425,000 shares of common stock at an exercise price
of $2.20, and (ii) a warrant dated October 27, 2020, to purchase 148,936 shares of common stock at an exercise price of $2.59.
The exercise of the warrants is subject to approval of the NYSE American.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<DIV STYLE="padding-right: 2%; padding-left: 2%; border: Black 1pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On November 9, 2020,
our <FONT STYLE="color: #231F20">wholly-owned subsidiary </FONT>Gresham Worldwide, Inc. (&ldquo;GWW&rdquo;) entered into a stock
purchase agreement with Tabard Holdings Inc., a Delaware corporation and wholly owned subsidiary of GWW (&ldquo;Tabard&rdquo;),
the legal and beneficial owners (the &ldquo;Sellers&rdquo;) of 100% of the issued shares in the capital of Relec Electronics Ltd.,
a corporation organized under the laws of England and Wales (&ldquo;Relec&rdquo;), and Peter Lappin, in his capacity as the representative
of the Sellers.&nbsp;&nbsp;Upon the terms and subject to the conditions set forth in the stock purchase agreement, Tabard agreed
to acquire Relec pursuant to the stock purchase agreement whereby the Sellers will sell to Tabard (i) 100% of the issued shares
of Relec. The purchase price is approximately &pound;3,000,000 plus an amount equal to Relec&rsquo;s cash balance immediately prior
to closing of the acquisition. The acquisition of Relec was consummated on November 30, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On November 19, 2020,
we issued to Esousa and two other institutional investors unsecured promissory notes in the aggregate principal face amount of
$2,250,000, with an interest rate of 12%. The outstanding principal face amount, plus any accrued and unpaid interest, was due
by February 18, 2021, or as otherwise provided in accordance with the terms set forth therein. These unsecured promissory notes
were repaid on December 28, 2020. In connection therewith, we delivered warrants to purchase an aggregate of 1,323,531 shares of
common stock at an exercise price of $1.87, subject to adjustments. Exercise of the warrants is subject to approval of the NYSE
American.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On November 20, 2020,
our former counsel, Sichenzia Ross Ference LLP as successor to Sichenzia Ross Ference Kesner LLP (&ldquo;SRF&rdquo;) filed a Complaint
(the &ldquo;Complaint&rdquo;) in the United States District Court for the Southern District of New York against us and two of our
subsidiaries (collectively, the &ldquo;Defendants&rdquo;), in an action captioned Sichenzia Ross Ference LLP as successor to Sichenzia
Ross Ference Kesner LLP v. Digital Power Corporation, et al., Case No. 20-CV-09811-JGK. The Complaint asserts claims for breach
of contract, account stated, unjust enrichment and quantum meruit, against the Defendants, and seeks monetary damages in the amount
of $2,558,122 plus interest thereon. On January 4, 2021, the Defendants filed a motion for a more definite statement (the &ldquo;Motion&rdquo;).
The Court has scheduled a pre-motion conference for January 11, 2021 in connection with the Motion. As of December 31, 2020, approximately
$2.3 million of the disputed legal fees were included in accounts payable. We intend to vigorously defend against the claims asserted
against us and are currently assessing whether we will assert any counterclaims against SRF in this action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December 20, 2020,
our wholly owned subsidiary Alliance Cloud Services, LLC (&ldquo;ACS&rdquo;), entered into a Real Estate Sale Contract (the &ldquo;Sale
Contract&rdquo;) with Prairie Ronde Realty Company, a Michigan corporation (the &ldquo;Seller&rdquo;). Pursuant to the Sale Contract,
ACS will acquire the Property described below for a purchase price of $3,900,000, subject to proration in accordance with the Sale
Contract. The Property consists of a parcel of land consisting of approximately 34.52 acres, commonly known as 415 East Prairie
Ronde Street, Dowagiac, MI 49047, including any buildings, improvements and appurtenances thereon (collectively, with the parcel
of land, the &ldquo;Real Property&rdquo;) and the following: (i)&nbsp;all appurtenances pertaining to the Real Property; (ii)&nbsp;certain
personal property as set forth in the Sale Contract; (iii)&nbsp;all of the Seller&rsquo;s right, title and interest in and to all
leases and service contracts, which ACS will assume as of the closing date of January 29, 2021; and (vi)&nbsp;all assignable (without
consent) permits and warranties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">On
January 19, 2021, we changed our name from DPW Holdings, Inc. to Ault Global Holdings, Inc. Our ticker symbol on the NYSE American,
or the Exchange, remains &ldquo;DPW.&rdquo; Concurrently with the change in our name, Milton C. Ault, III was appointed as our
Executive Chairman, William B. Horne was appointed as our Chief Executive Officer and remains as Vice Chairman of our board of
directors, and Henry Nisser was appointed as our President and remains as our General Counsel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On January 22, 2021,
we entered into an At-The-Market Issuance Sales Agreement (the &ldquo;Sales Agreement&rdquo;) with Ascendiant Capital Markets,
LLC to sell shares of common stock having an aggregate offering price of up to $50,000,000 from time to time, through an &ldquo;at
the market offering&rdquo; program (the &ldquo;2021 ATM Offering&rdquo;). The offer and sale of shares of common stock from the
2021 ATM Offering will be made pursuant to our effective &ldquo;shelf&rdquo; registration statement on Form&nbsp;S-3 and an accompanying
base prospectus contained therein (Registration Statement No.&nbsp;333-251995) which became effective on January 20, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;<B><I>Settlement of Derivative Litigation</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February 24, 2020,
we entered into a definitive settlement agreement (the &ldquo;Settlement Agreement&rdquo;) intended to settle the previously disclosed
derivative litigation captioned <I>Ethan Young and Greg Young, Derivatively on Behalf of Nominal Defendant, DPW Holdings, Inc.
v. Milton C. Ault, III, Amos Kohn, William B. Horne, Jeff Bentz, Mordechai Rosenberg, Robert O. Smith, and Kristine Ault and DPW
Holdings, Inc., as the nominal defendant</I> (Case No. 18-cv-6587) (as amended on March 11, 2019, the &ldquo;Amended Complaint&rdquo;)
against us and certain of our officers and directors pending in the United States District Court for the Central District of California
(the &ldquo;Court&rdquo;). As previously disclosed, the Amended Complaint alleges violations including breaches of fiduciary duties
and unjust enrichment claims based on the previously pled transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On April 15, 2020,
the Court issued an Order (the &ldquo;Order&rdquo;) approving a Motion for Preliminary Approval of Settlement in the Derivative
Action. On July 16, 2020, the Court issued an Order (the &ldquo;Final Order&rdquo;) approving a Motion for Final Approval of Settlement
in the Derivative Action filed against us as a Nominal Defendant and our directors who served on our board of directors on July
31, 2018 who were not dismissed from the action as a result of the Court&rsquo;s partial grant of the Motion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<DIV STYLE="padding-right: 2%; padding-left: 2%; border: Black 1pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In accordance with
the terms of the Final Order, the Board has adopted certain resolutions and amendments to our committee charters and/or bylaws,
to ensure adherence to certain corporate governance policies (collectively, the &ldquo;Reforms&rdquo;). The Final Order further
provides that such Reforms shall remain in effect for a period of no less than five (5) years and shall be subject to any of the
following: (a) a determination by a majority of the independent directors that the Reforms are no longer in our best interest,
including, but not limited to, due to circumstances making the Reforms no longer applicable, feasible, or available on commercially
reasonable terms, or (b) modifications which we reasonably believe are required by applicable law or regulation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with
the Settlement Agreement, the parties agreed to a payment of attorneys&rsquo; fees in the amount of $600,000, which sum was paid
by our directors &amp; officers liability insurance. The Settlement Agreement contains no admission of wrongdoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have always maintained
and continue to believe that neither we nor our current or former directors engaged in any wrongdoing or otherwise committed any
violation of federal or state securities laws or any other laws or regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Impact of Coronavirus
on Our Operations</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">On
March 16, 2020, to try and mitigate the spread of the novel coronavirus, San Diego County health officials issued orders mandating
that all restaurants must end dine-in services. As a result of these temporary closures by the San Diego County health officials
and the deteriorating business conditions at both our cryptocurrency mining and restaurant businesses, management concluded that
discontinuing these operations was ultimately in our best interest. Although we have ceased operations at Digital Farms, since
the assets and operations have not yet been abandoned, sold or distributed, these assets do not yet meet the requirement for presentation
as discontinued operations. However, management determined that the permanent closing of the restaurant operations met the criteria
for presentation as discontinued operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">In
March 2020, the World Health Organization declared the outbreak of a novel coronavirus (&ldquo;COVID-19&rdquo;) as a pandemic which
continues to spread throughout the United States and the World. We are monitoring the outbreak of COVID-19 and the related business
and travel restrictions and changes to behavior intended to reduce its spread, and its impact on operations, financial position,
cash flows, inventory, supply chains, customer purchasing trends, customer payments, and the industry in general, in addition to
the impact on our employees. Due to the rapid development and fluidity of this situation, the magnitude and duration of the pandemic
and its impact on our operations and liquidity is uncertain as of the date of this prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">However,
our business has been disrupted and materially adversely affected by the recent outbreak of COVID-19. We are still assessing our
business operations and system supports and the impact COVID-19 may have on our results and financial condition, but there can
be no assurance that this analysis will enable us to avoid part or all of any impact from the spread of COVID-19 or its consequences,
including downturns in business sentiment generally or in our sectors in particular.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Our
operations are located in Las Vegas, NV, Alameda County, CA, Orange County, CA, Fairfield County, CT, the United Kingdom, Israel
and members of our senior management work in Seattle, WA and New York, NY. We have been following the recommendations of local
health authorities to minimize exposure risk for our employees, including the temporary closures of our offices and having employees
work remotely to the extent possible, which has to an extent adversely affected their efficiency. California and the UK recently
reinstituted a second round of stay-at-home orders and lockdowns, respectively. For more information, see &ldquo;Risk Factors &ndash;
We face business disruption and related risks resulting from the recent outbreak of the novel coronavirus . . . .&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Corporate Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our corporate name
is Ault Global Holdings, Inc. for both legal and commercial purposes. Our principal address is 11411 Southern Highlands Parkway,
Suite 240, Las Vegas, NV 89141. Our phone number is (949) 444-5464. Our website is www.aultglobal.com. The information on our website
does not constitute part of this prospectus supplement.&nbsp; We have included our website address as a factual reference and do
not intend it to be an active link to our website.</P>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<DIV STYLE="padding-right: 2%; padding-left: 2%; border: Black 1pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>The Offering</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top; width: 31%"><B>Common stock offered by us pursuant <BR>
to this prospectus supplement:</B></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 68%; text-align: justify">Shares of our common stock having an aggregate offering price of up to $50,000,000.</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><B>Manner of offering:</B></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&ldquo;At the market offering&rdquo; that may be made from time to time through our sales agent, ACM. See &ldquo;Plan of Distribution&rdquo; on page&nbsp;S-31.</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><B>Use of proceeds:</B></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">We intend to use the net proceeds, if any, from this offering for the financing of possible acquisitions of other companies and technologies, business expansions and investments and for working capital and general corporate purposes, which may include the repayment, refinancing, redemption or repurchase of future indebtedness or capital stock. See &ldquo;Use of Proceeds&rdquo; on page&nbsp;S-29.</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><B>Risk factors:</B></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">Investing in our common stock involves a high degree of risk. See &ldquo;Risk Factors&rdquo; beginning on page S-6 of this prospectus supplement and other information included or incorporated by reference into this prospectus supplement and the accompanying prospectus for a discussion of factors you should carefully consider before investing in our securities.</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD><B>NYSE American trading symbol:</B></TD>
    <TD>&nbsp;</TD>
    <TD>DPW</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.45pt 0pt 0; text-align: center"><B>RISK FACTORS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>An investment in
our securities involves a high degree of risk.&nbsp; Prior to making a decision about investing in our securities, you should carefully
consider the specific factors discussed below and discussed under the section entitled &ldquo;Risk Factors&rdquo; contained in
our Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2019, as updated by our subsequent filings under the Exchange
Act, each of which is incorporated by reference in this prospectus supplement and accompanying prospectus in their entirety, together
with all of the other information contained or incorporated by reference in this prospectus supplement, the accompanying prospectus,
the documents incorporated by reference herein and therein, and any related free writing prospectus.&nbsp; The risks and uncertainties
we have described are not the only ones we face.&nbsp; Additional risks and uncertainties not presently known to us or that we
currently deem immaterial may also affect our operations. The occurrence of any of these known or unknown risks might cause you
to lose all or part of your investment in the offered securities.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Risks Related to Our Company</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We have historically incurred significant
losses and our financial situation creates doubt whether we will continue as a going concern</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have historically
experienced operating and net losses and anticipate continuing to experience such losses in the future. For the years ended December
31, 2019 and 2018, we had an operating loss of $26,941,797 and $19,605,456 and net losses of $32,913,412 and $32,233,881, respectively.
As of December 31, 2019 and 2018, we had a working capital deficiency of $19,150,075 and $18,445,302, respectively. There are no
assurances that we will be able to achieve a level of revenues adequate to generate sufficient cash flow from operations or obtain
additional financing through private placements, public offerings and/or bank financing necessary to support our working capital
requirements. To the extent that funds generated from any private placements, public offerings and/or bank financing are insufficient,
we will have to raise additional working capital. No assurance can be given that additional financing will be available, or if
available, will be on acceptable terms. These conditions raise substantial doubt about our ability to continue as a going concern.
If adequate working capital is not available we may be forced to discontinue operations, which would cause investors to lose their
entire investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We
expect to continue to incur losses for the foreseeable future and need to raise additional capital to continue business development
initiatives and to support our working capital requirements. However, if we are unable to raise additional capital, we may be required
to curtail operations and take additional measures to reduce costs, including reducing our workforce, eliminating outside consultants
and reducing legal fees in order to conserve cash in amounts sufficient to sustain operations and meet our obligations. As a result
of these financing uncertainties, during the year ended December 31, 2019, we recognized that our dependence on ongoing capital
requirements to fund our operations raise substantial doubt about our ability to continue as a going concern. Our ongoing capital
requirements have only increased since then, meaning that substantial doubt about our ability to continue as a going concern remains
and will likely do so for the foreseeable future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>We will need
to raise additional capital to fund our operations in furtherance of our business plan.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Until
we are profitable, we will need to quickly raise additional capital in order to fund our operations in furtherance of our business
plan. The proposed financing may include shares of common stock, shares of preferred stock, warrants to purchase shares of common
stock or preferred stock, debt securities, units consisting of the foregoing securities, equity investments from strategic development
partners or some combination of each. Any additional equity financings may be financially dilutive to, and will be dilutive from
an ownership perspective to our stockholders, and such dilution may be significant based upon the size of such financing. Additionally,
we cannot assure that such funding will be available on a timely basis, in needed quantities, or on terms favorable to us, if at
all.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We have a certain amount of indebtedness.
This indebtedness and the covenants contained in our loan documents with senior creditors substantially limit our financial and
operating flexibility</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have entered into
a transaction document, pursuant to which we are constrained by certain security and similar agreements (the &ldquo;Transaction
Documents&rdquo;), with a senior lender (the &ldquo;Senior Lender&rdquo;). These Transaction Documents grant priority security
interests in all of our assets to the Senior Lender. Such Transaction Documents contain restrictions that substantially limit our
financial flexibility. These Transaction Documents place limits on our ability to (i) incur additional indebtedness even if such
indebtedness is subordinated to the debt instruments issued to the Senior Lenders or conduct an equity financing, and (ii) grant
security to third persons, among other matters. These restrictions limit the Company&rsquo;s ability to finance its future operations
and capital needs. Absent the consent of the Senior Lender, we would be unable to, among other things, obtain additional debt to
raise additional capital, implement our business strategy, establish corporate infrastructure and in any other way fund the development
of our business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>We face business
disruption and related risks resulting from the continuing impact of the novel coronavirus (&ldquo;COVID-19&rdquo;), which could
have a material adverse effect on our business and results of operations and curtail our ability to raise financing.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our business has been
disrupted and materially adversely affected by the recent outbreak of COVID-19. As a result of measures imposed by the governments
in affected regions, businesses and schools have been suspended due to quarantines intended to contain this outbreak and many people
have been forced to work from home in those areas. The spread of COVID-19 from China to other countries has resulted in the Director
General of the World Health Organization declaring the outbreak of COVID-19 as a Public Health Emergency of International Concern,
based on the advice of the Emergency Committee under the International Health Regulations (2005), and the Centers for Disease Control
and Prevention in the U.S. issued a warning on February 25, 2020 regarding the likely spread of COVID-19 to the U.S. While the
COVID-19 outbreak is still in its early stages, international stock markets have begun to reflect the uncertainty associated with
the slow-down in the American, Israeli and UK economies and the reduced levels of international travel experienced since the beginning
of January and the significant decline in the Dow Industrial Average at the end of February 2020 was largely attributed to the
effects of COVID-19. We are still assessing our business operations and system supports and the impact COVID-19 may have on our
results and financial condition, but there can be no assurance that this analysis will enable us to avoid part or all of any impact
from the spread of COVID-19 or its consequences, including downturns in business sentiment generally or in our sectors in particular.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="color: #333333">Our
operations are located in Alameda County, CA, Orange County, CA, Fairfield County, CT, the United Kingdom, Israel and members of
our senior management work in Seattle, WA and New York, NY, which is also the location of the </FONT>offices of the Company&rsquo;s
independent auditor<FONT STYLE="color: #333333">. </FONT>We have been following the recommendations of local health authorities
to minimize exposure risk for its employees for the past several weeks, including the temporary closures of our offices and having
employees work remotely to the extent possible<FONT STYLE="color: #333333">, which has to an extent adversely affected their efficiency.
</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Updates by business unit are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">DPW Holdings&rsquo; corporate headquarters, located in Newport Beach, CA, has begun working remotely,
based on the occupancy and social distancing order from the Orange County Health Officer (http://www.ochealthinfo.com/phs/about/epidasmt/epi/dip/prevention/novel_coronavirus).
The headquarters staff has tested the secure remote access systems and technology infrastructure to adjust working arrangements
for its employees and believes it has adequate internal communications system and can remain operational with a remote staff.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">Coolisys Technologies Corp., currently located in Milpitas, CA, decreased the number of its employees
working at its prior site in Fremont, CA for 14 weeks as a result of the Alameda County Public Health Department&rsquo;s order
to cease all activities at facilities located within the County.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">Microphase shut down its Shelton, CT production facility for a week in early December as a result
of positive COVID-19 tests among its employees for deep cleaning and is required to have all workers tested before gradually resuming
operations at the start of 2021. Microphase continues to follow CDC guidelines for social distancing, face coverings and heightened
sanitizing to keep the workforce safe and healthy. Microphase has strictly limited access to the facility and mandated that all
employees minimize exposure to the others. All Microphase employees who can work from home will do so while COVID-19 levels remain
high in the surrounding communities. Microphase management is working with state and federal authorities to get all employees vaccinated
on a priority basis as &ldquo;essential workers&rdquo; whom the U.S. Department of Defense have officially designated as &ldquo;critical
infrastructure workforce&rdquo; as part of the &ldquo;defense industrial base.&rdquo;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">Gresham Power Electronics shut down production operations in its Salisbury, UK facility from mid-March
2020 through June 2020 before resuming production until a subsequent shutdown in November 2020. Production operations will remain
closed down with the current lockdown until mid-February. However, engineers, back office staff and management have worked from
home throughout the pandemic period and continue to do so now. The pandemic has delayed contract actions and other customer decision
making, but Gresham Power expects these delays only to defer orders and business to rebound strongly with pent up demand in the
latter half of 2021.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">Relec has, notwithstanding the lockdown in the UK, experienced no COVID-19 related disruptions
and continues normal operations. All who can work from home do so. Others who must work at the Wareham site to move product or
access systems continue to do so under strict safety protocols with face coverings, social distancing and heightened attention
to sanitization. The principal impact on Relec&rsquo;s operations has come from deferral of some orders and modest decrease in
revenue year over year. Relec expects to business to rebound and resume a steady growth pattern in Q3 2021.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">Enertec Systems 2001 Ltd., located in Karmiel, Israel, has been granted a waiver by the Israeli
government to remain open to complete key projects that impact national security. Approximately 50% of the Enertec workforce is
working remotely.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Due to the unprecedented
market conditions domestically and internationally, and the effect COVID-19 has had and will continue to have on the Company&rsquo;s
operations and financial performance, the extent of which is not currently known, the Company is temporarily suspending guidance
for 2020. We will monitor the situation rigorously and provide business updates as circumstances warrant and resume providing guidance
on our business when management believes that such information would be both reliable and substantively informative.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; color: #212529">The
duration and extent of the impact from the COVID-19 pandemic depends on future developments that cannot be accurately predicted
at this time, such as the severity and transmission rate of the virus, the extent and effectiveness of containment actions and
the impact of these and other factors on our employees, customers, partners and vendors. If we are not able to respond to and manage
the impact of such events effectively, our business will be harmed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; color: #212529">As
noted above, we rely to a great extent on external financing to fund our operations. The outbreak of COVD-19 has had a materially
adverse impact on our ability to raise financing for our operations. Unless investors&rsquo; outlook improves dramatically in the
near future, it will further inhibit our ability to raise the funds we need to sustain our operations. No assurance can be given
that additional financing will be available, or if available, will be on acceptable terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;Our limited operating history
makes it difficult to evaluate our future business prospects and to make decisions based on our historical performance</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although our executive
officers have been engaged in the industries in which we operate for varying degrees of time, we did not begin operations of our
current business until recently. We have a very limited operating history in our current form, which makes it difficult to evaluate
our business on the basis of historical operations. As a consequence, it is difficult, if not impossible, to forecast our future
results based upon our historical data. Reliance on our historical results may not be representative of the results we will achieve,
and for certain areas in which we operate, principally those unrelated to defense contracting, will not be indicative at all. Because
of the uncertainties related to our lack of historical operations, we may be hindered in our ability to anticipate and timely adapt
to increases or decreases in sales, product costs or expenses. If we make poor budgetary decisions as a result of unreliable historical
data, we could be less profitable or incur losses, which may result in a decline in our stock price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>We have an evolving business model, which increases the complexity
of our business.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our business model
has evolved in the past and continues to do so. In prior years we have added additional types of services and product offerings
and in some cases we have modified or discontinued those offerings. We intend to continue to try to offer additional types of products
or services, and we do not know whether any of them will be successful. From time to time we have also modified aspects of our
business model relating to our product mix. We do not know whether these or any other modifications will be successful. The additions
and modifications to our business have increased the complexity of our business and placed significant strain on our management,
personnel, operations, systems, technical performance, financial resources, and internal financial control and reporting functions.
Future additions to or modifications of our business are likely to have similar effects. Further, any new business or website we
launch that is not favorably received by the market could damage our reputation or our brand. The occurrence of any of the foregoing
could have a material adverse effect on our business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We are a holding company whose subsidiaries
are given a certain degree of independence and our failure to integrate our subsidiaries may adversely affect our financial condition</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have given our subsidiary
companies and their executives a certain degree of independence in decision-making. On the one hand, this independence may increase
the sense of ownership at all levels, on the other hand it has also increased the difficulty of the integration of operation and
management, which has resulted in increased difficulty of management integration. In the event we are not able to successfully
manage our subsidiaries this will result in operating difficulties and have a negative impact on our business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>We and our independent auditors have expressed doubt about
our ability to continue as a going concern. If we do not continue as a going concern, investors will lose their entire investment</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In its report on our
financial statements included in our Annual Report for the fiscal year ended December 31, 2019, our independent auditors have expressed
doubt about our ability to continue as a going concern. Our ability to continue as a going concern is an issue raised as a result
of ongoing operating losses and a lack of financing commitments then in place to meet expected cash requirements. Our ability to
continue as a going concern is subject to our ability to generate a profit and/or obtain necessary funding from outside sources,
including obtaining additional funding from the sale of our securities, increasing sales or obtaining loans and grants from various
financial institutions where possible. If we do not continue as a going concern, investors will lose their entire investment.</P>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We received an order and a subpoena
from the SEC in the investigation now known as &ldquo;<I>In the Matter of DPW Holdings, Inc</I></B>.<B><I>,&rdquo;</I> the consequences
of which are unknown.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We received an order
and related subpoena from the SEC that stated that the staff of the SEC is conducting an investigation now known as&nbsp;<I>&ldquo;In
the Matter of DPW Holdings, Inc.</I>,&rdquo; and that the subpoena was issued as part of an investigation as to whether we and
certain of our officers, directors, employees, partners, subsidiaries and/or affiliates, and/or other persons or entities, directly
or indirectly, violated certain provisions of the Securities Act and the Exchange Act, in connection with the offer and sale of
our securities. Although the order states that the SEC may have information relating to such alleged violations, the subpoena expressly
provides that the inquiry is not to be construed as an indication by the SEC or its staff that any violations of the federal securities
laws have occurred. We have produced documents in response to the subpoena. The SEC may in the future require us to produce additional
documents or information, or seek testimony from other members of our management team.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are unaware of the
scope or timing of the SEC&rsquo;s investigation. As a result, we do not know how the SEC&rsquo;s investigation is proceeding,
when the investigation will be concluded. We also are unable to predict what action, if any, might be taken in the future by the
SEC or its staff as a result of the matters that are the subject to its investigation or what impact, if any, the cost of continuing
to respond to subpoenas might have on our financial position, results of operations, or cash flows. We have not established any
provision for losses in respect of this matter In addition, complying with any such future requests by the SEC for documents or
testimony could distract the time and attention of our officers and directors or divert our resources away from ongoing business
matters. This investigation could result in significant legal expenses, the diversion of management&rsquo;s attention from our
business, damage to our business and reputation, and could subject us to a wide range of remedies, including an enforcement action
by the SEC. There can be no assurance that any final resolution of this and any similar matters will not have a material adverse
effect on our financial condition or results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;<B>Our inability to successfully integrate new acquisitions
could adversely affect our combined business; our operations are widely disbursed.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Our
growth strategy through acquisitions is subject to various risks. On June 2, 2017, we acquired a majority interest in Microphase
and on May 23, 2018 we acquired Enertec Systems 2001 Ltd. (&ldquo;Enertec&rdquo;). Further, on November 30, 2020, Gresham Worldwide
acquired Relec Electronics Ltd. from its present shareholders. Our strategy and business plan are dependent on our ability to successfully
integrate Microphase&rsquo;s, Enertec&rsquo;s and our other acquired entities&rsquo; operations. In addition, while we are based
in Newport Beach, CA, Microphase&rsquo;s operations are located in Shelton, Connecticut, Enertec&rsquo;s operations are located
in Karmiel, Israel and Gresham Power&rsquo;s operations are located in Salisbury, England. These distant locations and others that
we may become involved with in the future will stretch our resources and management time. Further, failure to quickly and adequately
integrate all of these operations and personnel could adversely affect our combined business and our ability to achieve our objectives
and strategy. No assurance can be given that we will realize synergies in the areas we currently operate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>If we make any additional acquisitions, they may disrupt
or have a negative impact on our business.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have plans to eventually
make additional acquisitions beyond Microphase, Enertec and Relec.&nbsp;Whenever we make acquisitions, we could have difficulty
integrating the acquired companies&rsquo; personnel and operations with our own. In addition, the key personnel of the acquired
business may not be willing to work for us. We cannot predict the effect expansion may have on our core business. Regardless of
whether we are successful in making an acquisition, the negotiations could disrupt our ongoing business, distract our management
and employees and increase our expenses. In addition to the risks described above, acquisitions are accompanied by a number of
inherent risks, including, without limitation, the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD>difficulty of integrating acquired products, services or operations;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD>potential disruption of the ongoing businesses and distraction of our management and the management of acquired companies;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD>difficulty of incorporating acquired rights or products into our existing business;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD>difficulties in disposing of the excess or idle facilities of an acquired company or business and expenses in maintaining such
facilities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD>difficulties in maintaining uniform standards, controls, procedures and policies;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1pt 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1pt 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD>potential impairment of relationships with employees and customers as a result of any integration of new management personnel;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD>potential inability or failure to achieve additional sales and enhance our customer base through cross-marketing of the products
to new and existing customers;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD>effect of any government regulations which relate to the business acquired; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD>potential unknown liabilities associated with acquired businesses or product lines, or the need to spend significant amounts
to retool, reposition or modify the marketing and sales of acquired products or the defense of any litigation, whether or not successful,
resulting from actions of the acquired company prior to our acquisition.&nbsp;&nbsp;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our business could
be severely impaired if and to the extent that we are unable to succeed in addressing any of these risks or other problems encountered
in connection with these acquisitions, many of which cannot be presently identified, these risks and problems could disrupt our
ongoing business, distract our management and employees, increase our expenses and adversely affect our results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>No assurance can be given as to the successful expansion
of our operations.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our significant increase
in the scope and the scale of our operations, including the hiring of additional personnel, has resulted in significantly higher
operating expenses. We anticipate that our operating expenses will continue to increase. Expansion of our operations may also make
significant demands on our management, finances and other resources. Our ability to manage the anticipated future growth, should
it occur, will depend upon a significant expansion of our accounting and other internal management systems and the implementation
and subsequent improvement of a variety of systems, procedures and controls. We cannot assure that significant problems in these
areas will not occur. Failure to expand these areas and implement and improve such systems, procedures and controls in an efficient
manner at a pace consistent with our business could have a material adverse effect on our business, financial condition and results
of operations. We cannot assure that attempts to expand our marketing, sales, manufacturing and customer support efforts will succeed
or generate additional sales or profits in any future period. As a result of the expansion of our operations and the anticipated
increase in our operating expenses, along with the difficulty in forecasting revenue levels, we expect to continue to experience
significant fluctuations in its results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We may be unable to successfully expand
our production capacity, which could result in material delays, quality issues, increased costs and loss of business opportunities,
which may negatively impact our product margins and profitability</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Part of our future
growth strategy is to increase our production capacity to meet increasing demand for our goods. Assuming we obtain sufficient funding
to increase our production capacity, any projects to increase such capacity may not be constructed on the anticipated timetable
or within budget. We may also experience quality control issues as we implement any production upgrades. Any material delay in
completing these projects, or any substantial cost increases or quality issues in connection with these projects could materially
delay our ability to bring our products to market and adversely affect our business, reduce our revenue, income and available cash,
all of which could harm our financial condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>If we fail to establish and maintain
an effective system of internal control over financial reporting, we may not be able to report our financial results accurately
or prevent fraud. Any inability to report and file our financial results accurately and timely could harm our reputation and adversely
impact the trading price of our common stock.&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Effective internal
control over financial reporting is necessary for us to provide reliable financial reports and prevent fraud. If we cannot provide
reliable financial reports or prevent fraud, we may not be able to manage our business as effectively as we would if an effective
control environment existed, and our business and reputation with investors may be harmed. As a result, our small size and any
current internal control deficiencies may adversely affect our financial condition, results of operations and access to capital.
We have carried out an evaluation under the supervision and with the participation of our management, including our principal executive
officer and principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures
as of the end of the most recent period covered by this report. Based on the foregoing, our principal executive officer and principal
financial officer concluded that our disclosure controls and procedures were not effective at the reasonable assurance level due
to the material weaknesses described below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">A
material weakness is a deficiency, or a combination of deficiencies, within the meaning of Public Company Accounting Oversight
Board (&ldquo;PCAOB&rdquo;) Audit Standard No. 5, in internal control over financial reporting, such that there is a reasonable
possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely
basis. Management has identified the following material weaknesses which have caused management to conclude that as of December
31, 2019, our internal control over financial reporting (&ldquo;ICFR&rdquo;) was not effective at the reasonable assurance level:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">1.</TD><TD STYLE="text-align: justify">We do not have sufficient resources in our accounting function, which restricts our ability to
gather, analyze and properly review information related to financial reporting, including fair value estimates, in a timely manner.
In addition, due to our size and nature, segregation of all conflicting duties may not always be possible and may not be economically
feasible. However, to the extent possible, the initiation of transactions, the custody of assets and the recording of transactions
should be performed by separate individuals. Management evaluated the impact of our failure to have segregation of duties during
our assessment of our disclosure controls and procedures and concluded that the control deficiency that resulted represented a
material weakness.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2.25pt; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">2.</TD><TD>We have inadequate controls to ensure that information necessary to properly record transactions is adequately communicated
on a timely basis from non-financial personnel to those responsible for financial reporting. Management evaluated the impact of
the lack of timely communication between non&ndash;financial and financial personnel on our assessment of our reporting controls
and procedures and has concluded that the control deficiency represented a material weakness.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">3.</TD><TD>We did not design or maintain effective general information technology (&ldquo;IT&rdquo;) controls over certain information
systems that are relevant to the mitigation of the risk pertaining to the misappropriation of assets. Specifically, we did not
design and implement p<FONT STYLE="background-color: white">rogram change management controls for certain financially relevant
systems to ensure that IT program and data changes affecting the Company&rsquo;s (i) financial IT applications, (ii) digital currency
mining equipment, (iii) digital currency hardware wallets, and (iv) underlying accounting records, are identified, tested, authorized
and implemented appropriately.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><I>Planned Remediation</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Management,
in coordination with the input, oversight and support of our board of directors, has identified the measures below to strengthen
our control environment and internal control over financial reporting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">In
January 2018, we hired a new Chief Financial Officer and engaged the services of a financial accounting advisory firm. In September
2018, we hired a Chief Accounting Officer and in January 2019, we hired a Senior Vice President of Finance. Finally, in May 2019,
we hired an Executive Vice President and General Counsel. We have tasked these individuals with expanding and monitoring the Company&rsquo;s
internal controls, to provide an additional level of review of complex financial issues and to assist with financial reporting.
On October 7, 2019, we created an Executive Committee comprised of our Chief Executive Officer, President and Executive Vice President
and General Counsel. The Executive Committee meets on a daily basis to address the Company&rsquo;s critical needs and provide a
forum to approve transactions. On December 16, 2020, we engaged Moss Adams LLP to further assist in our compliance with Section
404 of the Sarbanes-Oxley Act of 2002 and to identify internal control process improvement opportunities. Further, as we continue
to expand our internal accounting department, the Chairman of the Audit Committee will:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">assist with documentation and implementation of policies and procedures and monitoring of controls;
and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">review all anticipated transactions that are not considered in the ordinary course of business
to assist in the early identification of accounting issues and ensure that appropriate disclosures are made in our financial statements.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We
are currently working to improve and simplify our internal processes and implement enhanced controls, as discussed above, to address
the material weaknesses in our internal control over financial reporting and to remedy the ineffectiveness of our disclosure controls
and procedures. These material weaknesses will not be considered to be remediated until the applicable remediated controls are
operating for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>If our accounting
controls and procedures are circumvented or otherwise fail to achieve their intended purposes, our business could be seriously
harmed.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We
evaluate our disclosure controls and procedures as of the end of each fiscal quarter, and are annually reviewing and evaluating
our internal control over financial reporting in order to comply with the SEC&rsquo;s rules relating to internal control over financial
reporting adopted pursuant to the Sarbanes-Oxley Act of 2002. Because of its inherent limitations, internal control over financial
reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject
to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies
or procedures may deteriorate. If we fail to maintain effective internal control over financial reporting or our management does
not timely assess the adequacy of such internal control, we may be subject to regulatory sanctions, and our reputation may decline.</P>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>We face significant competition, including changes in pricing.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The markets for our
products are both competitive and price sensitive. Many competitors have significant financial, operations, sales and marketing
resources, plus experience in research and development, and compete with us by offering lower prices. Competitors could develop
new technologies that compete with our products to achieve a lower unit price. If a competitor develops lower cost superior technology
or cost-effective alternatives to our products and services, our business could be seriously harmed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The markets for some
of our products are also subject to specific competitive risks because these markets are highly price competitive. Our competitors
have competed in the past by lowering prices on certain products. If they do so again, we may be forced to respond by lowering
our prices. This would reduce sales revenues and increase losses. Failure to anticipate and respond to price competition may also
impact sales and aggravate losses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Many of our competitors are larger and
have greater financial and other resources than we do.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our products compete
and will compete with similar if not identical products produced by our competitors. These competitive products could be marketed
by well-established, successful companies that possess greater financial, marketing, distribution personnel, and other resources
than we do. Using said resources, these companies can implement extensive advertising and promotional campaigns, both generally
and in response to specific marketing efforts by competitors. They can introduce new products to new markets more rapidly. In certain
instances, competitors with greater financial resources may be able to enter a market in direct competition with us, offering attractive
marketing tools to encourage the sale of products that compete with our products or present cost features that consumers may find
attractive.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>Our growth strategy is subject to
a significant degree of risk.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Our
growth strategy through acquisitions involves a significant degree of risk. Some of the companies that we have identified as acquisition
targets or make a significant investment in may not have a developed business or are experiencing inefficiencies and incur losses.
Therefore, we may lose our investment in the event that these companies&rsquo; businesses do not develop as planned or that we
are unable to achieve the cost efficiencies or reduction of losses as anticipated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Further,
in order to implement our growth plan, we have hired additional staff and consultants to review potential investments and implement
our plan. As a result, we have substantially increased our infrastructure and costs. If we fail to quickly find new companies that
provide revenue to offset our costs, we will continue to experience losses. No assurance can be given that our product development
and investments will produce sufficient revenues to offset these increases in expenditures.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Our business and operations are growing
rapidly. If we fail to effectively manage our growth, our business and operating results could be harmed</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have experienced,
and may continue to experience, rapid growth in our operations. This has placed, and may continue to place, significant demands
on our management, operational and financial infrastructure. If we do not manage our growth effectively, the quality of our products
and services could suffer, which could negatively affect our operating results. To effectively manage our growth, we must continue
to improve our operational, financial and management controls and reporting systems and procedures. These systems improvements
may require significant capital expenditures and management resources. Failure to implement these improvements could hurt our ability
to manage our growth and our financial position.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>We are heavily dependent on our senior management, and a
loss of a member of our senior management team could cause our stock price to suffer</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we lose the services
of Milton C. Ault III, our Executive Chairman, William B. Horne, our Chief Executive Officer, or Henry Nisser, our President and
General Counsel, and/or certain key employees, we may not be able to find appropriate replacements on a timely basis, and our business
could be adversely affected. Our existing operations and continued future development depend to a significant extent upon the performance
and active participation of these individuals and certain key employees. Although we have entered into employment agreements with
Messrs. Ault, Horne and Nisser, and we may enter into employment agreements with additional key employees in the future, we cannot
guarantee that we will be successful in retaining the services of these individuals. If we were to lose any of these individuals,
we may not be able to find appropriate replacements on a timely basis and our financial condition and results of operations could
be materially adversely affected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We rely on highly skilled personnel
and the continuing efforts of our executive officers and, if we are unable to retain, motivate or hire qualified personnel, our
business may be severely disrupted.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our performance largely
depends on the talents, knowledge, skills, know-how and efforts of highly skilled individuals and in particular, the expertise
held by our Executive Chairman, Milton C. Ault III. His absence, were it to occur, would materially and adversely impact development
and implementation of our projects and businesses. Our future success depends on our continuing ability to identify, hire, develop,
motivate and retain highly skilled personnel for all areas of our organization. Our continued ability to compete effectively depends
on our ability to attract, among others, new technology developers and to retain and motivate our existing contractors. If one
or more of our executive officers are unable or unwilling to continue in their present positions, we may not be able to replace
them readily, if at all. Therefore, our business may be severely disrupted, and we may incur additional expenses to recruit and
retain new officers. In addition, if any of our executives joins a competitor or forms a competing company, we may lose some customers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Our operating results may vary from quarter to quarter.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our operating results
have in the past been subject to quarter-to-quarter fluctuations, and we expect that these fluctuations will continue, and may
increase in magnitude, in future periods. Demand for our products is driven by many factors, including the availability of funding
for our products in our customers&rsquo; capital budgets. There is a trend for some of our customers to place large orders near
the end of a quarter or fiscal year, in part to spend remaining available capital budget funds. Seasonal fluctuations in customer
demand for our products driven by budgetary and other concerns can create corresponding fluctuations in period-to-period revenues,
and we therefore cannot assure you that our results in one period are necessarily indicative of our revenues in any future period.
In addition, the number and timing of large individual sales and the ability to obtain acceptances of those sales, where applicable,
have been difficult for us to predict, and large individual sales have, in some cases, occurred in quarters subsequent to those
we anticipated, or have not occurred at all. The loss or deferral of one or more significant sales in a quarter could harm our
operating results for such quarter. It is possible that, in some quarters, our operating results will be below the expectations
of public market analysts or investors. In such events, or in the event adverse conditions prevail, the market price of our common
stock may decline significantly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>We may be classified as an inadvertent investment company.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are not engaged
in the business of investing, reinvesting, or trading in securities, and we do not hold ourselves out as being engaged in those
activities. Under the Investment Company Act, however, a company may be deemed an investment company under section 3(a)(1)(C) of
the Investment Company Act if the value of its investment securities is more than 40% of its total assets (exclusive of government
securities and cash items) on a consolidated basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our lending subsidiary,
Digital Power Lending, LLC (&ldquo;DP Lending&rdquo;), operates under California Finance Lending License #60DBO-77905. Per the
Investment Company Act of 1940 companies with substantially all their business confined to making small loans, industrial banking
or similar business, such as DP Lending, are excluded from the definition of an investment company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As Rule 3a-2 is available
to a company no more than once every three years, and assuming no other exclusion were available to us, we would have to keep within
the 40% limit for at least three years after we cease being an inadvertent investment company. This may limit our ability to make
certain investments or enter into joint ventures that could otherwise have a positive impact on our earnings. In any event, we
do not intend to become an investment company engaged in the business of investing and trading securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Classification as an
investment company under the Investment Company Act requires registration with the SEC. If an investment company fails to register,
it would have to stop doing almost all business, and its contracts would become voidable. Registration is time consuming and restrictive
and would require a restructuring of our operations, and we would be very constrained in the kind of business we could do as a
registered investment company. Further, we would become subject to substantial regulation concerning management, operations, transactions
with affiliated persons and portfolio composition, and would need to file reports under the Investment Company Act regime. The
cost of such compliance would result in our incurring substantial additional expenses, and the failure to register if required
would have a materially adverse impact to conduct our operations.</P>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We will not be able to successfully
execute our business strategy if we are deemed to be an investment company under the Investment Company Act.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">U.S. companies that
have more than 100 stockholders or are publicly traded in the U.S. and are, or hold themselves out as being, engaged primarily
in the business of investing, reinvesting or trading in securities are subject to regulation under the Investment Company Act.&nbsp;
Unless a substantial part of our assets consists of, and a substantial part of our income is derived from, interests in majority-owned
subsidiaries and companies that we primarily control, we may be required to register and become subject to regulation under the
Investment Company Act.&nbsp; If we were deemed to own but not operate one or more of our other subsidiaries, we would have difficulty
avoiding classification and regulation as an investment company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we were deemed to
be, and were required to register as, an investment company, we would be forced to comply with substantive requirements under the
Investment Company Act, including limitations on our ability to borrow, limitations on our capital structure; restrictions on acquisitions
of interests in associated companies, prohibitions on transactions with affiliates, restrictions on specific investments, and compliance
with reporting, record keeping, voting, proxy disclosure and other rules and regulations.&nbsp; If we were forced to comply with
the rules and regulations of the Investment Company Act, our operations would significantly change, and we would be prevented from
successfully executing our business strategy.&nbsp; To avoid regulation under the Investment Company Act and related rules promulgated
by the SEC, we could need to sell bitcoin and other assets which we would otherwise want to retain and could be unable to sell
assets which we would otherwise want to sell.&nbsp; In addition, we could be forced to acquire additional, or retain existing,
income-generating or loss-generating assets which we would not otherwise have acquired or retained and could need to forgo opportunities
to acquire bitcoin and other assets that would benefit our business.&nbsp; If we were forced to sell, buy or retain assets in this
manner, we could be prevented from successfully executing our business strategy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Securitization of our assets subjects us to various risks</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may securitize assets
to generate cash for funding new investments. We refer to the term securitize to describe a form of leverage under which a company
(sometimes referred to as an &ldquo;originator&rdquo; or &ldquo;sponsor&rdquo;) transfers income producing assets to a single-purpose,
bankruptcy-remote subsidiary (also referred to as a &ldquo;special purpose entity&rdquo; or &ldquo;SPE&rdquo;), which is established
solely for the purpose of holding such assets and entering into a structured finance transaction. The SPE would then issue notes
secured by such assets. The special purpose entity may issue the notes in the capital markets either publicly or privately to a
variety of investors, including banks, non-bank financial institutions and other investors. There may be a single class of notes
or multiple classes of notes, the most senior of which carries less credit risk and the most junior of which may carry substantially
the same credit risk as the equity of the SPE.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">An important aspect
of most debt securitization transactions is that the sale and/or contribution of assets into the SPE be considered a true sale
and/or contribution for accounting purposes and that a reviewing court would not consolidate the SPE with the operations of the
originator in the event of the originator's bankruptcy based on equitable principles. Viewed as a whole, a debt securitization
seeks to lower risk to the note purchasers by isolating the assets collateralizing the securitization in an SPE that is not subject
to the credit and bankruptcy risks of the originator. As a result of this perceived reduction of risk, debt securitization transactions
frequently achieve lower overall leverage costs for originators as compared to traditional secured lending transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In accordance with
the above description, to securitize loans, we may create a wholly owned subsidiary and contribute a pool of our assets to such
subsidiary. The SPE may be funded with, among other things, whole loans or interests from other pools and such loans may or may
not be rated. The SPE would then sell its notes to purchasers whom we would expect to be willing to accept a lower interest rate
and the absence of any recourse against us to invest in a pool of income producing assets to which none of our creditors would
have access. We would retain all or a portion of the equity in the SPE. An inability to successfully securitize portions of our
portfolio or otherwise leverage our portfolio through secured and unsecured borrowings could limit our ability to grow our business
and fully execute our business strategy, and could decrease our earnings, if any. However, the successful securitization of portions
of our portfolio exposes us to a risk of loss for the equity we retain in the SPE and might expose us to greater risk on our remaining
portfolio because the assets we retain may tend to be those that are riskier and more likely to generate losses. A successful securitization
may also impose financial and operating covenants that restrict our business activities and may include limitations that could
hinder our ability to finance additional loans and investments. The Investment Company Act may also impose restrictions on the
structure of any securitizations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Interests we hold in
the SPE, if any, will be subordinated to the other interests issued by the SPE. As such, we will only receive cash distributions
on such interests if the SPE has made all cash interest and other required payments on all other interests it has issued. In addition,
our subordinated interests will likely be unsecured and rank behind all of the secured creditors, known or unknown, of the SPE,
including the holders of the senior interests it has issued. Consequently, to the extent that the value of the SPE's portfolio
of assets has been reduced as a result of conditions in the credit markets, or as a result of defaults, the value of the subordinated
interests we retain would be reduced. Securitization imposes on us the same risks as borrowing except that our risk in a securitization
is limited to the amount of subordinated interests we retain, whereas in a borrowing or debt issuance by us directly we would be
at risk for the entire amount of the borrowing or debt issuance.</P>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may also engage
in transactions utilizing SPEs and securitization techniques where the assets sold or contributed to the SPE remain on our balance
sheet for accounting purposes. If, for example, we sell the assets to the SPE with recourse or provide a guarantee or other credit
support to the SPE, its assets will remain on our balance sheet. Consolidation would also generally result if we, in consultation
with the SEC, determine that consolidation would result in a more accurate reflection of our assets, liabilities and results of
operations. In these structures, the risks will be essentially the same as in other securitization transactions but the assets
will remain our assets for purposes of the limitations described above on investing in assets that are not qualifying assets and
the leverage incurred by the SPE will be treated as borrowings incurred by us for purposes of our limitation on the issuance of
senior securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>We may not be able to utilize our net operating loss carry
forwards.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At December 31, 2019,
we had federal net operating loss carry forwards (&ldquo;NOLs&rdquo;) for income tax purposes of approximately $52,884,756. Approximately
$12,302,381 of NOLs generated prior to 2018 has begun to expire in 2020. The Coronavirus Aid, Relief, and Economic Security Act
signed in to law on March 27, 2020 provided that NOLs generated in a taxable year beginning in 2018, 2019, or 2020, may now be
carried back five years and forward indefinitely. In addition, the 80% taxable income limitation is temporarily removed, allowing
NOLs to fully offset net taxable income. However, we do not know if or when we will have any earnings and capital gains against
which we could apply these carry forwards.&nbsp; Furthermore, as a result of changes in the ownership of our common stock, our
ability to use our federal NOLs will be limited under Internal Revenue Code Section 382.&nbsp; State NOLs are subject to similar
limitations in many cases.&nbsp; As a result, our substantial NOLs may not have any value to us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Changes in the U.S. tax and other laws and regulations may
adversely affect our business.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The U.S. government
may revise tax laws, regulations or official interpretations in ways that could have a significant adverse effect on our business,
including modifications that could reduce the profits that we can effectively realize from our international operations, or that
could require costly changes to those operations, or the way in which they are structured.&nbsp; For example, the effective tax
rates for most U.S. companies reflect the fact that income earned and reinvested outside the U.S. is generally taxed at local rates,
which may be much lower than U.S. tax rates.&nbsp; If we expand abroad and there are changes in tax laws, regulations or interpretations
that significantly increase the tax rates on non-U.S. income, our effective tax rate could increase and our profits could be reduced.&nbsp;
If such increases resulted from our status as a U.S. company, those changes could place us at a disadvantage to our non-U.S. competitors
if those competitors remain subject to lower local tax rates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Risks Related to Related Party Transactions</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There may be conflicts
of interest between our company and certain of our related parties and their respective directors and officers which might not
be resolved in our favor. More importantly, there may be conflicts between certain of our related parties and their respective
directors and officers which might not be resolved in our favor. These risks are set forth below appurtenant to the relevant related
party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Ault &amp; Company</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Our relationship with Ault &amp; Company
may enhance the difficulty inherent in obtaining financing for us as well as expose us to certain conflicts of interest.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of the date of this
prospectus, Ault &amp; Company, of which Milton C. Ault is the chief executive officer, beneficially owned 1,362,795 shares of
our common stock, consisting of 1,078,967 shares owned, 275,862 shares of common stock underlying the 8% Convertible Promissory
Note in the outstanding principal amount of $400,000 sold by us to Ault &amp; Company on February 5, 2020, assuming no conversion
of accrued, unpaid interest on this note, warrants to purchase 94 shares of common stock that are currently exercisable and shares
owned by Philou Ventures, of which Ault &amp; Company, Inc. is the Manager, consisting of: (i) 125,000 shares of Series B Preferred
Stock that are convertible into 2,232 shares of common stock, (ii) warrants to purchase 2,232 shares of common stock that are exercisable
within 60 days of the date hereof and (iii) 3,408 shares of common stock. Assuming Ault &amp; Company converted its note on the
date of this prospectus, Ault &amp; Company would own a number of shares of common stock equal to 4.9% of the number of shares
of common stock on the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Further, Ault &amp;
Company and our company are negotiating the terms of a proposed purchase by Ault &amp; Company of a certain number of shares of
Series C Preferred Stock. Presently, neither the number nor the terms of any such Series C Preferred Stock has been determined,
and any such purchase would have to be approved by our stockholders before Ault &amp; Company would be able to vote or convert
such shares of Series C Preferred Stock. Notwithstanding the presently indeterminate nature of any such acquisition of Series Preferred
Stock, you should be aware that the consummation of such a transaction, assuming the receipt by the Company of its stockholders
approval thereof, could substantially increase Ault &amp; Company&rsquo;s beneficial ownership of our shares of common stock.</P>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Given the close relationship
between Ault &amp; Company on the one hand, and our company on the other, it is far from inconceivable that we could enter into
additional securities purchase agreements with Ault &amp; Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although we have relied
on Philou, which no longer beneficially owns any meaningful number of our shares of common stock, to finance us in the past, and
anticipate that Ault &amp; Company may purchase shares of our Series C Preferred Stock under an agreement providing for the purchase
thereof, we cannot assure you that either Philou or Ault &amp; Company will assist us in the future. We would far prefer to rely
on these entities&rsquo; assistance compared to other sources of financing as the terms they provide us are in general more favorable
to us than we could obtain elsewhere. However, Messrs. Ault, Horne and Nisser could face a conflict of interest in that they serve
on the board of directors of each of Ault &amp; Company and our company. If they determine that an investment in our company is
not in Ault &amp; Company&rsquo;s best interest, we could be forced to seek financing from other sources that would not necessarily
be likely to provide us with equally favorable terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Other conflicts of
interest between us, on the one hand, and Ault &amp; Company, on the other hand, may arise relating to commercial or strategic
opportunities or initiatives. Mr. Ault, as the controlling shareholder of Ault &amp; Company, may not resolve such conflicts in
our favor. For example, we cannot assure you that Ault &amp; Company would not pursue opportunities to provide financing to other
entities whether or not it currently has a relationship with such other entities. Furthermore, our ability to explore alternative
sources of financing other than Ault &amp; Company may be constrained due to Mr. Ault&rsquo;s vision for us and he may not wish
for us to receive any financing at all other than from entities that he controls.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Alzamend Neuro, Inc.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Our relationship with Alzamend Neuro
may expose us to certain conflicts of interest.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1pt; text-align: justify; text-indent: 0.5in">In August 2020,
Alzamend Neuro entered into a securities purchase agreement with our company to sell a convertible promissory note of Alzamend
Neuro, in the aggregate principal amount of $50,000 and issue a 5-year warrant to purchase 16,667 of shares of its common stock.
The convertible promissory note bears interest at 8% per annum, which principal and all accrued and unpaid interest are due six
months after the date of issuance. The principal and interest earned on the convertible promissory note may be converted into shares
of the Alzamend Neuro&rsquo;s common stock at $1.50 per share. The exercise price of the warrant is $3.00 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In December 2020, we
provided Alzamend Neuro $1,000,000 in short-term advances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Messrs. Ault, Horne
and Nisser could face a conflict of interest in that they serve on the board of directors of each of Alzamend Neuro and our company.
Mr. Cragun, our chief financial officer, is also the chief financial officer of Alzamend Neuro.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Avalanche International Corp</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We have lent a substantial amount of
funds to Avalanche, a related party, whose ability to repay us is subject to significant doubt and it may not be in our stockholders&rsquo;
best interest to convert the notes into shares of Avalanche common stock even if we had a reasonably viable means of doing so.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On September 6, 2017,
we entered into a Loan and Security Agreement with Avalanche (&ldquo;AVLP Loan Agreement&rdquo;) with an effective date of August
21, 2017 pursuant to which we will provide Avalanche a non-revolving credit facility of up to $10,000,000 for a period ending on
August 21, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At September 30, 2020,
we had provided Avalanche with $10,153,661 pursuant to the non-revolving credit facility. The warrants issued in conjunction with
the non-revolving credit facility entitles us to purchase up to 20,306,921 shares of Avalanche common stock at an exercise price
of $0.50 per share for a period of five years. The exercise price of $0.50 is subject to adjustment for customary stock splits,
stock dividends, combinations or similar events. The warrants may be exercised for cash or on a cashless basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There is currently
no liquid market for the Avalanche common stock. Consequently, even if we were inclined to convert the debt owed us by Avalanche
into shares of its common stock, our ability to sell such shares is severely limited. Avalanche is not current in its filings with
the SEC and is not required to register the shares of its common stock underlying the amount provided pursuant to the non-revolving
credit facility or any other loan arrangement we have made with Avalanche described above. Further, even if Avalanche were willing
to register such shares, it would not be permitted to do so until it has registered the shares of its common stock underlying the
Third Party Note.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a result, there
is considerable doubt as to whether Avalanche will ever have the ability to repay its debts to us, or if we convert the debt owed
us by Avalanche into shares of its common stock, our ability to convert such shares into cash through the sale of such shares would
be severely limited until such time, if ever, a liquid market for Avalanche&rsquo;s common stock develops. If we are unable to
recoup our investment in Avalanche in the foreseeable future or at all, such failure would have a materially adverse effect on
our financial condition and future prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Originally, the loans we made to Avalanche
were secured by a lien on all of Avalanche&rsquo;s assets. Presently, we only have third priority interest.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Originally, the loans
we made to Avalanche were secured by a lien on all of Avalanche&rsquo;s assets. When Avalanche entered into the Exchange Agreement
with MTIX (see below), the former owners of MTIX were granted a first priority interest in all of MTIX&rsquo;s assets, which constitute
virtually all of Avalanche&rsquo;s assets and reduced our interest to that of a second position, greatly diminishing its value.
When Avalanche issued the Third Party Note referred to above, it granted the third party a first priority security interest in
all its assets, to include those comprised of MTIX. Both we and the former owners of MTIX consented to the subordination of our
respective security interests. Since our security interests have been reduced to a third position, we will have no ability to use
Avalanche&rsquo;s assets to offset any default in Avalanche&rsquo;s debt obligations to us unless and until the two other security
interests are terminated, which would not occur until Avalanche&rsquo;s debts to the senior creditors have been repaid. We do not
anticipate that Avalanche will repay its debts to these creditors within the foreseeable future and will therefore have no recourse
should Avalanche default on its debts to us during this period of time. Any failure by Avalanche to repay us would therefore have
a materially adverse effect on our results of operations, financial condition and future prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Milton C. Ault, III and William Horne,
our Executive Chairman and Chief Executive Officer, respectively, and two of our directors are directors of Avalanche. In addition,
Philou is the controlling stockholder of Avalanche.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Milton C. Ault, III
and William Horne, our Executive Chairman and Chief Executive Officer, respectively, and two of our directors are directors of
Avalanche. In addition, Philou is the controlling stockholder of Avalanche. Certain conflicts of interest between us, on the one
hand, and Avalanche, on the other hand, may arise relating to commercial or strategic opportunities or initiatives, in addition
to the conflicts related to the debt that Avalanche owes us. For example, Messrs. Ault and Horne may find it difficult to determine
how to meet their fiduciary duties to us as well as Avalanche, which could result in a less favorable result for us than would
be the case if they were solely directors of our company. Further, even if Messrs. Ault and Horne were able to successfully meet
their fiduciary obligations to us and Avalanche, the fact that are members of the board of directors of both companies could attenuate
their ability to focus on our business and best interests, possibly to the detriment of both companies. Mr. Ault&rsquo;s control
of Philou through Ault &amp; Company only enhances the risk inherent in having Messrs. Ault and Horne serve as directors of both
our company and Avalanche.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Risks Related to Our Business and Industry - Overview</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Technology changes rapidly in our business,
and if we fail to anticipate new technologies, the quality, timeliness and competitiveness of our products will suffer.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Rapid technology changes
in our industry require us to anticipate, sometimes years in advance, which technologies and/or distribution platforms our products
must take advantage of in order to make them competitive in the market at the time they are released. Therefore, we usually start
our product development with a range of technical development goals that we hope to be able to achieve. We may not be able to achieve
these goals, or our competition may be able to achieve them more quickly than we can. In either case, our products may be technologically
inferior to competitive products, or less appealing to consumers, or both. If we cannot achieve our technology goals within the
original development schedule of our products, then we may delay products until these technology goals can be achieved, which may
delay or reduce revenue and increase our development expenses. Alternatively, we may increase the resources employed in research
and development in an attempt to accelerate our development of new technologies, either to preserve our product launch schedule
or to keep up with our competition, which would increase our development expenses and adversely affect our operations and financial
condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We are dependent upon our ability, and
our contract manufacturers&rsquo; ability, to timely procure electronic components.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Because of the global
economy, many raw material vendors have reduced capacities, closed production lines and, in some cases, even discontinued their
operations. As a result, there is a global shortage of certain electronic or mineral components, which may extend our production
lead-time and our production costs. Some materials are no longer available to support some of our products, thereby requiring us
to search for cross materials or, even worse, redesign some of our products to support currently-available materials. Such redesign
efforts may require certain regulatory and safety agency re-submittals, which may cause further production delays. While we have
initiated actions that we believe will limit our exposure to such problems, the dynamic business conditions in many of our markets
may challenge the solutions that have been put in place, and issues may recur in the future.</P>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, some of
our products are manufactured, assembled and tested by third party subcontractors and contract manufacturers located in Asia. While
we have had relationships with many of these third parties in the past, we cannot predict how or whether these relationships will
continue in the future. In addition, changes in management, financial viability, manufacturing demand or capacity, or other factors,
at these third parties could hurt our ability to manufacture our products.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Our strategic focus on our custom power
supply solution competencies and concurrent cost reduction plans may be ineffective or may limit our ability to compete.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a result of our
strategic focus on custom power supply solutions, we will continue to devote significant resources to developing and manufacturing
custom power supply solutions for a large number of customers, where each product represents a uniquely tailored solution for a
specific customer&rsquo;s requirements. Failure to meet these customer product requirements or a failure to meet production schedules
and/or product quality standards may put us at risk with one or more of these customers. Moreover, changes in market conditions
and strategic changes at the direction of our customers may affect their decision to continue to purchase from us. The loss of
one or more of our significant custom power supply solution customers could have a material adverse impact on our revenues, business
or financial condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have also implemented
a series of initiatives designed to increase efficiency and reduce costs. While we believe that these actions will reduce costs,
they may not be sufficient to achieve the required operational efficiencies that will enable us to respond more quickly to changes
in the market or result in the improvements in our business that we anticipate. In such event, we may be forced to take additional
cost-reducing initiatives, including those involving our personnel, which may negatively impact quarterly earnings and profitability
as we account for severance and other related costs. In addition, there is the risk that such measures could have long-term adverse
effects on our business by reducing our pool of talent, decreasing or slowing improvements in our products or services, making
it more difficult for us to respond to customers, limiting our ability to increase production quickly if and when the demand for
our solutions increases and limiting our ability to hire and retain key personnel. These circumstances could cause our earnings
to be lower than they otherwise might be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We<FONT STYLE="color: red">&nbsp;</FONT>depend
upon a few major customers for a majority of our revenues, and the loss of any of these customers, or the substantial reduction
in the quantity of products that they purchase from us, would significantly reduce our revenues and net income.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We currently depend
upon a few major OEMs and other customers for a significant portion of our revenues. If our major OEM customers will reduce or
cancel their orders scaling back some of their activities, our revenues and net income would be significantly reduced. Furthermore,
diversions in the capital spending of certain of these customers to new network elements have and could continue to lead to their
reduced demand for our products, which could, in turn, have a material adverse effect on our business and results of operations.
If the financial condition of one or more of our major customers should deteriorate, or if they have difficulty acquiring investment
capital due to any of these or other factors, a substantial decrease in our revenues would likely result. We are dependent on the
electronic equipment industry, and accordingly will be affected by the impact on that industry of current economic conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Substantially all of
our existing customers are in the electronic equipment industry, and they manufacture products that are subject to rapid technological
change, obsolescence, and large fluctuations in demand. This industry is further characterized by intense competition and volatility.
The OEMs serving this industry are pressured for increased product performance and lower product prices. OEMs, in turn, make similar
demands on their suppliers, such as us, for increased product performance and lower prices. Such demands may adversely affect our
ability to successfully compete in certain markets or our ability to sustain our gross margins.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Our reliance on subcontract manufacturers
to manufacture certain aspects of our products involves risks, including delays in product shipments and reduced control over product
quality.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Since we do not own
significant manufacturing facilities, we must rely on, and will continue to rely on, a limited number of subcontract manufacturers
to manufacture our power supply products. Our reliance upon such subcontract manufacturers involves several risks, including reduced
control over manufacturing costs, delivery times, reliability and quality of components, unfavorable currency exchange fluctuations,
and continued inflationary pressures on many of the raw materials used in the manufacturing of our power supply products. If we
were to encounter a shortage of key manufacturing components from limited sources of supply, or experience manufacturing delays
caused by reduced manufacturing capacity, inability of our subcontract manufacturers to procure raw materials, the loss of key
assembly subcontractors, difficulties associated with the transition to our new subcontract manufacturers or other factors, we
could experience lost revenues, increased costs, and delays in, or cancellations or rescheduling of, orders or shipments, any of
which would materially harm our business.</P>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We outsource, and are dependent upon
developer partners for, the development of some of our custom design products.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We made an operational
decision to outsource some of our custom design products to numerous developer partners. This business structure will remain in
place until the custom design volume justifies expanding our in house capabilities. Incomplete product designs that do not fully
comply with the customer specifications and requirements might affect our ability to transition to a volume production stage of
the custom designed product where the revenue goals are dependent on the high volume of custom product production. Furthermore,
we rely on the design partners&rsquo; ability to provide high quality prototypes of the designed product for our customer approval
as a critical stage to approve production.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We face intense industry competition,
price erosion and product obsolescence, which, in turn, could reduce our profitability.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We operate in an industry
that is generally characterized by intense competition. We believe that the principal bases of competition in our markets are breadth
of product line, quality of products, stability, reliability and reputation of the provider, along with cost. Quantity discounts,
price erosion, and rapid product obsolescence due to technological improvements are therefore common in our industry as competitors
strive to retain or expand market share. Product obsolescence can lead to increases in unsaleable inventory that may need to be
written off and, therefore, could reduce our profitability. Similarly, price erosion can reduce our profitability by decreasing
our revenues and our gross margins. In fact, we have seen price erosion over the last several years on most of the products we
sell, and we expect additional price erosion in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Our future results are dependent on
our ability to establish, maintain and expand our manufacturers&rsquo; representative OEM relationships and our other relationships.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We market and sell
our products through domestic and international OEM relationships and other distribution channels, such as manufacturers&rsquo;
representatives and distributors. Our future results are dependent on our ability to establish, maintain and expand our relationships
with OEMs as well as with manufacturers&rsquo; representatives and distributors to sell our products. If, however, the third parties
with whom we have entered into such OEM and other arrangements should fail to meet their contractual obligations, cease doing,
or reduce the amount of their, business with us or otherwise fail to meet their own performance objectives, customer demand for
our products could be adversely affected, which would have an adverse effect on our revenues.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We may not be able to procure necessary
key components for our products, or we may purchase too much inventory or the wrong inventory.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The power supply industry,
and the electronics industry as a whole, can be subject to business cycles. During periods of growth and high demand for our products,
we may not have adequate supplies of inventory on hand to satisfy our customers' needs. Furthermore, during these periods of growth,
our suppliers may also experience high demand and, therefore, may not have adequate levels of the components and other materials
that we require to build products so that we can meet our customers' needs. Our inability to secure sufficient components to build
products for our customers could negatively impact our sales and operating results. We may choose to mitigate this risk by increasing
the levels of inventory for certain key components. Increased inventory levels can increase the potential risk for excess and obsolescence
should our forecasts fail to materialize or if there are negative factors impacting our customers&rsquo; end markets. If we purchase
too much inventory or the wrong inventory, we may have to record additional inventory reserves or write-off the inventory, which
could have a material adverse effect on our gross margins and on our results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Although we depend on sales of our legacy
products for a meaningful portion of our revenues, these products are mature and their sales will decline.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A relatively large
portion of our sales have historically been attributable to our legacy products. We expect that these products may continue to
account for a meaningful percentage of our revenues for the foreseeable future. However, these sales are declining. Although we
are unable to predict future prices for our legacy products, we expect that prices for these products will continue to be subject
to significant downward pressure in certain markets for the reasons described above. Accordingly, our ability to maintain or increase
revenues will be dependent on our ability to expand our customer base, to increase unit sales volumes of these products and to
successfully, develop, introduce and sell new products such as custom design and value-added products. We cannot assure you that
we will be able to expand our customer base, increase unit sales volumes of existing products or develop, introduce and/or sell
new products.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Failure of our information technology
infrastructure to operate effectively could adversely affect our business.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We depend heavily on
information technology infrastructure to achieve our business objectives. If a problem occurs that impairs this infrastructure,
the resulting disruption could impede our ability to record or process orders, manufacture and ship in a timely manner, or otherwise
carry on business in the normal course. Any such events could cause us to lose customers or revenue and could require us to incur
significant expense to remediate.</P>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We are subject to certain governmental
regulatory restrictions relating to our international sales.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Some of our products
are subject to International Traffic in Arms Regulation (&ldquo;ITAR&rdquo;), which are interpreted, enforced and administered
by the U.S. Department of State. ITAR regulation controls not only the export, import and trade of certain products specifically
designed, modified, configured or adapted for military systems, but also the export of related technical data and defense services
as well as foreign production. Any delays in obtaining the required export, import or trade licenses for products subject to ITAR
regulation and rules could have a material adverse effect on our business, financial condition, and/or operating results. In addition,
changes in United States export and import laws that require us to obtain additional export and import licenses or delays in obtaining
export or import licenses currently being sought could cause significant shipment delays and, if such delays are too great, could
result in the cancellation of orders. Any future restrictions or charges imposed by the United States or any other country on our
international sales or foreign subsidiary could have a materially adverse effect on our business, financial condition, and/or operating
results. In addition, from time to time, we have entered into contracts with the Israeli Ministry of Defense which were governed
by the U.S. Foreign Military Financing program (&ldquo;FMF&rdquo;). Any such future sales would be subject to these regulations.
Failure to comply with ITAR or FMF rules could have a material adverse effect on our financial condition, and/or operating results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We depend on international operations
for a substantial majority of our components and products.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We purchase a substantial
majority of our components from foreign manufacturers and have a substantial majority of our commercial products assembled, packaged,
and tested by subcontractors located outside the United States. These activities are subject to the uncertainties associated with
international business operations, including trade barriers and other restrictions, changes in trade policies, governmental regulations,
currency exchange fluctuations, reduced protection for intellectual property, war and other military activities, terrorism, changes
in social, political, or economic conditions, and other disruptions or delays in production or shipments, any of which could have
a materially adverse effect on our business, financial condition, and/or operating results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>We depend on international sales for a portion of our revenues.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Sales to customers
outside of North America accounted for 56.9% and 29.9% of net revenues for the years ended December 31, 2019 and 2018, and we expect
that international sales will continue to represent a material portion of our total revenues. International sales are subject to
the risks of international business operations as described above, as well as generally longer payment cycles, greater difficulty
collecting accounts receivable, and currency restrictions. In addition, Gresham, our wholly-owned subsidiary in the United Kingdom,
supports our European and other international customers, distributors, and sales representatives, and therefore is also subject
to local regulation. International sales are also subject to the export laws and regulations of the United States and other countries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Our sales and profitability may be affected
by changes in economic, business and industry conditions</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the economic climate
in the United States or abroad deteriorates, customers or potential customers could reduce or delay their technology and entertainment
investments. Reduced or delayed technology and entertainment investments could decrease our sales and profitability. In this environment,
our customers may experience financial difficulty, cease operations and fail to budget or reduce budgets for the purchase of our
products and professional services. This may lead to longer sales cycles, delays in purchase decisions, payment and collection,
and can also result in downward price pressures, causing our sales and profitability to decline. In addition, general economic
uncertainty and general declines in capital spending in the information technology sector make it difficult to predict changes
in the purchasing requirements of our customers and the markets we serve. There are many other factors which could affect our business,
including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">The introduction and market acceptance of new technologies, products and services;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.15pt"></TD><TD STYLE="width: 35.85pt">&bull;</TD><TD STYLE="text-align: justify">New competitors and new forms of competition;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.15pt"></TD><TD STYLE="width: 35.85pt">&bull;</TD><TD STYLE="text-align: justify">The size and timing of customer orders (for retail distributed physical product);&nbsp;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.15pt"></TD><TD STYLE="width: 35.85pt">&bull;</TD><TD>The size and timing of capital expenditures by our customers;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.15pt"></TD><TD STYLE="width: 35.85pt">&bull;</TD><TD STYLE="text-align: justify">Adverse changes in the credit quality of our customers and suppliers;&nbsp;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.15pt"></TD><TD STYLE="width: 35.85pt">&bull;</TD><TD STYLE="text-align: justify">Changes in the pricing policies of, or the introduction of, new products and services by us or
our competitors;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.15pt"></TD><TD STYLE="width: 35.85pt">&bull;</TD><TD STYLE="text-align: justify">Changes in the terms of our contracts with our customers or suppliers;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.15pt"></TD><TD STYLE="width: 35.85pt">&bull;</TD><TD STYLE="text-align: justify">The availability of products from our suppliers; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.15pt"></TD><TD STYLE="width: 35.85pt">&bull;</TD><TD STYLE="text-align: justify">Variations in product costs and the mix of products sold.&nbsp;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">These trends and factors
could adversely affect our business, profitability and financial condition and diminish our ability to achieve our strategic objectives.</P>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The sale of our products is dependent
upon our ability to satisfy the proprietary requirements of our customers.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We depend upon a relatively
narrow range of products for the majority of our revenue. Our success in marketing our products is dependent upon their continued
acceptance by our customers. In some cases, our customers require that our products meet their own proprietary requirements. If
we are unable to satisfy such requirements, or forecast and adapt to changes in such requirements, our business could be materially
harmed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The sale of our products is dependent
on our ability to respond to rapid technological change, including evolving industry-wide standards, and may be adversely affected
by the development, and acceptance by our customers, of new technologies which may compete with, or reduce the demand for, our
products.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Rapid technological
change, including evolving industry standards, could render our products obsolete. To the extent our customers adopt such new technology
in place of our products, the sales of our products may be adversely affected. Such competition may also increase pricing pressure
for our products and adversely affect the revenues from such products.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Our limited ability to protect our proprietary
information and technology may adversely affect our ability to compete, and our products could infringe upon the intellectual property
rights of others, resulting in claims against us, the results of which could be costly.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Many of our products
consist entirely or partly of proprietary technology owned by us. Although we seek to protect our technology through a combination
of copyrights, trade secret laws and contractual obligations, these protections may not be sufficient to prevent the wrongful appropriation
of our intellectual property, nor will they prevent our competitors from independently developing technologies that are substantially
equivalent or superior to our proprietary technology. In addition, the laws of some foreign countries do not protect our proprietary
rights to the same extent as the laws of the United States. In order to defend our proprietary rights in the technology utilized
in our products from third party infringement, we may be required to institute legal proceedings, which would be costly and would
divert our resources from the development of our business. If we are unable to successfully assert and defend our proprietary rights
in the technology utilized in our products, our future results could be adversely affected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although we attempt
to avoid infringing known proprietary rights of third parties in our product development efforts, we may become subject to legal
proceedings and claims for alleged infringement from time to time in the ordinary course of business. Any claims relating to the
infringement of third-party proprietary rights, even if not meritorious, could result in costly litigation, divert management&rsquo;s
attention and resources, require us to reengineer or cease sales of our products or require us to enter into royalty or license
agreements which are not advantageous to us. In addition, parties making claims may be able to obtain an injunction, which could
prevent us from selling our products in the United States or abroad.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>If we are unable to satisfy our customers&rsquo;
specific product quality, certification or network requirements, our business could be disrupted and our financial condition could
be harmed.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our customers demand
that our products meet stringent quality, performance and reliability standards. We have, from time to time, experienced problems
in satisfying such standards. Defects or failures have occurred in the past, and may in the future occur, relating to our product
quality, performance and reliability. From time to time, our customers also require us to implement specific changes to our products
to allow these products to operate within their specific network configurations. If we are unable to remedy these failures or defects
or if we cannot effect such required product modifications, we could experience lost revenues, increased costs, including inventory
write-offs, warranty expense and costs associated with customer support, delays in, or cancellations or rescheduling of, orders
or shipments and product returns or discounts, any of which would harm our business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>If we ship products that contain defects,
the market acceptance of our products and our reputation will be harmed and our customers could seek to recover their damages from
us.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our products are complex,
and despite extensive testing, may contain defects or undetected errors or failures that may become apparent only after our products
have been shipped to our customers and installed in their network or after product features or new versions are released. Any such
defect, error or failure could result in failure of market acceptance of our products or damage to our reputation or relations
with our customers, resulting in substantial costs for us and our customers as well as the cancellation of orders, warranty costs
and product returns. In addition, any defects, errors, misuse of our products or other potential problems within or out of our
control that may arise from the use of our products could result in financial or other damages to our customers. Our customers
could seek to have us pay for these losses. Although we maintain product liability insurance, it may not be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="background-color: white"><B>Some
of our business is subject to U.S. government procurement laws and regulations</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="background-color: white">We
must comply with certain laws and regulations relating to the formation, administration and performance of federal government contracts.
These laws and regulations affect how we conduct business with our federal government contracts, including the business that we
do as a subcontractor. In complying with these laws and regulations, we may incur additional costs, and non-compliance may lead
to the assessment of fines and penalties, including contractual damages, or the loss of business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Risks Related to Our Business and Industry - Microphase</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Microphase has a history of losses and
our future profitability on a quarterly or annual basis is uncertain, which could have a harmful effect on our business and the
value of our company.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the past three
fiscal years Microphase has incurred losses from operations. These losses are attributable to lower volumes of its products sold
to major defense contractors partially as a result of the overall reduction in defense spending and sequestration by the U.S. Congress.
Since the financial crisis of 2008, Microphase has been significantly short of capital needed to acquire parts for production of
its products to complete orders for such products. At times, Microphase has not had the cash available to make advance payments
for the purchase of parts, and then, as a consequence, Microphase would not receive the parts from its vendors required to finish
a customer order. This would then delay the delivery of products to customers, and would also delay recognition of the resulting
revenues and the receipt of cash from the customer. Sometimes after experiencing a delay in delivery of an order from Microphase,
the customer would not place its next order with Microphase, resulting in a loss of business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Microphase&rsquo;s
future profitability depends upon many factors, including several that are beyond its control. These factors include, without limitation:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">changes in the demand for ITS products and services;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">loss of key customers or contracts;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">the introduction of competitive products;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">the failure to gain market acceptance of ITS new and existing products; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">the failure to successfully and cost effectively develop, introduce and market new products, services
and product enhancements in a timely manner.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, Microphase
is incurring significant legal, accounting, and other expenses related to being a reporting company without there being a trading
market for any of its securities. As a result of these expenditures, Microphase will have to generate and sustain increased revenue
to achieve and maintain future profitability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>A large percentage of Microphase&rsquo;s
current revenue is derived from prime defense contractors to the U.S. government and its allies, and the loss of these relationships,
a reduction in U.S. government funding or a change in U.S. government spending priorities or bidding processes could have an adverse
impact on its business, financial condition, results of operations and cash flows.&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Microphase is highly
dependent on sales to major defense contractors of the U.S. military and its allies, including Lockheed Martin, Raytheon, BAE Systems
and SAAB. The percentages of its revenue that were derived from sales to these named major defense contractors and directly to
the U.S. Government were 51.5% in fiscal 2019 and 55.6% in fiscal 2018. Therefore, any significant disruption or deterioration
of Microphase&rsquo;s relationship with any such major defense contractors or the U.S. Government could materially reduce its revenue.&nbsp;
During the year ended December 31, 2019 there were three customers that accounted for more than 10% of sales:&nbsp; BAE Systems,
Raytheon Company and Lockheed Martin.&nbsp; During the year ended December 31, 2018 there were four customers that accounted for
more than 10% of sales: BAE Systems, Raytheon Company, Saab and Lockheed Martin. Microphase&rsquo;s competitors continuously engage
in efforts to expand their business relationships with the same major defense contractors and the U.S. Government and will continue
these efforts in the future, and the U.S. Government may choose to use other contractors. Microphase expects that a majority of
the business that it seeks will be awarded through competitive bidding. Microphase operates in highly competitive markets and its
competitors have more extensive or more specialized engineering, manufacturing and marketing capabilities than Microphase does
in many areas, and Microphase may not be able to continue to win competitively awarded contracts or to obtain task orders under
multi-award contracts. Further, the competitive bidding process involves significant cost and managerial time to prepare bids and
proposals for contracts that may not be awarded to Microphase, as well as the risk that Microphase may fail to accurately estimate
the resources and costs required to fulfill any contract awarded to us. Following any contract award, Microphase may experience
significant expense or delay, contract modification or contract rescission as a result of its competitors protesting or challenging
contracts awarded to it in competitive bidding. Major defense contractors to whom Microphase supplies components for systems must
compete with other major defense contractors (to which Microphase may not supply components) for military orders from the U.S.
Government.</P>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, Microphase
competes with other policy needs, which may be viewed as more necessary, for limited resources and an ever-changing amount of available
funding in the budget and appropriation process. Budget and appropriations decisions made by the U.S. Government are outside of
Microphase control and have long-term consequences for its business. U.S. Government spending priorities and levels remain uncertain
and difficult to predict and are affected by numerous factors, including until recently sequestration (automatic, across-the-board
U.S. Government budgetary spending cuts), and the purchase of our products could be superseded by alternate arrangements. While
the US defense budget was recently increased, there can be no assurance that this increase will be maintained for the foreseeable
future, particularly in light of the recent federal expenditures the federal government has made with a view to ameliorating the
economic damage suffered as a result of COVID-19. A change in U.S. Government spending priorities or an increase in non-procurement
spending at the expense of our programs, or a reduction in total U.S. Government spending, could have material adverse consequences
on Microphase&rsquo;s future business.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Microphase&rsquo;s U.S. government contracts
may be terminated by the federal government at any time prior to their completion, which could lead to unexpected loss of sales
and reduction in Microphase&rsquo;s backlog.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Under the terms of Microphase&rsquo;s U.S.
government contracts, the U.S. government may unilaterally:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD>terminate or modify existing contracts;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD>reduce the value of existing contracts through partial termination; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD>delay the payment of Microphase&rsquo;s invoices by government payment offices.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The federal government
can terminate or modify any of its contracts with Microphase or its prime contractors either for the federal government&rsquo;s
convenience, or if Microphase or its prime contractors default, by failing to perform under the terms of the applicable contract.
A termination arising out of Microphase&rsquo;s default could expose it to liability and have a material adverse effect on its
ability to compete for future federal government contracts and subcontracts. If the federal government or its prime contractors
terminate and/or materially modify any of Microphase&rsquo;s contracts or if any applicable options are not exercised, Microphase&rsquo;s
failure to replace sales generated from such contracts would result in lower sales and would adversely affect its earnings, which
could have a material adverse effect on Microphase&rsquo;s business, results of operations and financial condition. Microphase&rsquo;s
backlog as of December 31, 2019 was approximately $6.4 million. Microphase&rsquo;s backlog could be adversely affected if contracts
are modified or terminated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Microphase&rsquo;s products with military
applications are subject to export regulations, and compliance with these regulations may be costly.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Microphase is required
to obtain export licenses before filling foreign orders for many of its products that have military or other governmental applications.
United States Export Administration regulations control technology exports like its products for reasons of national security and
compliance with foreign policy, to guarantee domestic reserves of products in short supply and, under certain circumstances, for
the security of a destination country. Thus, any foreign sales of its products requiring export licenses must comply with these
general policies. Compliance with these regulations is costly, and these regulations are subject to change, and any such change
may require Microphase to improve its technologies, incur expenses or both in order to comply with such regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Microphase depends on U.S. government
contracts issued to major defense contractors, which often are only partially funded, subject to immediate termination, and heavily
regulated and audited. The termination or failure to fund, or negative audit findings for, one or more of these contracts could
have an adverse impact on Microphase&rsquo;s business.&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Over its lifetime,
a U.S. Government program awarded to a major defense contractor may be implemented by the award of many different individual contracts
and subcontracts. The funding of U.S. Government programs is subject to Congressional appropriations. Although multi-year contracts
may be authorized and appropriated in connection with major procurements, Congress generally appropriates funds on a fiscal year
basis. Procurement funds are typically made available for obligations over the course of one to three years. Consequently, programs
often receive only partial funding initially, and additional funds are designated only as Congress authorizes further appropriations.
The termination of funding for a U.S. Government program with respect to major defense contractors for which Microphase is a subcontractor
would result in a loss of anticipated future revenue attributable to that program, which could have an adverse impact on its operations.
In addition, the termination of, or failure to commit additional funds to, a program for which Microphase is a subcontractor could
result in lost revenue and increase its overall costs of doing business.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Generally, U.S. Government
contracts are subject to oversight audits by U.S. Government representatives. Such audits could result in adjustments to Microphase&rsquo;s
contract costs. Any costs found to be improperly allocated to a specific contract will not be reimbursed, and such costs already
reimbursed must be refunded. Microphase has recorded contract revenues based on costs Microphase expect to realize upon final audit.
However, Microphase does not know the outcome of any future audits and adjustments, and Microphase may be required to materially
reduce its revenues or profits upon completion and final negotiation of audits. Negative audit findings could also result in termination
of a contract, forfeiture of profits, suspension of payments, fines and suspension or debarment from U.S. Government contracting
or subcontracting for a period of time.</P>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, U.S. Government
contracts generally contain provisions permitting termination, in whole or in part, without prior notice at the U.S. Government&rsquo;s
convenience upon the payment only for work done and commitments made at the time of termination. Microphase can give no assurance
that one or more of the U.S. Government contracts with a major defense contractor under which Microphase provides component products
will not be terminated under these circumstances. Also, Microphase can give no assurance that it will be able to procure new contracts
to offset the revenue or backlog lost as a result of any termination of its U.S. Government contracts. Because a significant portion
of Microphase&rsquo;s revenue is dependent on its performance and payment under its U.S. Government contracts, the loss of one
or more large contracts could have a material adverse impact on its business, financial condition, results of operations and cash
flows.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Microphase&rsquo;s
government business also is subject to specific procurement regulations and other requirements. These requirements, though customary
in U.S. Government contracts, increase its performance and compliance costs. In addition, these costs might increase in the future,
thereby reducing Microphase&rsquo;s margins, which could have an adverse effect on its business, financial condition, results of
operations and cash flows. Failure to comply with these regulations and requirements could lead to fines, penalties, repayments,
or compensatory or treble damages, or suspension or debarment from U.S. Government contracting or subcontracting for a period of
time. Among the causes for debarment are violations of various laws, including those related to procurement integrity, export control,
U.S. Government security regulations, employment practices, protection of the environment, accuracy of records, proper recording
of costs and foreign corruption. The termination of a U.S. Government contract or relationship as a result of any of these acts
would have an adverse impact on Microphase&rsquo;s operations and could have an adverse effect on its standing and eligibility
for future U.S. Government contracts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;&nbsp;</B></P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Microphase&rsquo;s business could be
negatively impacted by cybersecurity threats and other security threats and disruptions.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a U.S. Government
defense contractor, Microphase faces certain security threats, including threats to its information technology infrastructure,
attempts to gain access to its proprietary or classified information, threats to physical security, and domestic terrorism events.
Microphase&rsquo;s information technology networks and related systems are critical to the operation of its business and essential
to its ability to successfully perform day-to-day operations. Microphase is also involved with information technology systems for
certain customers and other third parties, which generally face similar security threats. Cybersecurity threats in particular,
are persistent, evolve quickly and include, but are not limited to, computer viruses, attempts to access information, denial of
service and other electronic security breaches. Microphase believes that it has implemented appropriate measures and controls and
has invested in skilled information technology resources to appropriately identify threats and mitigate potential risks, but there
can be no assurance that such actions will be sufficient to prevent disruptions to mission critical systems, the unauthorized release
of confidential information or corruption of data. A security breach or other significant disruption involving these types of information
and information technology networks and related systems could:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">disrupt the proper functioning of these networks and systems and therefore its operations and/or
those of certain of its customers;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">result in the unauthorized access to, and destruction, loss, theft, misappropriation or release
of, proprietary, confidential, sensitive or otherwise valuable information of Microphase or its customers, including trade secrets,
which others could use to compete against Microphase or for disruptive, destructive or otherwise harmful purposes and outcomes;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">compromise national security and other sensitive government functions;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">require significant management attention and resources to remedy the damages that result;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">subject Microphase to claims for breach of contract, damages, credits, penalties or termination;
and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">damage Microphase&rsquo;s reputation with its customers (particularly agencies of the U.S. Government)
and the public generally.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Any or all of the foregoing could have a
negative impact on its business, financial condition, results of operations and cash flows.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Microphase enters into fixed-price contracts
that could subject it to losses in the event of cost overruns or a significant increase in inflation.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Microphase has a number
of fixed-price contracts which allow it to benefit from cost savings but subject it to the risk of potential cost overruns, particularly
for firm fixed-price contracts, because Microphase assumes the entire cost burden. If its initial estimates are incorrect, Microphase
can lose money on these contracts. U.S. Government contracts can expose Microphase to potentially large losses because the U.S.
Government can hold Microphase responsible for completing a project or, in certain circumstances, paying the entire cost of its
replacement by another provider regardless of the size or foreseeability of any cost overruns that occur over the life of the contract.
Because many of these contracts involve new technologies and applications, unforeseen events such as technological difficulties,
fluctuations in the price of raw materials, problems with its suppliers and cost overruns, can result in the contractual price
becoming less favorable or even unprofitable to Microphase. The U.S. and other countries also may experience a significant increase
in inflation. A significant increase in inflation rates could have a significant adverse impact on the profitability of these contracts.
Furthermore, if Microphase does not meet contract deadlines or specifications, Microphase may need to renegotiate contracts on
less favorable terms, be forced to pay penalties or liquidated damages or suffer major losses if the customer exercises its right
to terminate. In addition, some of its contracts have provisions relating to cost controls and audit rights, and if Microphase
fails to meet the terms specified in those contracts Microphase may not realize their full benefits. Microphase&rsquo;s results
of operations are dependent on its ability to maximize its earnings from its contracts. Cost overruns could have an adverse impact
on its financial results.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Risks Related to Our Business and Industry - Enertec</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;<B>Potential political, economic and military instability
in Israel could adversely affect our operations.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1pt; text-align: justify; text-indent: 35.9pt">Enertec&rsquo;s
operating facilities are located in Israel. Accordingly, political, economic and military conditions in Israel directly affect
Enertec&rsquo;s operations. Since the establishment of the State of Israel in 1948, a number of armed conflicts have taken place
between Israel and its Arab neighbors. A state of hostility, varying in degree and intensity, has led to security and economic
problems for Israel. Since October 2000, there has been an increase in hostilities between Israel and the Palestinian Arabs, which
has adversely affected the peace process and has negatively influenced Israel&rsquo;s relationship with its Arab citizens and several
Arab countries, including the Israel-Gaza conflict. Such ongoing hostilities may hinder Israel&rsquo;s international trade relations
and may limit the geographic markets where Enertec can sell its products and solutions. Hostilities involving or threatening Israel,
or the interruption or curtailment of trade between Israel and its present trading partners, could materially and adversely affect
Enertec&rsquo;s operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, Israel-based
companies and companies doing business with Israel have been the subject of an economic boycott by members of the Arab League and
certain other predominantly Muslim countries since Israel&rsquo;s establishment. Although Israel has entered into various agreements
with certain Arab countries and the Palestinian Authority, and various declarations have been signed in connection with efforts
to resolve some of the economic and political problems in the Middle East, we cannot predict whether or in what manner these problems
will be resolved. Wars and acts of terrorism have resulted in significant damage to the Israeli economy, including reducing the
level of foreign and local investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Furthermore, certain
of our officers and employees may be obligated to perform annual reserve duty in the Israel Defense Forces and are subject to being
called up for active military duty at any time. All Israeli male citizens who have served in the army are subject to an obligation
to perform reserve duty until they are between 40 and 49 years old, depending upon the nature of their military service.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Enertec may become subject to claims
for remuneration or royalties for assigned service invention rights by its employees, which could result in litigation and harm
our business.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A significant portion
of the intellectual property covered by Enertec&rsquo;s products has been developed by Enertec&rsquo;s employees in the course
of their employment for Enertec. Under the Israeli Patent Law, 5727-1967, or the Patent Law, and recent decisions by the Israeli
Supreme Court and the Israeli Compensation and Royalties Committee, a body constituted under the Patent Law, Israeli employees
may be entitled to remuneration for intellectual property that they develop for us unless they explicitly waive any such rights.
To the extent that Enertec is unable to enter into agreements with its future employees pursuant to which they agree that any inventions
created in the scope of their employment or engagement are owned exclusively by Enertec (as it has done in the past), Enertec may
face claims demanding remuneration. As a consequence of such claims, Enertec could be required to pay additional remuneration or
royalties to its current and former employees, or be forced to litigate such claims, which could negatively affect its business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;<B><U>Risks Related to Ownership
of Our Common Stock and this Offering</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>It is not possible to predict the aggregate
proceeds resulting from sales made under the ATM Sales Agreement.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to certain
limitations in the sales agreement and compliance with applicable law, we have the discretion to deliver a placement notice to
the sales agent at any time throughout the term of the sales agreement. The number of shares that are sold through the sales agent,
if any, after delivering a placement notice will fluctuate based on a number of factors, including the market price of our common
stock during the sales period, the limits we set with the sales agent in any applicable placement notice, and the demand for our
common stock during the sales period. Because the price per share of each share sold will fluctuate during the sales period, it
is not currently possible to predict the aggregate proceeds to be raised in connection with those sales.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The common stock offered hereby will
be sold in </B>&ldquo;<B>at the market offerings,</B>&rdquo; <B>and investors who buy shares at different times will likely pay
different prices.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Investors who purchase
shares in this offering at different times will likely pay different prices, and so may experience different levels of dilution
and different outcomes in their investment results. We will have discretion, subject to market demand, to vary the timing, prices
and number of shares sold in this offering. In addition, subject to the final determination by our board of directors, there is
no minimum or maximum sales price for shares to be sold in this offering. Investors may experience a decline in the value of the
shares they purchase in this offering as a result of sales made at prices lower than the prices they paid.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We will need additional capital to fund
our future operational plans but cannot assure you that we will be able to obtain sufficient capital from this offering or from
other potential sources, and we may have to limit the scope of our operations or take actions that may dilute your financial interest.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We currently need additional
capital to fund our operations. The proceeds from this offering, if any, and funds from other potential sources, along with our
cash and cash equivalents, may not be sufficient to fund our operations for the near future and we may not be able to obtain additional
financing. If adequate additional financing is not available on reasonable terms or available at all, we may not be able to undertake
expansion or continue our marketing efforts and we would have to modify our business plans accordingly. The extent of our capital
needs will depend on numerous factors, including (i) our profitability, (ii) the release of competitive products and/or services
by our competition, (iii) the level of our investment in new product development, (iv) the amount of our capital expenditures and
(v) our growth. We cannot assure you that we will be able to obtain capital in the future to meet these needs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We cannot be certain
the amount of proceeds that will be generated from this offering or that additional funding and incremental working capital will
be available to us on acceptable terms, if at all, or that it will exist in a timely and/or adequate manner to allow for the proper
execution of our near and long-term business strategy. If sufficient funds are not available on terms and conditions acceptable
to management and stockholders, we may be required to delay, reduce the scope of, or eliminate further development of our business
operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Even if we obtain requisite
financing, it may be on terms not favorable to us, it may be costly and it may require us to agree to covenants or other provisions
that will favor new investors over existing stockholders or other restrictions that may adversely affect our business. Additional
funding, if obtained, may also result in significant dilution to our stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>A substantial number of shares of our
Common Stock may be sold in this offering, which could cause the price of such shares to decline.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are offering up
to $50,000,000 of our common stock through this prospectus supplement. At an assumed price of $5.00 per share, the closing price
of our common stock on January 21, 2021, this would result in the issuance of 10,000,000 shares of our common stock through this
prospectus supplement.&nbsp; As of January 21, 2021, such shares represent approximately 26.5% of our outstanding shares of common
stock after giving effect to the sale of the shares in this offering. This offering could adversely affect the price of our common
stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;<B>We have broad discretion in
the use of the net proceeds of this offering and may not use them effectively. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We intend to use the
net proceeds of this offering to finance our growth strategy, and for working capital and general corporate purposes. However,
our management will have broad discretion in the application of the net proceeds from this offering and could spend the proceeds
in ways that do not improve our results of operations or enhance the value of our common stock. The failure by management to apply
these funds effectively could result in financial losses that could have a material adverse effect on our business, cause the price
of our common stock to decline and delay the implementation of our growth strategy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>If we do not
continue to satisfy the NYSE American continued listing requirements, our common stock could be delisted from NYSE American.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
listing of our common stock on the NYSE American is contingent on our compliance with the NYSE American&rsquo;s conditions for
continued listing. On July 24, 2020, we were notified by the NYSE American that we were no longer in compliance with the NYSE American
continued listing standards because our reported stockholders' equity was below continued listing standards. The NYSE American
requires that a listed company's stockholders' equity be $6.0 million or more if it has reported losses from continuing operations
and/or net losses in its five most recent fiscal years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Following
submission of our compliance plan demonstrating how we intend to regain compliance with the continued listing standards, we were
notified on October 8, 2020, that the NYSE American granted us a listing extension on the basis of our plan until January 24, 2022.
We are subject to periodic review by NYSE American staff during the extension period. Failure to make progress consistent with
the plan or to regain compliance with the continued listing standards by the end of the extension period could result in our common
stock being delisted from the NYSE American.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">On
January 4, 2021, we were notified by the NYSE American we failed to comply with the NYSE American continued listing standards because
of our inability to hold an annual meeting of stockholders no later than one year after the end of our last fiscal year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">In
light of our continued losses and inability to obtain quorum for our annual meeting, there is no assurance that we will be able
to regain compliance with the NYSE American continued listing standards. If we fail to meet the NYSE American listing requirement,
we may be subject to delisting by the NYSE American. In the event our common stock is no longer listed for trading on the NYSE
American, our trading volume and share price may decrease and we may experience further difficulties in raising capital which could
materially affect our operations and financial results. Further, delisting from the NYSE American could also have other negative
effects, including potential loss of confidence by partners, lenders, suppliers and employees and could also trigger various defaults
under our lending agreements and other outstanding agreements. Finally, delisting could make it harder for us to raise capital
and sell securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>You may experience future dilution as a result of future
equity offerings.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In order to raise additional
capital, we may in the future offer additional shares of our common stock or other securities convertible into or exchangeable
for our common stock at prices that may not be the same as the price per share in this offering. We may sell shares or other securities
in any other offering at a price per share that is less than the price per share paid by investors in this offering, and investors
purchasing shares or other securities in the future could have rights superior to existing stockholders. The price per share at
which we sell additional shares of our common stock, or securities convertible or exchangeable into common stock, in future transactions
may be higher or lower than the price per share paid by investors in this offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Our common stock price is volatile.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our common stock is
listed on the NYSE American. In the past, our trading price has fluctuated widely, depending on many factors that may have little
to do with our operations or business prospects. The exercise of outstanding options and warrants may adversely affect our stock
price and a stockholder&rsquo;s percentage of ownership. As of December 31, 2020, we had outstanding options to purchase an aggregate
of 925 shares of common stock, with a weighted average exercise price of $564.43 per share, exercisable at prices ranging from
$480 to $1,352 per share and warrants to purchase up to 3,315,560 shares of common stock, with a weighted average exercise price
of $6.19 per share, at exercise prices ranging from $0.88 to $2,000 per share.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On April 2, 2019, pursuant
to the underwriting agreement with A.G.P./Alliance Global Partners entered into on March 29, 2019, as referenced above, we issued
an aggregate of 793,325 shares of common stock, including shares of common stock underlying warrants. The sale of these shares
of our common stock, including those underlying the warrants (assuming exercise thereof), has had a material and adverse effect
on the market price of our common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, we have
previously agreed to register shares of common stock, and common stock underlying outstanding warrants and convertible debt in
connection with private placement of our securities that are not being registered in this prospectus. Our shares of common stock
are thinly traded. Therefore, the resale of a large number of shares of common stock and common stock underlying warrants and convertible
debt by the selling stockholders may adversely affect the market price of our common stock.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Volatility in our common stock price may subject us to securities
litigation.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Stock markets, in general,
have experienced, and continue to experience, significant price and volume volatility, and the market price of our common stock
may continue to be subject to similar market fluctuations unrelated to our operating performance or prospects. This increased volatility,
coupled with depressed economic conditions, could continue to have a depressing effect on the market price of our common stock.
The following factors, many of which are beyond our control, may influence our stock price:</P>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">the status of our growth strategy including the development of new products with any proceeds we
may be able to raise in the future;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">announcements of technological or competitive developments;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">regulatory developments affecting us, our customers or our competitors;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">announcements regarding patent or other intellectual property litigation or the issuance of patents
to us or our competitors or updates with respect to the enforceability of patents or other intellectual property rights generally
in the US or internationally;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">actual or anticipated fluctuations in our quarterly operating results;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">changes in financial estimates by securities research analysts;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">changes in the economic performance or market valuations of our competitors;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">additions or departures of our executive officers; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">sales or perceived sales of additional shares of our common stock.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, the securities
markets have, from time to time, experienced significant price and volume fluctuations that are not related to the operating performance
of particular companies. Any of these factors could result in large and sudden changes in the volume and trading price of our common
stock and could cause our stockholders to incur substantial losses. In the past, following periods of volatility in the market
price of a company&rsquo;s securities, stockholders have often instituted securities class action litigation against that company.
If we were involved in a class action suit or other securities litigation, it would divert the attention of our senior management,
require us to incur significant expense and, whether or not adversely determined, have a material adverse effect on our business,
financial condition, results of operations and prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>We have a substantial
number of convertible notes, warrants, options and preferred stock outstanding that could affect our price.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Due
to a number of financings, we have a substantial number of shares that are subject to issuance pursuant to outstanding convertible
debt, warrants and options. These conversion prices and exercise prices range from $0.88 to $2,000 per share of common stock. As
of&nbsp;the date of this prospectus, the number of shares of common stock subject to convertible notes, warrants, options and preferred
stock were 440,862, 3,315,560, 925 and 2,232,&nbsp;respectively. The issuance of common stock pursuant to convertible notes, warrants,
options and preferred stock at conversion or exercise prices less than market prices may have the effect of limiting an increase
in market price of our common stock until all of these underling shares have been issued.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The issuance of shares of our Class
B Common Stock to our management or others could provide such persons with voting control leaving our other stockholders unable
to elect our directors and the holders of our shares of common stock will have little influence over our Management.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although there are
currently no shares of our Class B Common Stock issued and outstanding, our certificate of incorporation authorizes the issuance
of 25,000,000 shares of Class B Common Stock. Each share of Class B Common Stock provides the holder thereof with ten (10) votes
on all matters submitted to a stockholder vote. Our certificate of incorporation does not provide for cumulative voting for the
election of directors. Any person or group who controls or can obtain more than 50% of the votes cast for the election of each
director will control the election of directors and the other stockholders will not be able to elect any directors or exert any
influence over management decisions. As a result of the super-voting rights of our shares of Class B Common Stock, the issuance
of such shares to our management or others could provide such persons with voting control and our other stockholders will not be
able to elect our directors and will have little influence over our management. While we are listed on the NYSE American or any
other national securities exchange it is highly unlikely that we would issue any shares of Class B Common Stock as doing so would
jeopardize our continued listing any such exchange. However, if were to be delisted for some other reason and our shares of Class
A Common Stock trade on an over-the-counter market, then we would face no restriction on issuing shares of Class B Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>We have a number
of shares of common stock subject to registration rights.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Due
to a number of financings, we have contractually agreed to register with the SEC shares of common stock, and common stock underlying
outstanding warrants and convertible debt in connection with private placements of our securities. The potential resale at the
same time of a large number of shares of common stock and common stock underlying warrants and convertible debt by the selling
stockholders may adversely affect the market price of our common stock.</P>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The rights of the holders of common
stock may be impaired by the potential issuance of preferred stock.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our certificate of
incorporation gives our board of directors the right to create new series of preferred stock. As a result, the board of directors
may, without stockholder approval, issue preferred stock with voting, dividend, conversion, liquidation or other rights which could
adversely affect the voting power and equity interest of the holders of common stock. Preferred stock, which could be issued with
the right to more than one vote per share, could be utilized as a method of discouraging, delaying or preventing a change of control.
The possible impact on takeover attempts could adversely affect the price of our common stock. Although we have no present intention
to issue any shares of preferred stock or to create a series of preferred stock, we may issue such shares in the future.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The requirements of being a public company
may strain our resources, divert management&rsquo;s attention and affect our ability to attract and retain qualified board members.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are a public company
and subject to the reporting requirements of the Exchange Act, and the Sarbanes-Oxley Act of 2002. The Exchange Act requires, among
other things, that we file annual, quarterly and current reports with respect to our business and financial condition. The Sarbanes-Oxley
Act requires, among other things, that we maintain effective disclosure controls and procedures and internal controls for financial
reporting. For example, Section&nbsp;404 of the Sarbanes-Oxley Act requires that our management report on the effectiveness of
our internal controls structure and procedures for financial reporting. Section&nbsp;404 compliance may divert internal resources
and will take a significant amount of time and effort to complete.&nbsp;If we fail to maintain compliance under Section 404, or
if in the future management&nbsp;determines that our internal control over financial reporting are not effective as defined under
Section&nbsp;404, we could be subject to sanctions or investigations by the NYSE American should we in the future be listed on
this market, the SEC, or other regulatory authorities. Furthermore, investor perceptions of our company may suffer, and this could
cause a decline in the market price of our common stock. Any failure of our internal controls could have a material adverse effect
on our stated results of operations and harm our reputation. If we are unable to implement these changes effectively or efficiently,
it could harm our operations, financial reporting or financial results and could result in an adverse opinion on internal controls
from our independent auditors. We may need to hire a number of additional employees with public accounting and disclosure experience
in order to meet our ongoing obligations as a public company, particularly if we become fully subject to Section 404 and its auditor
attestation requirements, which will increase costs. Our management team and other personnel will need to devote a substantial
amount of time to new compliance initiatives and to meeting the obligations that are associated with being a public company, which
may divert attention from other business concerns, which could have a material adverse effect on our business, financial condition
and results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>If we fail to comply with the rules&nbsp;under
the Sarbanes-Oxley Act of 2002 related to accounting controls and procedures, or if we discover material weaknesses and deficiencies
in our internal control and accounting procedures, our stock price could decline significantly and raising capital could be more
difficult.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we fail to comply
with the rules&nbsp;under the Sarbanes-Oxley Act of 2002 related to disclosure controls and procedures, or, if we discover material
weaknesses and other deficiencies in our internal control and accounting procedures, our stock price could decline significantly
and raising capital could be more difficult. Section&nbsp;404 of the Sarbanes-Oxley Act requires annual management assessments
of the effectiveness of our internal control over financial reporting. If material weaknesses or significant deficiencies are discovered
or if we otherwise fail to achieve and maintain the adequacy of our internal control, we may not be able to ensure that we can
conclude on an ongoing basis that we have effective internal controls over financial reporting in accordance with Section&nbsp;404
of the Sarbanes-Oxley Act. Moreover, effective internal controls are necessary for us to produce reliable financial reports and
are important to helping prevent financial fraud. If we cannot provide reliable financial reports or prevent fraud, our business
and operating results could be harmed, investors could lose confidence in our reported financial information, and the trading price
of our common stock could drop significantly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>If securities or industry analysts do
not publish research or reports about our business, or if they change their recommendations regarding our stock adversely, our
stock price and trading volume could decline.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The trading market
for our common stock will be influenced by the research and reports that industry or securities analysts publish about us or our
business. Our research coverage by industry and financial analysts is currently limited. Even if our analyst coverage increases,
if one or more of the analysts who cover us downgrade our stock, our stock price would likely decline. If one or more of these
analysts cease coverage of our company or fail to regularly publish reports on us, we could lose visibility in the financial markets,
which in turn could cause our stock price or trading volume to decline.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The elimination of monetary liability
against our directors, officers and employees under law and the existence of indemnification rights for or obligations to our directors,
officers and employees may result in substantial expenditures by us and may discourage lawsuits against our directors, officers
and employees</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our certificate of
incorporation contains a provision permitting us to eliminate the personal liability of our directors to us and our stockholders
for damages for the breach of a fiduciary duty as a director or officer to the extent provided by Delaware law. We may also have
contractual indemnification obligations under any future employment agreements with our officers. The foregoing indemnification
obligations could result in us incurring substantial expenditures to cover the cost of settlement or damage awards against directors
and officers, which we may be unable to recoup. These provisions and the resulting costs may also discourage us from bringing a
lawsuit against directors and officers for breaches of their fiduciary duties, and may similarly discourage the filing of derivative
litigation by our stockholders against our directors and officers even though such actions, if successful, might otherwise benefit
us and our stockholders.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We do not anticipate paying dividends
on our common stock and, accordingly, stockholders must rely on stock appreciation for any return on their investment.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have never declared
or paid cash dividends on our common stock and do not expect to do so in the foreseeable future. The declaration of dividends is
subject to the discretion of our board of directors and will depend on various factors, including our operating results, financial
condition, future prospects and any other factors deemed relevant by our board of directors. You should not rely on an investment
in our company if you require dividend income from your investment in our company. The success of your investment will likely depend
entirely upon any future appreciation of the market price of our common stock, which is uncertain and unpredictable. There is no
guarantee that our common stock will appreciate in value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>USE OF PROCEEDS</B></P>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may issue and sell
shares of our common stock having aggregate sales proceeds of up to $50,000,000 from time to time. Because there is no minimum
offering amount required as a condition to close this offering, the actual total public offering amount, commissions, expenses,
and proceeds to us, if any, are not determinable at this time but will be reported in our periodic reports.</P>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We intend to use the
net proceeds, if any, from this offering for the financing of possible acquisitions of companies and technologies, business expansions
and investments and for working capital and general corporate purposes, which may include the repayment, refinancing, redemption
or repurchase of future indebtedness or capital stock. We do not have agreements or commitments for any specific acquisitions at
this time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The timing and amount
of our actual expenditures will be based on many factors, including cash flows from operations and the anticipated growth of our
business.&nbsp;As of the date of this prospectus supplement, we cannot specify with certainty all of the particular uses for the
net proceeds to us from this offering. As a result, our management will have broad discretion regarding the timing and application
of the net proceeds from this offering.&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif">Pending these uses, we intend
to invest the net proceeds from this offering in short-term, investment-grade, interest-bearing securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any portion of the
$50,000,000 included in this prospectus supplement not previously sold or included in an active placement notice pursuant to the
sales agreement, may be later made available for sale in other offerings pursuant to the accompanying base prospectus, and if no
shares have been sold under the sales agreement, the full $50,000,000 of shares of common stock may be later made available for
sale in other offerings pursuant to the accompanying base prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>DILUTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our net tangible book
value as of September 30, 2020 was approximately $(6,559,739), or $(0.57) per share. Net tangible book value per share is determined
by dividing our total tangible assets, less total liabilities, by the number of shares of our common stock outstanding as of September
30, 2020. Dilution with respect to net tangible book value per share represents the difference between the amount per share paid
by purchasers of shares of common stock in this offering and the net tangible book value per share of our common stock immediately
after this offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">After giving effect
to the sale of 10,000,000 shares of our common stock in this offering at an assumed offering price of $5.00 per share, the last
reported sale price of our common stock on the Exchange on January 21, 2021, and after deducting estimated offering commissions
and offering expenses payable by us, our as adjusted net tangible book value as of September 30, 2020 would have been approximately
$41,740,261, or $1.94 per share. This represents an immediate increase in net tangible book value of $2.51 per share to existing
stockholders and immediate decrease of $3.06 per share to investors purchasing our common stock in this offering at the public
offering price. The following table illustrates this accretion on a per share basis:</P>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 82%">Assumed public offering price per share</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 15%; text-align: right">5.00</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Net tangible book value per share of as September 30, 2020</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(0.57</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Increase in net tangible book value per share attributable to this offering</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2.51</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">As adjusted net tangible book value per share as of September 30, 2020, after giving effect to this offering</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1.94</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Decrease per share to investors purchasing our common stock in this offering</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(3.06</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
</TABLE>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The above discussion
and table are based on shares of our common stock outstanding as of September 30, 2020, and exclude:</P>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">950 shares of our common stock issuable upon the exercise of stock options outstanding as of September
30, 2020, at a weighted average exercise price of $564.32 per share;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">3,588,616 shares of our common stock issuable upon exercise of warrants outstanding as of September
30, 2020, at a weighted average exercise price of $5.91 per share; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">2,232 shares of our common stock reserved for issuance pursuant to the conversion of preferred
stock outstanding as of September 30, 2020.</TD></TR></TABLE>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The table above assumes
for illustrative purposes that an aggregate of $10,000,000 shares of our common stock are sold during the term of the sales agreement
with ACM at a price of $5.00 per share, the last reported sale price of our common stock on January 21, 2021, for aggregate gross
proceeds of $50,000,000<FONT STYLE="color: red">. </FONT>The shares subject to the sales agreement with ACM are being sold from
time to time at various prices. An increase of $2.00 per share in the price at which the shares are sold from the assumed offering
price of $5.00 per share shown in the table above, assuming that all of our shares of common stock in the aggregate amount of $50,000,000
during the term of the sales agreement with ACM are sold at that price, would increase our adjusted net tangible book value per
share after the offering to $2.24 per share and would create a decrease in the net tangible book value per share to new investors
in this offering of $4.76 per share, after deducting commissions and estimated aggregate offering expenses payable by us. This
information is supplied for illustrative purposes only.</P>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To the extent that
outstanding options or warrants outstanding as of September 30, 2020 have been or may be exercised or other shares issued, investors
purchasing our common stock in this offering may experience further dilution. In addition, we may choose to raise additional capital
due to market conditions or strategic considerations even if we believe we have sufficient funds for our current or future operating
plans. To the extent that additional capital is raised through the sale of equity or convertible debt securities, the issuance
of these securities could result in further dilution to our stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>DIVIDEND POLICY</B></P>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have never declared
or paid cash dividends on our common stock. We currently intend to retain our future earnings, if any, for use in our business
and therefore do not anticipate paying cash dividends in the foreseeable future. Payment of future dividends, if any, will be at
the discretion of our board of directors after taking into account various factors, including our financial condition, operating
results, current and anticipated cash needs and plans for expansion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #DE1A1E"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PLAN OF DISTRIBUTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have entered into
a sales agreement with ACM, under which we may issue and sell shares of our common stock having an aggregate gross sales price
of up to $<FONT STYLE="font-family: Times New Roman, Times, Serif">50,000,000 </FONT>from time to time through ACM acting as a
sales agent. Sales of our common stock, if any, under this prospectus may be made in sales deemed to be &ldquo;at the market offerings&rdquo;
as defined in Rule&nbsp;415 under the Securities Act. <FONT STYLE="font-family: Times New Roman, Times, Serif">The sales agreement
has been filed as an exhibit to our Current Report on Form&nbsp;8-K filed with the SEC on January 25, 2021, which is incorporated
by reference in this prospectus supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each time we wish to
issue and sell common stock, we will notify ACM of the number of shares to be issued, the dates on which such sales are anticipated
to be made, any minimum price below which sales may not be made and other sales parameters as we deem appropriate. Once we have
so instructed ACM, unless ACM declines to accept the terms of the notice, ACM has agreed, subject to the terms and conditions of
the sales agreement, to use its commercially reasonable efforts consistent with its normal trading and sales practices to sell
such shares up to the amount specified on such terms. We may instruct ACM not to sell shares of common stock if the sales cannot
be effected at or above the price designated by us in any such instruction. We or ACM may suspend the offering of shares of common
stock being made through ACM under the sales agreement upon proper notice to the other party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will pay ACM commissions
for its services in acting as agent in the sale of our common stock. ACM will be entitled to compensation at a commission rate
equal to 3.25% of the aggregate gross sales price of the shares sold. Because there is no minimum offering amount in this offering,
the actual total public offering amount, commissions and proceeds to us, if any, are not determinable at this time. We have also
agreed to reimburse ACM for certain specified expenses, including the fees and disbursements of its legal counsel in an amount
not to exceed $25,000 and, thereafter, the reasonable fees and expenses of Ascendiant&rsquo;s legal counsel over $25,000 incurred
in connection with quarterly and annual bring-downs required thereunder, as provided in the sales agreement.</P>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Settlement for sales
of common stock will occur on the second business day following the date on which any sales are made, or on some other date that
is agreed upon by us and ACM in connection with a particular transaction, in return for payment of the net proceeds to us. There
is no arrangement for funds to be received in an escrow, trust or similar arrangement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with
the sale of the common stock on our behalf, ACM will be deemed to be an &ldquo;underwriter&rdquo; within the meaning of the Securities
Act and the compensation of ACM will be deemed to be underwriting commissions or discounts. We have agreed to provide indemnification
and contribution to ACM against certain civil liabilities, including liabilities under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The offering of our
common stock pursuant to the sales agreement will terminate upon the earlier of (1)&nbsp;the sale of all shares of our common stock
subject to the sales agreement having an aggregate offering price of&nbsp;$50,000,000 (unless the parties agree to extend the sales
agreement)&nbsp;or (2)&nbsp;termination of the sales agreement as permitted therein. We may terminate the sales agreement at any
time upon five days&rsquo; prior notice and ACM&nbsp;may terminate the sales agreement at any time upon ten days&rsquo; prior notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our common stock is
traded on the NYSE American under the symbol &ldquo;DPW.&rdquo; The transfer agent of our common stock is Computershare Trust Company,
N.A., 8742 Lucent Blvd., Suite 225, Highlands Ranch, CO 80129.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">ACM and/or its affiliates
may in the future provide various investment banking and other financial services for us for which services they may in the future
receive customary fees. <FONT STYLE="font-family: Times New Roman, Times, Serif">To the extent required by Regulation&nbsp;M promulgated
under the Exchange Act, ACM&nbsp;will not engage in any market making activities involving our common stock while the offering
is ongoing under this prospectus supplement.</FONT></P>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This summary of the
material provisions of the sales agreement does not purport to be a complete statement of its terms and conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>LEGAL MATTERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Olshan Frome Wolosky&nbsp;LLP,
New York, New York, as our counsel, will pass upon the validity of the common stock offered by this prospectus supplement and accompanying
prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXPERTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The consolidated financial
statements as of December 31, 2019 and December 31, 2018, and for the years then ended incorporated by reference in this prospectus
supplement have been so incorporated in reliance on the report of Marcum, LLP, an independent registered public accounting firm,
incorporated herein by reference, given on the authority of said firm as experts in auditing and accounting.</P>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The consolidated financial
statements of Enertec Systems 2001 LTD., as of December 31, 2019 and December 31, 2018, and for the years then ended incorporated
by reference in this prospectus supplement have been so incorporated in reliance on the report of BDO ZIV HAFT, an independent
registered public accounting firm, incorporated herein by reference, given on the authority of said firm as experts in auditing
and accounting.</P>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>WHERE YOU CAN FIND MORE INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus supplement
and the accompanying prospectus are part of the registration statement on Form&nbsp;S-3 we filed with the SEC under the Securities
Act, and do not contain all the information set forth in the registration statement. Whenever a reference is made in this prospectus
supplement or the accompanying prospectus to any of our contracts, agreements or other documents, the reference may not be complete,
and you should refer to the exhibits that are a part of the registration statement or the exhibits to the reports or other documents
incorporated by reference into this prospectus supplement and the accompanying prospectus for a copy of such contract, agreement
or other document. You may inspect a copy of the registration statement, including the exhibits and schedules, without charge,
at the SEC's public reference room mentioned below, or obtain a copy from the SEC upon payment of the fees prescribed by the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We file annual, quarterly
and current reports, proxy statements and other information with the SEC. You may read, without charge, and copy the documents
we file at the SEC&rsquo;s public reference rooms in Washington, D.C. at 100 F Street, NE, Room&nbsp;1580, Washington, DC 20549.
You can request copies of these documents by writing to the SEC and paying a fee for the copying cost.&nbsp;Please call the SEC
at 1-800-SEC-0330 for further information on the public reference rooms.&nbsp;Our SEC filings are also available to the public
at no cost from the SEC&rsquo;s website at http://www.sec.gov.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INCORPORATION OF DOCUMENTS BY REFERENCE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We incorporate by reference
the filed documents listed below, except as superseded, supplemented or modified by this prospectus supplement, and any future
filings we will make with the SEC under Sections&nbsp;13(a), 13(c), 14 or 15(d) of the Exchange Act (unless otherwise noted, the
SEC file number for each of the documents listed below is 001-36019):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 27pt"></TD><TD STYLE="width: 20.25pt">&#9679;</TD><TD STYLE="text-align: justify">Annual Report on Form 10-K for the period ended December 31, 2019, as amended;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 27pt"></TD><TD STYLE="width: 20.25pt">&#9679;</TD><TD STYLE="text-align: justify">Quarterly Reports on Form 10-Q for the quarters ended March 31, 2020, and June 30, 2020 and September
30, 2020;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 27pt"></TD><TD STYLE="width: 20.25pt">&#9679;</TD><TD STYLE="text-align: justify">Current Reports on Form 8-K filed with the SEC on January 2, 2020; January 16, 2020; January 22,
2020; February 6, 2020; February 10, 2020; an amendment filed on February 25, 2020; February 25, 2020; February 25, 2020; February
28, 2020; March 26, 2020; March 27, 2020; an amendment filed on April 9, 2020; April 14, 2020; April 20, 2020; May 1, 2020; May
13, 2020; May 29, 2020; June 29, 2020; July 8, 2020; July 17, 2020; an amendment filed on July 22, 2020; July 24, 2020; August
14, 2020; August 20, 2020; September 17, 2020; September 18, 2020; an amendment filed on September 30, 2020; October 2, 2020; October
13, 2020; October 23, 2020; October 27, 2020; November 11, 2020; November 20, 2020; November 30, 2020; December 1, 2020; December
3, 2020; December 21, 2020; December 30, 2020; January 4, 2021; January 19, 2021 and January 25, 2021;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 27pt"></TD><TD STYLE="width: 20.25pt">&#9679;</TD><TD STYLE="text-align: justify">Definitive Proxy Statement filed with the SEC on May 18, 2020 and November 13, 2020; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 27pt"></TD><TD STYLE="width: 20.25pt">&#9679;</TD><TD STYLE="text-align: justify">Description of our common stock contained in our Form 8-A filed with the SEC on January 30, 1997.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We also incorporate
by reference into this prospectus supplement and accompanying prospectus additional documents (other than current reports furnished
under Item 2.02 or Item 7.01 of Form&nbsp;8-K and exhibits on such form that are related to such items) that we may file with the
SEC under Sections 13(a), 13(c), 14 or 15(d)&nbsp;of the Exchange Act prior to the completion or termination of the offering, including
all such documents we may file with the SEC after the date of the initial registration statement and prior to the effectiveness
of the registration statement, but excluding any information deemed furnished and not filed with the SEC.&nbsp; Any statements
contained in a previously filed document incorporated by reference into this prospectus supplement and accompanying prospectus
is deemed to be modified or superseded for purposes of this prospectus supplement and accompanying prospectus to the extent that
a statement contained in this prospectus supplement or accompanying prospectus, or in a subsequently filed document also incorporated
by reference herein, modifies or supersedes that statement.</P>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus supplement
and accompanying prospectus may contain information that updates, modifies or is contrary to information in one or more of the
documents incorporated by reference in this prospectus supplement and accompanying prospectus. You should rely only on the information
incorporated by reference or provided in this prospectus supplement and accompanying prospectus. We have not authorized anyone
else to provide you with different information. You should not assume that the information in this prospectus supplement or accompanying
prospectus is accurate as of any date other than the date of this prospectus supplement or accompanying prospectus, or the date
of the documents incorporated by reference in this prospectus supplement and accompanying prospectus.</P>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will provide to
each person, including any beneficial owner, to whom this prospectus supplement and accompanying prospectus is delivered, upon
written or oral request, at no cost to the requester, a copy of any and all of the information that is incorporated by reference
in this prospectus supplement and accompanying prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will provide you,
without charge upon written or oral request, a copy of any and all of the information that has been incorporated by reference in
this prospectus supplement and that has not been delivered with this prospectus supplement. Requests should be directed to Ault
Global Holdings, Inc., 11411 Southern Highlands Parkway, Suite 240, Las Vegas, NV 89141, tel.: (949) 444-5464, Attention: Milton
C. (Todd) Ault III, Executive Chairman.&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 37 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1pt; text-align: center"><B>PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1pt; text-align: center"><IMG SRC="dpwlogo.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>$200,000,000</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Preferred Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Debt Securities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Warrants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Rights</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Units</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may offer and sell,
from time to time in one or more offerings, any combination of common stock, preferred stock, debt securities, warrants, rights
or units having an aggregate initial offering price not exceeding $200,000,000. The preferred stock, debt securities, warrants,
rights and units may be convertible, exercisable or exchangeable for common stock or preferred stock or other securities of ours.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each time we sell a
particular class or series of securities, we will provide specific terms of the securities offered in a supplement to this prospectus.&nbsp;
The prospectus supplement may also add, update or change information in this prospectus.&nbsp; You should read this prospectus
and any prospectus supplement, as well as the documents incorporated by reference or deemed to be incorporated by reference into
this prospectus, carefully before you invest in any securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>This prospectus
may not be used to offer or sell our securities unless accompanied by a prospectus supplement relating to the offered securities.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our common stock is
presently listed on the NYSE American under the symbol &ldquo;DPW&rdquo;.&nbsp; On January 21, 2021, the last reported sale price
of our common stock was $5.00.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">These securities may
be sold directly by us, through dealers or agents designated from time to time, to or through underwriters or dealers or through
a combination of these methods on a continuous or delayed basis.&nbsp; See &ldquo;Plan of Distribution&rdquo; in this prospectus.&nbsp;
We may also describe the plan of distribution for any particular offering of our securities in a prospectus supplement. If any
agents, underwriters or dealers are involved in the sale of any securities in respect of which this prospectus is being delivered,
we will disclose their names and the nature of our arrangements with them in a prospectus supplement. The net proceeds we expect
to receive from any such sale will also be included in a prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;An
investment in our common stock involves a high degree of risk. You should review carefully the risks and uncertainties described
under the heading &ldquo;Risk Factors&rdquo; contained herein on page 7 and in our Annual Report on Form 10-K/A for the year ended
December 31, 2019, as well as our subsequently filed periodic and current reports, which we file with the Securities and Exchange
Commission and which are incorporated by reference into the registration statement of which this prospectus is a part. You should
read the entire prospectus carefully before you make your investment decision.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Neither the Securities
and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the
adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>This prospectus is dated&nbsp;January
25, 2021</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="border-bottom: Black 2px solid; margin-top: 8pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>TABLE OF CONTENTS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="white-space: nowrap; width: 93%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; vertical-align: bottom; width: 6%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Page</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; vertical-align: top">About this Prospectus</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">1</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="white-space: nowrap; vertical-align: top">Disclosure Regarding Forward-Looking Statements</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">1</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; vertical-align: top">About the Company</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">2</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="white-space: nowrap; vertical-align: top">Risk Factors</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">7</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; vertical-align: top">Use of Proceeds</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">30</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="white-space: nowrap; vertical-align: top">The Securities We May Offer</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">30</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; vertical-align: top">Description of Capital Stock</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">31</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="white-space: nowrap; vertical-align: top">Description of Debt Securities</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">32</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; vertical-align: top">Description of Warrants</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">39</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="white-space: nowrap; vertical-align: top">Description of Rights</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">41</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; vertical-align: top">Description of Units</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">42</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="white-space: nowrap; vertical-align: top">Plan of Distribution</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">42</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; vertical-align: top">Legal Matters</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">44</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: justify">Experts</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">44</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; vertical-align: top">Where you can find more Information</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">44</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="white-space: nowrap; vertical-align: top">Incorporation of Documents by Reference</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">44</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: NewSection -->
    <DIV STYLE="border-bottom: Black 2px solid; margin-top: 8pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo --><!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ABOUT THIS PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus is
part of a shelf registration statement that we filed with the Securities and Exchange Commission (the &ldquo;Commission&rdquo;)
using a &ldquo;shelf&rdquo; registration process. Under this shelf registration process, we may sell any combination of the securities
described in this prospectus in one or more offerings from time to time having an aggregate initial offering price of $200,000,000.
This prospectus provides you with a general description of the securities we may offer. Each time we offer securities, we will
provide you with a prospectus supplement that describes the specific amounts, prices and terms of the securities we offer. The
prospectus supplement also may add, update or change information contained in this prospectus. You should read carefully both this
prospectus and any prospectus supplement together with additional information described below under the caption &ldquo;Where You
Can Find More Information.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus does
not contain all the information provided in the registration statement we filed with the Commission. You should read both this
prospectus, including the section titled &ldquo;Risk Factors,&rdquo; and the accompanying prospectus supplement, together with
the additional information described under the heading &ldquo;Where You Can Find More Information.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus may
be supplemented from time to time to add, to update or change information in this prospectus. Any statement contained in this prospectus
will be deemed to be modified or superseded for purposes of this prospectus to the extent that a statement contained in such prospectus
supplement modifies or supersedes such statement. Any statement so modified will be deemed to constitute a part of this prospectus
only as so modified, and any statement so superseded will be deemed not to constitute a part of this prospectus. You should rely
only on the information contained or incorporated by reference in this prospectus, any applicable prospectus supplement or any
related free writing prospectus. We have not authorized any other person to provide you with different information. If anyone provides
you with different or inconsistent information, you should not rely on it. No dealer, salesperson or other person is authorized
to give any information or to represent anything not contained in this prospectus, any applicable prospectus supplement or any
related free writing prospectus. This prospectus is not an offer to sell securities, and it is not soliciting an offer to buy securities,
in any jurisdiction where the offer or sale is not permitted. You should assume that the information appearing in this prospectus
or any prospectus supplement, as well as information we have filed with the SEC that is incorporated by reference, is accurate
as of the date on the front of those documents only, regardless of the time of delivery of this prospectus or any applicable prospectus
supplement, or any sale of a security. Our business, financial condition, results of operations and prospects may have changed
since those dates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No person is authorized
in connection with this prospectus to give any information or to make any representations about us, the securities offered hereby
or any matter discussed in this prospectus, other than the information and representations contained in this prospectus. If any
other information or representation is given or made, such information or representation may not be relied upon as having been
authorized by us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus contains
summaries of certain provisions contained in some of the documents described herein, but reference is made to the actual documents
for complete information. All of the summaries are qualified in their entirety by the actual documents. Copies of some of the documents
referred to herein have been filed, will be filed or will be incorporated by reference as exhibits to the registration statement
of which this prospectus is a part, and you may obtain copies of those documents as described below under &ldquo;Where You Can
Find More Information.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For investors outside
the United States: Neither we nor any Underwriter has done anything that would permit this offering or possession or distribution
of this prospectus in any jurisdiction where action for that purpose is required, other than in the United States. You are required
to inform yourselves about and to observe any restrictions relating to this offering and the distribution of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless otherwise stated
or the context requires otherwise, references to &ldquo;DPW,&rdquo; the &ldquo;Company,&rdquo; &ldquo;we,&rdquo; &ldquo;us&rdquo;
or &ldquo;our&rdquo; are to DPW Holdings, Inc.&nbsp;and its subsidiaries.<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>DISCLOSURE REGARDING FORWARD-LOOKING
STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus and
the documents incorporated by reference in it contain forward-looking statements regarding future events and our future results
that are subject to the safe harbors created under the Securities Act of 1933 and the Securities Exchange Act of 1934. All statements
other than statements of historical facts are statements that could be deemed forward-looking statements. These statements are
based on our expectations, beliefs, forecasts, intentions and future strategies and are signified by the words &ldquo;expects,&rdquo;
&ldquo;anticipates,&rdquo; &ldquo;intends,&rdquo; &ldquo;believes&rdquo; or similar language. In addition, any statements that
refer to projections of our future financial performance, our anticipated growth, trends in our business and other characterizations
of future events or circumstances are forward-looking statements. These forward-looking statements are only predictions and are
subject to risks, uncertainties and assumptions that are difficult to predict, including those identified above, under &ldquo;Risk
Factors&rdquo; and elsewhere in this prospectus. Therefore, actual results may differ materially and adversely from those expressed
in any forward-looking statements. All forward-looking statements included in this prospectus are based on information available
to us on the date of this prospectus and speak only as of the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 3; Options: NewSection -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We disclaim any current
intention to update our &ldquo;forward-looking statements,&rdquo; and the estimates and assumptions within them, at any time or
for any reason. In particular, the following factors, among others, could cause actual results to differ materially from those
described in the &ldquo;forward-looking statements&rdquo;:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 35.05pt">&bull;</TD><TD STYLE="text-align: justify">our continued operating and net losses in the future;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.1pt"></TD><TD STYLE="width: 35.05pt">&bull;</TD><TD STYLE="text-align: justify">our need for additional capital for our operations and to fulfill our business plans;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.1pt"></TD><TD STYLE="width: 35.05pt">&bull;</TD><TD STYLE="text-align: justify">the effect of COVID-19;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.1pt"></TD><TD STYLE="width: 35.05pt">&bull;</TD><TD STYLE="text-align: justify">dependency on our ability, and the ability of our contract manufacturers, to timely procure electronic
components;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.1pt"></TD><TD STYLE="width: 35.05pt">&bull;</TD><TD STYLE="text-align: justify">the potential ineffectiveness of our strategic focus on power supply solution competencies;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.1pt"></TD><TD STYLE="width: 35.05pt">&bull;</TD><TD STYLE="text-align: justify">dependency on developer partners for the development of some of our custom design products;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.1pt"></TD><TD STYLE="width: 35.05pt">&bull;</TD><TD STYLE="text-align: justify">dependency on sales of our legacy products for a meaningful portion of our revenues;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.1pt"></TD><TD STYLE="width: 35.05pt">&bull;</TD><TD STYLE="text-align: justify">the possible failure of our custom product development efforts to result in products which meet
customers&rsquo; needs or such customers&rsquo; failure to accept such new products;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.1pt"></TD><TD STYLE="width: 35.05pt">&bull;</TD><TD STYLE="text-align: justify">our ability to attract, retain and motivate key personnel;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.1pt"></TD><TD STYLE="width: 35.05pt">&bull;</TD><TD STYLE="text-align: justify">dependence on a few major customers;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.1pt"></TD><TD STYLE="width: 35.05pt">&bull;</TD><TD STYLE="text-align: justify">dependence on the electronic equipment industry;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.1pt"></TD><TD STYLE="width: 35.05pt">&bull;</TD><TD STYLE="text-align: justify">reliance on third-party subcontract manufacturers to manufacture certain aspects of the products
sold by us;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.1pt"></TD><TD STYLE="width: 35.05pt">&bull;</TD><TD STYLE="text-align: justify">reduced profitability as a result of increased competition, price erosion and product obsolescence
within the industry;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.1pt"></TD><TD STYLE="width: 35.05pt">&bull;</TD><TD STYLE="text-align: justify">our ability to establish, maintain and expand its OEM relationships and other distribution channels;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.1pt"></TD><TD STYLE="width: 35.05pt">&bull;</TD><TD STYLE="text-align: justify">our inability to procure necessary key components for its products, or the purchase of excess or
the wrong inventory;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.1pt"></TD><TD STYLE="width: 35.05pt">&bull;</TD><TD STYLE="text-align: justify">variations in operating results from quarter to quarter;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.1pt"></TD><TD STYLE="width: 35.05pt">&bull;</TD><TD STYLE="text-align: justify">dependence on international sales and the impact of certain governmental regulatory restrictions
on such international sales and operations; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.1pt"></TD><TD STYLE="width: 35.05pt">&bull;</TD><TD STYLE="text-align: justify">the risk factors included in our most recent filings with the SEC, including, but not limited to,
our Forms 10-K and 10-Q. All filings are also available on our website at&nbsp;<U>www.dpwholdings.com</U>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ABOUT THE COMPANY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>This summary highlights
selected information contained in other parts of this prospectus. Because it is a summary, it does not contain all of the information
that you should consider in making your investment decision. Before investing in our securities, you should read the entire prospectus
carefully, including the information set forth under the heading &ldquo;Risk Factors.&rdquo;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;Company Overview</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1pt; text-align: justify; text-indent: 35.9pt">DPW Holdings,
Inc. is a diversified holding company that owns operating subsidiaries and divisions engaged in a number of diversified business
operations including the defense, aerospace, commercial, health/medical, finance and commercial lending sectors. Our largest subsidiary
is Gresham Worldwide, which provides advanced bespoke military and commercial applications. We began implementing our strategy
in late 2016 led by our Chairman and CEO Milton &ldquo;Todd&rdquo; Ault, III and Vice Chairman and President William B. Horne.
DPW is presently led by an Executive Committee, the members of which are Messrs. Ault and Horne and Henry Nisser, our Executive
Vice President and General Counsel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We operate as a holding
company with operations conducted primarily through our subsidiaries. We conduct our activities in a manner so as not to be deemed
an investment company under the Investment Company Act of 1940, as amended (the &ldquo;Investment Company Act&rdquo;). Generally,
this means that we do not invest or intend to invest in securities as our primary business and that no more than 40% of our total
assets will be invested in investment securities as such term is defined in the Investment Company Act. Pursuant to the Investment
Company Act, companies such as our subsidiary Digital Power Lending, LLC (&ldquo;DP Lending&rdquo;) are excluded from the definition
of an investment company since its business consists of making small loans and industrial banking. We also maintain a large investment
in Avalanche International, Corp., <FONT STYLE="color: #231F20">which does business as MTIX International.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Originally, we were
primarily a solution-driven organization that designed, developed, manufactured and sold high-grade customized and flexible power
system solutions for the medical, military, telecom and industrial markets. Although we are actively seeking growth through acquisitions,
we will continue to focus on high-grade and custom product designs for the commercial, medical and military/defense markets, where
customers demand high density, high efficiency and ruggedized products to meet the harshest and/or military mission critical operating
conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have operations
located in Europe through our wholly-owned subsidiary, Gresham Power Electronics (formerly Digital Power Limited) (&ldquo;Gresham
Power&rdquo;), located in Salisbury, England. Gresham Power designs, manufactures and sells power products and system solutions
mainly for the European marketplace, including power conversion, power distribution equipment, DC/AC (direct current/active current)
inverters and UPS (uninterrupted power supply) products. Gresham Power is specialized in the field of naval power distribution
products, as well as our wholly owned subsidiary Relec Electronics (&ldquo;Relec&rdquo;) located in Dorset, England. Relec was
established in 1978 with the aim of providing specialist power conversion and display products to support professionals in the
electronics industry. Relec&rsquo;s aerospace background means it consistently and meticulously delivers high performance and robust
power and display solutions. Relec exerts its utmost effort to customize a product or a feature to achieve optimum performance
and service delivery. Relec continues to be guided by this philosophy and currently operates in specific fields, specializing in
AC-DC Power Supplies, DC-DC Converters, Displays and EMC Filters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;<B>Recent Events</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Reorganization
of Our Corporate Structure</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Commencing in October
and continuing through July 2020, we reorganized our corporate structure pursuant to a series of transactions among our company
and our directly and indirectly-owned subsidiaries. The purpose of the reorganization was to align our various businesses by the
products and services that constitute the majority of each subsidiaries&rsquo; revenues. As a result of the foregoing transactions,
our corporate structure is as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;<IMG SRC="chart2.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On January 7, 2020,
we formed Coolisys Technologies Corp. (&ldquo;CTC&rdquo;) in order to hold Digital Power Corporation. Coolisys is presently owned
by GWW and owns Microphase Corporation, Gresham Power Electronics, Relec and Enertec Systems. We may dispose of Coolisys in the
future, leaving GWW as the direct owner of the four foregoing subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Other Matters</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">In
January 2018, we formed Super Crypto Mining, Inc., a wholly-owned subsidiary, which recently changed its name to Digital Farms,
Inc. (&ldquo;DFI&rdquo;). DFI was established to operate our newly formed cryptocurrency business, which mined a variety of digital
currency for our own account. These cryptocurrencies include Bitcoin, Litecoin and Ethereum.&nbsp;We made the decision to discontinue
DFI&rsquo;s operations in the first quarter of 2020.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">On
May 23, 2018, DP Lending entered into and closed a securities purchase agreement with I. AM, Inc. (&ldquo;I. AM&rdquo;). <FONT STYLE="background-color: white">I.
AM&rsquo;s operations were discontinued in the first quarter of 2020 and it is currently in bankruptcy proceedings.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On October 2, 2020,
we entered into an At-The-Market Issuance Sales Agreement (the &ldquo;Sales Agreement&rdquo;) with Ascendiant Capital Markets,
LLC to sell shares of common stock having an aggregate offering price of up to $8,975,000 from time to time, through an &ldquo;at
the market offering&rdquo; program (the &ldquo;2020 ATM Offering&rdquo;). On December 1, 2020, we filed an amendment to the prospectus
supplement with the SEC to increase the amount of common stock that may be offered and sold in the ATM Offering, as amended under
the Sales Agreement to $40,000,000 in the aggregate, inclusive of the up to $8,975,000 in shares of common stock previously sold
in the 2020 ATM Offering. The offer and sale of shares of common stock from the 2020 ATM Offering was made pursuant to our effective
&ldquo;shelf&rdquo; registration statement on Form&nbsp;S-3 and an accompanying base prospectus contained therein (Registration
Statement No.&nbsp;333-222132) which became effective on January 11, 2018. Through December 31, 2020, we had received gross proceeds
of $39,978,350 through the sale of 12,582,000 shares of common stock from the 2020 ATM Offering. The 2020 ATM Offering was terminated
on December 31, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August 5, 2020,
we received $2,000,000 from Esousa Holdings, LLC (&ldquo;Esousa&rdquo;) and on October 22, 2020, we issued to Esousa a promissory
note in the principal face amount of $2,000,000, with an interest rate of 13%. The outstanding principal face amount, plus any
accrued and unpaid interest, is due by November 3, 2020, or as otherwise provided in accordance with the terms set forth therein.
In connection therewith, we delivered to Esousa a warrant to purchase 729,927 shares of common stock at an exercise price of $3.01.
The exercise of the warrant is subject to approval of the NYSE American. The foregoing debt was paid off in December of 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On October 27, 2020,
we issued to Esousa two unsecured promissory notes in the aggregate principal face amount of $1,200,000, of which $850,000 was
received prior to September 30, 2020. The principal amount of $850,000 of the first note dated October 27, 2020, together with
all accrued unpaid interest at an annual rate of 14%, was due and payable on December 28, 2020. The principal amount of $350,000
of the second note dated October 27, 2020, together with all accrued unpaid interest at an annual rate of 14%, was due and payable
on January 7, 2021. Both unsecured promissory notes were repaid on December 14, 2020. In connection with the two promissory notes,
we delivered to the Esousa (i) a warrant dated October 27, 2020, to purchase 425,000 shares of common stock at an exercise price
of $2.20, and (ii) a warrant dated October 27, 2020, to purchase 148,936 shares of common stock at an exercise price of $2.59.
The exercise of the warrants is subject to approval of the NYSE American.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On November 9, 2020,
our <FONT STYLE="color: #231F20">wholly-owned subsidiary </FONT>Gresham Worldwide, Inc. (&ldquo;GWW&rdquo;) entered into a stock
purchase agreement with Tabard Holdings Inc., a Delaware corporation and wholly owned subsidiary of GWW (&ldquo;Tabard&rdquo;),
the legal and beneficial owners (the &ldquo;Sellers&rdquo;) of 100% of the issued shares in the capital of Relec Electronics Ltd.,
a corporation organized under the laws of England and Wales (&ldquo;Relec&rdquo;), and Peter Lappin, in his capacity as the representative
of the Sellers.&nbsp;&nbsp;Upon the terms and subject to the conditions set forth in the stock purchase agreement, Tabard agreed
to acquire Relec pursuant to the stock purchase agreement whereby the Sellers will sell to Tabard (i) 100% of the issued shares
of Relec. The purchase price is approximately &pound;3,000,000 plus an amount equal to Relec&rsquo;s cash balance immediately prior
to closing of the acquisition. The acquisition of Relec was consummated on November 30, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On November 19, 2020,
we issued to Esousa and two other institutional investors unsecured promissory notes in the aggregate principal face amount of
$2,250,000, with an interest rate of 12%. The outstanding principal face amount, plus any accrued and unpaid interest, was due
by February 18, 2021, or as otherwise provided in accordance with the terms set forth therein. These unsecured promissory notes
were repaid on December 28, 2020. In connection therewith, we delivered warrants to purchase an aggregate of 1,323,531 shares of
common stock at an exercise price of $1.87, subject to adjustments. Exercise of the warrants is subject to approval of the NYSE
American.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On November 20, 2020,
our former counsel, Sichenzia Ross Ference LLP as successor to Sichenzia Ross Ference Kesner LLP (&ldquo;SRF&rdquo;) filed a Complaint
(the &ldquo;Complaint&rdquo;) in the United States District Court for the Southern District of New York against us and two of our
subsidiaries (collectively, the &ldquo;Defendants&rdquo;), in an action captioned Sichenzia Ross Ference LLP as successor to Sichenzia
Ross Ference Kesner LLP v. Digital Power Corporation, et al., Case No. 20-CV-09811-JGK. The Complaint asserts claims for breach
of contract, account stated, unjust enrichment and quantum meruit, against the Defendants, and seeks monetary damages in the amount
of $2,558,121.89 plus interest thereon. On January 4, 2021, the Defendants filed a motion for a more definite statement (the &ldquo;Motion&rdquo;).
The Court has scheduled a pre-motion conference for January 11, 2021 in connection with the Motion. As of December 31, 2020, approximately
$2.3 million of the disputed legal fees were included in accounts payable. We intend to vigorously defend against the claims asserted
against us and are currently assessing whether we will assert any counterclaims against SRF in this action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December 20, 2020,
our wholly owned subsidiary Alliance Cloud Services, LLC (&ldquo;ACS&rdquo;), entered into a Real Estate Sale Contract (the &ldquo;Sale
Contract&rdquo;) with Prairie Ronde Realty Company, a Michigan corporation (the &ldquo;Seller&rdquo;). Pursuant to the Sale Contract,
ACS will acquire the Property described below for a purchase price of $3,900,000, subject to proration in accordance with the Sale
Contract. The Property consists of a parcel of land consisting of approximately 34.52 acres, commonly known as 415 East Prairie
Ronde Street, Dowagiac, MI 49047, including any buildings, improvements and appurtenances thereon (collectively, with the parcel
of land, the &ldquo;Real Property&rdquo;) and the following: (i)&nbsp;all appurtenances pertaining to the Real Property; (ii)&nbsp;certain
personal property as set forth in the Sale Contract; (iii)&nbsp;all of the Seller&rsquo;s right, title and interest in and to all
leases and service contracts, which ACS will assume as of the closing date of January 29, 2021; and (vi)&nbsp;all assignable (without
consent) permits and warranties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>Settlement of Derivative Litigation</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February 24, 2020,
we entered into a definitive settlement agreement (the &ldquo;Settlement Agreement&rdquo;) intended to settle the previously disclosed
derivative litigation captioned <I>Ethan Young and Greg Young, Derivatively on Behalf of Nominal Defendant, DPW Holdings, Inc.
v. Milton C. Ault, III, Amos Kohn, William B. Horne, Jeff Bentz, Mordechai Rosenberg, Robert O. Smith, and Kristine Ault and DPW
Holdings, Inc., as the nominal defendant</I> (Case No. 18-cv-6587) (as amended on March 11, 2019, the &ldquo;Amended Complaint&rdquo;)
against us and certain of our officers and directors pending in the United States District Court for the Central District of California
(the &ldquo;Court&rdquo;). As previously disclosed, the Amended Complaint alleges violations including breaches of fiduciary duties
and unjust enrichment claims based on the previously pled transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On April 15, 2020,
the Court issued an Order (the &ldquo;Order&rdquo;) approving a Motion for Preliminary Approval of Settlement in the Derivative
Action. On July 16, 2020, the Court issued an Order (the &ldquo;Final Order&rdquo;) approving a Motion for Final Approval of Settlement
in the Derivative Action filed against DPW as a Nominal Defendant and its directors who served on its board of directors on July
31, 2018 who were not dismissed from the action as a result of the Court&rsquo;s partial grant of the Motion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In accordance with
the terms of the Final Order, the Board has adopted certain resolutions and amendments to our committee charters and/or bylaws,
to ensure adherence to certain corporate governance policies (collectively, the &ldquo;Reforms&rdquo;). The Final Order further
provides that such Reforms shall remain in effect for a period of no less than five (5) years and shall be subject to any of the
following: (a) a determination by a majority of the independent directors that the Reforms are no longer in our best interest,
including, but not limited to, due to circumstances making the Reforms no longer applicable, feasible, or available on commercially
reasonable terms, or (b) modifications which we reasonably believe are required by applicable law or regulation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with
the Settlement Agreement, the parties agreed to a payment of attorneys&rsquo; fees in the amount of $600,000, which sum was paid
by our directors &amp; officers liability insurance. The Settlement Agreement contains no admission of wrongdoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have always maintained
and continue to believe that neither we nor our current or former directors engaged in any wrongdoing or otherwise committed any
violation of federal or state securities laws or any other laws or regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Impact of Coronavirus
on Our Operations</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">On
March 16, 2020, to try and mitigate the spread of the novel coronavirus, San Diego County health officials issued orders mandating
that all restaurants must end dine-in services. As a result of these temporary closures by the San Diego County health officials
and the deteriorating business conditions at both our cryptocurrency mining and restaurant businesses, management concluded that
discontinuing these operations was ultimately in our best interest. Although we have ceased operations at Digital Farms, since
the assets and operations have not yet been abandoned, sold or distributed, these assets do not yet meet the requirement for presentation
as discontinued operations. However, management determined that the permanent closing of the restaurant operations met the criteria
for presentation as discontinued operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">In
March 2020, the World Health Organization declared the outbreak of a novel coronavirus (&ldquo;COVID-19&rdquo;) as a pandemic which
continues to spread throughout the United States and the World. We are monitoring the outbreak of COVID-19 and the related business
and travel restrictions and changes to behavior intended to reduce its spread, and its impact on operations, financial position,
cash flows, inventory, supply chains, customer purchasing trends, customer payments, and the industry in general, in addition to
the impact on our employees. Due to the rapid development and fluidity of this situation, the magnitude and duration of the pandemic
and its impact on our operations and liquidity is uncertain as of the date of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">However,
our business has been disrupted and materially adversely affected by the recent outbreak of COVID-19. We are still assessing our
business operations and system supports and the impact COVID-19 may have on our results and financial condition, but there can
be no assurance that this analysis will enable us to avoid part or all of any impact from the spread of COVID-19 or its consequences,
including downturns in business sentiment generally or in our sectors in particular.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Our
operations are located in Alameda County, CA, Orange County, CA, Fairfield County, CT, the United Kingdom, Israel and members of
our senior management work in Seattle, WA and New York, NY. We have been following the recommendations of local health authorities
to minimize exposure risk for our employees, including the temporary closures of our offices and having employees work remotely
to the extent possible, which has to an extent adversely affected their efficiency. California and the UK recently reinstituted
a second round of stay-at-home orders and lockdowns, respectively. For more information, see &ldquo;Risk Factors &ndash; We face
business disruption and related risks resulting from the recent outbreak of the novel coronavirus . . . .&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Corporate Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our corporate name
is DPW Holdings, Inc. for both legal and commercial purposes. Our principal address is 201 Shipyard Way, Suite E, Newport Beach,
CA 92663. Our phone number is (949) 444-5464. Our website is www.dpwholdings.com. The information on our website does not constitute
part of this prospectus.&nbsp; We have included our website address as a factual reference and do not intend it to be an active
link to our website.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>RISK FACTORS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1pt; text-align: justify; text-indent: 35.9pt">An investment
in our securities is speculative and involves a high degree of risk. Our business, financial condition or results of operations
could be adversely affected by any of these risks. You should carefully consider the risks described below and those risks set
forth in the reports that we file with the SEC and that we incorporate by reference into this prospectus, before deciding to invest
in our securities. The risks and uncertainties we have described are not the only ones we face. Additional risks and uncertainties
not presently known to us or that we currently deem immaterial may also affect our operations. Past financial performance may not
be a reliable indicator of future performance, and historical trends should not be used to anticipate results or trends in future
periods. If any of these risks actually occurs, our business, business prospects, financial condition or results of operations
could be seriously harmed. This could cause the trading price of our shares of common stock to decline, resulting in a loss of
all or part of your investment. Please also read carefully the section above entitled &ldquo;Disclosure Regarding Forward-Looking
Statements.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Risks Related to Our Company</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We have historically incurred significant
losses and our financial situation creates doubt whether we will continue as a going concern</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have historically
experienced operating and net losses and anticipate continuing to experience such losses in the future. For the years ended December
31, 2019 and 2018, we had an operating loss of $26,941,797 and $19,605,456 and net losses of $32,913,412 and $32,233,881, respectively.
As of December 31, 2019 and 2018, we had a working capital deficiency of $19,150,075 and $18,445,302, respectively. There are no
assurances that we will be able to achieve a level of revenues adequate to generate sufficient cash flow from operations or obtain
additional financing through private placements, public offerings and/or bank financing necessary to support our working capital
requirements. To the extent that funds generated from any private placements, public offerings and/or bank financing are insufficient,
we will have to raise additional working capital. No assurance can be given that additional financing will be available, or if
available, will be on acceptable terms. These conditions raise substantial doubt about our ability to continue as a going concern.
If adequate working capital is not available we may be forced to discontinue operations, which would cause investors to lose their
entire investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We
expect to continue to incur losses for the foreseeable future and need to raise additional capital to continue business development
initiatives and to support our working capital requirements. However, if we are unable to raise additional capital, we may be required
to curtail operations and take additional measures to reduce costs, including reducing our workforce, eliminating outside consultants
and reducing legal fees in order to conserve cash in amounts sufficient to sustain operations and meet our obligations. As a result
of these financing uncertainties, during the year ended December 31, 2019, we recognized that our dependence on ongoing capital
requirements to fund our operations raise substantial doubt about our ability to continue as a going concern. Our ongoing capital
requirements have only increased since then, meaning that substantial doubt about our ability to continue as a going concern remains
and will likely do so for the foreseeable future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>We will need
to raise additional capital to fund our operations in furtherance of our business plan.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Until
we are profitable, we will need to quickly raise additional capital in order to fund our operations in furtherance of our business
plan. The proposed financing may include shares of common stock, shares of preferred stock, warrants to purchase shares of common
stock or preferred stock, debt securities, units consisting of the foregoing securities, equity investments from strategic development
partners or some combination of each. Any additional equity financings may be financially dilutive to, and will be dilutive from
an ownership perspective to our stockholders, and such dilution may be significant based upon the size of such financing. Additionally,
we cannot assure that such funding will be available on a timely basis, in needed quantities, or on terms favorable to us, if at
all.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We have a certain amount of indebtedness.
This indebtedness and the covenants contained in our loan documents with senior creditors substantially limit our financial and
operating flexibility</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have entered into
a transaction document, pursuant to which we are constrained by certain security and similar agreements (the &ldquo;Transaction
Documents&rdquo;), with a senior lender (the &ldquo;Senior Lender&rdquo;). These Transaction Documents grant priority security
interests in all of our assets to the Senior Lender. Such Transaction Documents contain restrictions that substantially limit our
financial flexibility. These Transaction Documents place limits on our ability to (i) incur additional indebtedness even if such
indebtedness is subordinated to the debt instruments issued to the Senior Lenders or conduct an equity financing, and (ii) grant
security to third persons, among other matters. These restrictions limit the Company&rsquo;s ability to finance its future operations
and capital needs. Absent the consent of the Senior Lender, we would be unable to, among other things, obtain additional debt to
raise additional capital, implement our business strategy, establish corporate infrastructure and in any other way fund the development
of our business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>We face business
disruption and related risks resulting from the continuing impact of the novel coronavirus (&ldquo;COVID-19&rdquo;), which could
have a material adverse effect on our business and results of operations and curtail our ability to raise financing.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our business has been
disrupted and materially adversely affected by the recent outbreak of COVID-19. As a result of measures imposed by the governments
in affected regions, businesses and schools have been suspended due to quarantines intended to contain this outbreak and many people
have been forced to work from home in those areas. The spread of COVID-19 from China to other countries has resulted in the Director
General of the World Health Organization declaring the outbreak of COVID-19 as a Public Health Emergency of International Concern,
based on the advice of the Emergency Committee under the International Health Regulations (2005), and the Centers for Disease Control
and Prevention in the U.S. issued a warning on February 25, 2020 regarding the likely spread of COVID-19 to the U.S. While the
COVID-19 outbreak is still in its early stages, international stock markets have begun to reflect the uncertainty associated with
the slow-down in the American, Israeli and UK economies and the reduced levels of international travel experienced since the beginning
of January and the significant decline in the Dow Industrial Average at the end of February 2020 was largely attributed to the
effects of COVID-19. We are still assessing our business operations and system supports and the impact COVID-19 may have on our
results and financial condition, but there can be no assurance that this analysis will enable us to avoid part or all of any impact
from the spread of COVID-19 or its consequences, including downturns in business sentiment generally or in our sectors in particular.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="color: #333333">Our
operations are located in Alameda County, CA, Orange County, CA, Fairfield County, CT, the United Kingdom, Israel and members of
our senior management work in Seattle, WA and New York, NY, which is also the location of the </FONT>offices of the Company&rsquo;s
independent auditor<FONT STYLE="color: #333333">. </FONT>We have been following the recommendations of local health authorities
to minimize exposure risk for its employees for the past several weeks, including the temporary closures of our offices and having
employees work remotely to the extent possible<FONT STYLE="color: #333333">, which has to an extent adversely affected their efficiency.
</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Updates by business unit are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">DPW Holdings&rsquo; corporate headquarters, located in Newport Beach, CA, has begun working remotely,
based on the occupancy and social distancing order from the Orange County Health Officer (http://www.ochealthinfo.com/phs/about/epidasmt/epi/dip/prevention/novel_coronavirus).
The headquarters staff has tested the secure remote access systems and technology infrastructure to adjust working arrangements
for its employees and believes it has adequate internal communications system and can remain operational with a remote staff.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">Coolisys Technologies Corp., currently located in Milpitas, CA, decreased the number of its employees
working at its prior site in Fremont, CA for 14 weeks as a result of the Alameda County Public Health Department&rsquo;s order
to cease all activities at facilities located within the County.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">Microphase shut down its Shelton, CT production facility for a week in early December as a result
of positive COVID-19 tests among its employees for deep cleaning and is required to have all workers tested before gradually resuming
operations at the start of 2021. Microphase continues to follow CDC guidelines for social distancing, face coverings and heightened
sanitizing to keep the workforce safe and healthy. Microphase has strictly limited access to the facility and mandated that all
employees minimize exposure to the others. All Microphase employees who can work from home will do so while COVID-19 levels remain
high in the surrounding communities. Microphase management is working with state and federal authorities to get all employees vaccinated
on a priority basis as &ldquo;essential workers&rdquo; whom the U.S. Department of Defense have officially designated as &ldquo;critical
infrastructure workforce&rdquo; as part of the &ldquo;defense industrial base.&rdquo;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">Gresham Power Electronics shut down production operations in its Salisbury, UK facility from mid-March
2020 through June 2020 before resuming production until a subsequent shutdown in November 2020. Production operations will remain
closed down with the current lockdown until mid-February. However, engineers, back office staff and management have worked from
home throughout the pandemic period and continue to do so now. The pandemic has delayed contract actions and other customer decision
making, but Gresham Power expects these delays only to defer orders and business to rebound strongly with pent up demand in the
latter half of 2021.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">Relec has, notwithstanding the lockdown in the UK, experienced no COVID-19 related disruptions
and continues normal operations. All who can work from home do so. Others who must work at the Wareham site to move product or
access systems continue to do so under strict safety protocols with face coverings, social distancing and heightened attention
to sanitization. The principal impact on Relec&rsquo;s operations has come from deferral of some orders and modest decrease in
revenue year over year. Relec expects to business to rebound and resume a steady growth pattern in Q3 2021.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">Enertec Systems 2001 Ltd., located in Karmiel, Israel, has been granted a waiver by the Israeli
government to remain open to complete key projects that impact national security. Approximately 50% of the Enertec workforce is
working remotely.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Due to the unprecedented
market conditions domestically and internationally, and the effect COVID-19 has had and will continue to have on the Company&rsquo;s
operations and financial performance, the extent of which is not currently known, the Company is temporarily suspending guidance
for 2020. We will monitor the situation rigorously and provide business updates as circumstances warrant and resume providing guidance
on our business when management believes that such information would be both reliable and substantively informative.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; color: #212529">The
duration and extent of the impact from the COVID-19 pandemic depends on future developments that cannot be accurately predicted
at this time, such as the severity and transmission rate of the virus, the extent and effectiveness of containment actions and
the impact of these and other factors on our employees, customers, partners and vendors. If we are not able to respond to and manage
the impact of such events effectively, our business will be harmed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; color: #212529">As
noted above, we rely to a great extent on external financing to fund our operations. The outbreak of COVD-19 has had a materially
adverse impact on our ability to raise financing for our operations. Unless investors&rsquo; outlook improves dramatically in the
near future, it will further inhibit our ability to raise the funds we need to sustain our operations. No assurance can be given
that additional financing will be available, or if available, will be on acceptable terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;Our limited operating history
makes it difficult to evaluate our future business prospects and to make decisions based on our historical performance</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although our executive
officers have been engaged in the industries in which we operate for varying degrees of time, we did not begin operations of our
current business until recently. We have a very limited operating history in our current form, which makes it difficult to evaluate
our business on the basis of historical operations. As a consequence, it is difficult, if not impossible, to forecast our future
results based upon our historical data. Reliance on our historical results may not be representative of the results we will achieve,
and for certain areas in which we operate, principally those unrelated to defense contracting, will not be indicative at all. Because
of the uncertainties related to our lack of historical operations, we may be hindered in our ability to anticipate and timely adapt
to increases or decreases in sales, product costs or expenses. If we make poor budgetary decisions as a result of unreliable historical
data, we could be less profitable or incur losses, which may result in a decline in our stock price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>We have an evolving business model, which increases the complexity
of our business.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our business model
has evolved in the past and continues to do so. In prior years we have added additional types of services and product offerings
and in some cases we have modified or discontinued those offerings. We intend to continue to try to offer additional types of products
or services, and we do not know whether any of them will be successful. From time to time we have also modified aspects of our
business model relating to our product mix. We do not know whether these or any other modifications will be successful. The additions
and modifications to our business have increased the complexity of our business and placed significant strain on our management,
personnel, operations, systems, technical performance, financial resources, and internal financial control and reporting functions.
Future additions to or modifications of our business are likely to have similar effects. Further, any new business or website we
launch that is not favorably received by the market could damage our reputation or our brand. The occurrence of any of the foregoing
could have a material adverse effect on our business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We are a holding company whose subsidiaries
are given a certain degree of independence and our failure to integrate our subsidiaries may adversely affect our financial condition</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have given our subsidiary
companies and their executives a certain degree of independence in decision-making. On the one hand, this independence may increase
the sense of ownership at all levels, on the other hand it has also increased the difficulty of the integration of operation and
management, which has resulted in increased difficulty of management integration. In the event we are not able to successfully
manage our subsidiaries this will result in operating difficulties and have a negative impact on our business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>We and our independent auditors have expressed doubt about
our ability to continue as a going concern. If we do not continue as a going concern, investors will lose their entire investment</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In its report on our
financial statements included in our Annual Report for the fiscal year ended December 31, 2019, our independent auditors have expressed
doubt about our ability to continue as a going concern. Our ability to continue as a going concern is an issue raised as a result
of ongoing operating losses and a lack of financing commitments then in place to meet expected cash requirements. Our ability to
continue as a going concern is subject to our ability to generate a profit and/or obtain necessary funding from outside sources,
including obtaining additional funding from the sale of our securities, increasing sales or obtaining loans and grants from various
financial institutions where possible. If we do not continue as a going concern, investors will lose their entire investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We received an order and a subpoena
from the SEC in the investigation now known as &ldquo;<I>In the Matter of DPW Holdings, Inc</I></B>.<B><I>,&rdquo;</I> the consequences
of which are unknown.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We received an order
and related subpoena from the SEC that stated that the staff of the SEC is conducting an investigation now known as&nbsp;<I>&ldquo;In
the Matter of DPW Holdings, Inc.</I>,&rdquo; and that the subpoena was issued as part of an investigation as to whether we and
certain of our officers, directors, employees, partners, subsidiaries and/or affiliates, and/or other persons or entities, directly
or indirectly, violated certain provisions of the Securities Act and the Exchange Act, in connection with the offer and sale of
our securities. Although the order states that the SEC may have information relating to such alleged violations, the subpoena expressly
provides that the inquiry is not to be construed as an indication by the SEC or its staff that any violations of the federal securities
laws have occurred. We have produced documents in response to the subpoena. The SEC may in the future require us to produce additional
documents or information, or seek testimony from other members of our management team.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are unaware of the
scope or timing of the SEC&rsquo;s investigation. As a result, we do not know how the SEC&rsquo;s investigation is proceeding,
when the investigation will be concluded. We also are unable to predict what action, if any, might be taken in the future by the
SEC or its staff as a result of the matters that are the subject to its investigation or what impact, if any, the cost of continuing
to respond to subpoenas might have on our financial position, results of operations, or cash flows. We have not established any
provision for losses in respect of this matter In addition, complying with any such future requests by the SEC for documents or
testimony could distract the time and attention of our officers and directors or divert our resources away from ongoing business
matters. This investigation could result in significant legal expenses, the diversion of management&rsquo;s attention from our
business, damage to our business and reputation, and could subject us to a wide range of remedies, including an enforcement action
by the SEC. There can be no assurance that any final resolution of this and any similar matters will not have a material adverse
effect on our financial condition or results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;<B>Our inability to successfully integrate new acquisitions
could adversely affect our combined business; our operations are widely disbursed.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Our
growth strategy through acquisitions is subject to various risks. On June 2, 2017, we acquired a majority interest in Microphase
and on May 23, 2018 we acquired Enertec Systems 2001 Ltd. (&ldquo;Enertec&rdquo;). Further, on November 30, 2020, Gresham Worldwide
acquired Relec Electronics Ltd. from its present shareholders. Our strategy and business plan are dependent on our ability to successfully
integrate Microphase&rsquo;s, Enertec&rsquo;s and our other acquired entities&rsquo; operations. In addition, while we are based
in Newport Beach, CA, Microphase&rsquo;s operations are located in Shelton, Connecticut, Enertec&rsquo;s operations are located
in Karmiel, Israel and Gresham Power&rsquo;s operations are located in Salisbury, England. These distant locations and others that
we may become involved with in the future will stretch our resources and management time. Further, failure to quickly and adequately
integrate all of these operations and personnel could adversely affect our combined business and our ability to achieve our objectives
and strategy. No assurance can be given that we will realize synergies in the areas we currently operate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>If we make any additional acquisitions, they may disrupt
or have a negative impact on our business.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have plans to eventually
make additional acquisitions beyond Microphase, Enertec and Relec.&nbsp;Whenever we make acquisitions, we could have difficulty
integrating the acquired companies&rsquo; personnel and operations with our own. In addition, the key personnel of the acquired
business may not be willing to work for us. We cannot predict the effect expansion may have on our core business. Regardless of
whether we are successful in making an acquisition, the negotiations could disrupt our ongoing business, distract our management
and employees and increase our expenses. In addition to the risks described above, acquisitions are accompanied by a number of
inherent risks, including, without limitation, the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD>difficulty of integrating acquired products, services or operations;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD>potential disruption of the ongoing businesses and distraction of our management and the management of acquired companies;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD>difficulty of incorporating acquired rights or products into our existing business;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD>difficulties in disposing of the excess or idle facilities of an acquired company or business and expenses in maintaining such
facilities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD>difficulties in maintaining uniform standards, controls, procedures and policies;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1pt 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1pt 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD>potential impairment of relationships with employees and customers as a result of any integration of new management personnel;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD>potential inability or failure to achieve additional sales and enhance our customer base through cross-marketing of the products
to new and existing customers;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD>effect of any government regulations which relate to the business acquired; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD>potential unknown liabilities associated with acquired businesses or product lines, or the need to spend significant amounts
to retool, reposition or modify the marketing and sales of acquired products or the defense of any litigation, whether or not successful,
resulting from actions of the acquired company prior to our acquisition.&nbsp;&nbsp;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our business could
be severely impaired if and to the extent that we are unable to succeed in addressing any of these risks or other problems encountered
in connection with these acquisitions, many of which cannot be presently identified, these risks and problems could disrupt our
ongoing business, distract our management and employees, increase our expenses and adversely affect our results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>No assurance can be given as to the successful expansion
of our operations.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our significant increase
in the scope and the scale of our operations, including the hiring of additional personnel, has resulted in significantly higher
operating expenses. We anticipate that our operating expenses will continue to increase. Expansion of our operations may also make
significant demands on our management, finances and other resources. Our ability to manage the anticipated future growth, should
it occur, will depend upon a significant expansion of our accounting and other internal management systems and the implementation
and subsequent improvement of a variety of systems, procedures and controls. We cannot assure that significant problems in these
areas will not occur. Failure to expand these areas and implement and improve such systems, procedures and controls in an efficient
manner at a pace consistent with our business could have a material adverse effect on our business, financial condition and results
of operations. We cannot assure that attempts to expand our marketing, sales, manufacturing and customer support efforts will succeed
or generate additional sales or profits in any future period. As a result of the expansion of our operations and the anticipated
increase in our operating expenses, along with the difficulty in forecasting revenue levels, we expect to continue to experience
significant fluctuations in its results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We may be unable to successfully expand
our production capacity, which could result in material delays, quality issues, increased costs and loss of business opportunities,
which may negatively impact our product margins and profitability</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Part of our future
growth strategy is to increase our production capacity to meet increasing demand for our goods. Assuming we obtain sufficient funding
to increase our production capacity, any projects to increase such capacity may not be constructed on the anticipated timetable
or within budget. We may also experience quality control issues as we implement any production upgrades. Any material delay in
completing these projects, or any substantial cost increases or quality issues in connection with these projects could materially
delay our ability to bring our products to market and adversely affect our business, reduce our revenue, income and available cash,
all of which could harm our financial condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>If we fail to establish and maintain
an effective system of internal control over financial reporting, we may not be able to report our financial results accurately
or prevent fraud. Any inability to report and file our financial results accurately and timely could harm our reputation and adversely
impact the trading price of our common stock.&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Effective internal
control over financial reporting is necessary for us to provide reliable financial reports and prevent fraud. If we cannot provide
reliable financial reports or prevent fraud, we may not be able to manage our business as effectively as we would if an effective
control environment existed, and our business and reputation with investors may be harmed. As a result, our small size and any
current internal control deficiencies may adversely affect our financial condition, results of operations and access to capital.
We have carried out an evaluation under the supervision and with the participation of our management, including our principal executive
officer and principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures
as of the end of the most recent period covered by this report. Based on the foregoing, our principal executive officer and principal
financial officer concluded that our disclosure controls and procedures were not effective at the reasonable assurance level due
to the material weaknesses described below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">A
material weakness is a deficiency, or a combination of deficiencies, within the meaning of Public Company Accounting Oversight
Board (&ldquo;PCAOB&rdquo;) Audit Standard No. 5, in internal control over financial reporting, such that there is a reasonable
possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely
basis. Management has identified the following material weaknesses which have caused management to conclude that as of December
31, 2019, our internal control over financial reporting (&ldquo;ICFR&rdquo;) was not effective at the reasonable assurance level:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">1.</TD><TD STYLE="text-align: justify">We do not have sufficient resources in our accounting function, which restricts our ability to
gather, analyze and properly review information related to financial reporting, including fair value estimates, in a timely manner.
In addition, due to our size and nature, segregation of all conflicting duties may not always be possible and may not be economically
feasible. However, to the extent possible, the initiation of transactions, the custody of assets and the recording of transactions
should be performed by separate individuals. Management evaluated the impact of our failure to have segregation of duties during
our assessment of our disclosure controls and procedures and concluded that the control deficiency that resulted represented a
material weakness.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2.25pt; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">2.</TD><TD>We have inadequate controls to ensure that information necessary to properly record transactions is adequately communicated
on a timely basis from non-financial personnel to those responsible for financial reporting. Management evaluated the impact of
the lack of timely communication between non&ndash;financial and financial personnel on our assessment of our reporting controls
and procedures and has concluded that the control deficiency represented a material weakness.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">3.</TD><TD>We did not design or maintain effective general information technology (&ldquo;IT&rdquo;) controls over certain information
systems that are relevant to the mitigation of the risk pertaining to the misappropriation of assets. Specifically, we did not
design and implement p<FONT STYLE="background-color: white">rogram change management controls for certain financially relevant
systems to ensure that IT program and data changes affecting the Company&rsquo;s (i) financial IT applications, (ii) digital currency
mining equipment, (iii) digital currency hardware wallets, and (iv) underlying accounting records, are identified, tested, authorized
and implemented appropriately.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><I>Planned Remediation</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Management,
in coordination with the input, oversight and support of our board of directors, has identified the measures below to strengthen
our control environment and internal control over financial reporting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">In
January 2018, we hired a new Chief Financial Officer and engaged the services of a financial accounting advisory firm. In September
2018, we hired a Chief Accounting Officer and in January 2019, we hired a Senior Vice President of Finance. Finally, in May 2019,
we hired an Executive Vice President and General Counsel. We have tasked these individuals with expanding and monitoring the Company&rsquo;s
internal controls, to provide an additional level of review of complex financial issues and to assist with financial reporting.
On October 7, 2019, we created an Executive Committee comprised of our Chief Executive Officer, President and Executive Vice President
and General Counsel. The Executive Committee meets on a daily basis to address the Company&rsquo;s critical needs and provide a
forum to approve transactions. On December 16, 2020, we engaged Moss Adams LLP to further assist in our compliance with Section
404 of the Sarbanes-Oxley Act of 2002 and to identify internal control process improvement opportunities. Further, as we continue
to expand our internal accounting department, the Chairman of the Audit Committee will:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">assist with documentation and implementation of policies and procedures and monitoring of controls;
and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">review all anticipated transactions that are not considered in the ordinary course of business
to assist in the early identification of accounting issues and ensure that appropriate disclosures are made in our financial statements.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We
are currently working to improve and simplify our internal processes and implement enhanced controls, as discussed above, to address
the material weaknesses in our internal control over financial reporting and to remedy the ineffectiveness of our disclosure controls
and procedures. These material weaknesses will not be considered to be remediated until the applicable remediated controls are
operating for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>If our accounting
controls and procedures are circumvented or otherwise fail to achieve their intended purposes, our business could be seriously
harmed.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We
evaluate our disclosure controls and procedures as of the end of each fiscal quarter, and are annually reviewing and evaluating
our internal control over financial reporting in order to comply with the SEC&rsquo;s rules relating to internal control over financial
reporting adopted pursuant to the Sarbanes-Oxley Act of 2002. Because of its inherent limitations, internal control over financial
reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject
to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies
or procedures may deteriorate. If we fail to maintain effective internal control over financial reporting or our management does
not timely assess the adequacy of such internal control, we may be subject to regulatory sanctions, and our reputation may decline.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>We face significant competition, including changes in pricing.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The markets for our
products are both competitive and price sensitive. Many competitors have significant financial, operations, sales and marketing
resources, plus experience in research and development, and compete with us by offering lower prices. Competitors could develop
new technologies that compete with our products to achieve a lower unit price. If a competitor develops lower cost superior technology
or cost-effective alternatives to our products and services, our business could be seriously harmed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The markets for some
of our products are also subject to specific competitive risks because these markets are highly price competitive. Our competitors
have competed in the past by lowering prices on certain products. If they do so again, we may be forced to respond by lowering
our prices. This would reduce sales revenues and increase losses. Failure to anticipate and respond to price competition may also
impact sales and aggravate losses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Many of our competitors are larger and
have greater financial and other resources than we do.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our products compete
and will compete with similar if not identical products produced by our competitors. These competitive products could be marketed
by well-established, successful companies that possess greater financial, marketing, distribution personnel, and other resources
than we do. Using said resources, these companies can implement extensive advertising and promotional campaigns, both generally
and in response to specific marketing efforts by competitors. They can introduce new products to new markets more rapidly. In certain
instances, competitors with greater financial resources may be able to enter a market in direct competition with us, offering attractive
marketing tools to encourage the sale of products that compete with our products or present cost features that consumers may find
attractive.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>Our growth strategy is subject to
a significant degree of risk.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Our
growth strategy through acquisitions involves a significant degree of risk. Some of the companies that we have identified as acquisition
targets or make a significant investment in may not have a developed business or are experiencing inefficiencies and incur losses.
Therefore, we may lose our investment in the event that these companies&rsquo; businesses do not develop as planned or that we
are unable to achieve the cost efficiencies or reduction of losses as anticipated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Further,
in order to implement our growth plan, we have hired additional staff and consultants to review potential investments and implement
our plan. As a result, we have substantially increased our infrastructure and costs. If we fail to quickly find new companies that
provide revenue to offset our costs, we will continue to experience losses. No assurance can be given that our product development
and investments will produce sufficient revenues to offset these increases in expenditures.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Our business and operations are growing
rapidly. If we fail to effectively manage our growth, our business and operating results could be harmed</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have experienced,
and may continue to experience, rapid growth in our operations. This has placed, and may continue to place, significant demands
on our management, operational and financial infrastructure. If we do not manage our growth effectively, the quality of our products
and services could suffer, which could negatively affect our operating results. To effectively manage our growth, we must continue
to improve our operational, financial and management controls and reporting systems and procedures. These systems improvements
may require significant capital expenditures and management resources. Failure to implement these improvements could hurt our ability
to manage our growth and our financial position.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>We are heavily dependent on our senior management, and a
loss of a member of our senior management team could cause our stock price to suffer</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we lose the services
of Milton C. Ault III, our Chairman and Chief Executive Officer, William B. Horne, our President, or Henry Nisser, our Executive
Vice President and General Counsel, and/or certain key employees, we may not be able to find appropriate replacements on a timely
basis, and our business could be adversely affected. Our existing operations and continued future development depend to a significant
extent upon the performance and active participation of these individuals and certain key employees. Although we have entered into
employment agreements with Messrs. Ault, Horne and Nisser, and we may enter into employment agreements with additional key employees
in the future, we cannot guarantee that we will be successful in retaining the services of these individuals. If we were to lose
any of these individuals, we may not be able to find appropriate replacements on a timely basis and our financial condition and
results of operations could be materially adversely affected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We rely on highly skilled personnel
and the continuing efforts of our executive officers and, if we are unable to retain, motivate or hire qualified personnel, our
business may be severely disrupted.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our performance largely
depends on the talents, knowledge, skills, know-how and efforts of highly skilled individuals and in particular, the expertise
held by our Chairman and Chief Executive Officer, Milton C. Ault III. His absence, were it to occur, would materially and adversely
impact development and implementation of our projects and businesses. Our future success depends on our continuing ability to identify,
hire, develop, motivate and retain highly skilled personnel for all areas of our organization. Our continued ability to compete
effectively depends on our ability to attract, among others, new technology developers and to retain and motivate our existing
contractors. If one or more of our executive officers are unable or unwilling to continue in their present positions, we may not
be able to replace them readily, if at all. Therefore, our business may be severely disrupted, and we may incur additional expenses
to recruit and retain new officers. In addition, if any of our executives joins a competitor or forms a competing company, we may
lose some customers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Our operating results may vary from quarter to quarter.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our operating results
have in the past been subject to quarter-to-quarter fluctuations, and we expect that these fluctuations will continue, and may
increase in magnitude, in future periods. Demand for our products is driven by many factors, including the availability of funding
for our products in our customers&rsquo; capital budgets. There is a trend for some of our customers to place large orders near
the end of a quarter or fiscal year, in part to spend remaining available capital budget funds. Seasonal fluctuations in customer
demand for our products driven by budgetary and other concerns can create corresponding fluctuations in period-to-period revenues,
and we therefore cannot assure you that our results in one period are necessarily indicative of our revenues in any future period.
In addition, the number and timing of large individual sales and the ability to obtain acceptances of those sales, where applicable,
have been difficult for us to predict, and large individual sales have, in some cases, occurred in quarters subsequent to those
we anticipated, or have not occurred at all. The loss or deferral of one or more significant sales in a quarter could harm our
operating results for such quarter. It is possible that, in some quarters, our operating results will be below the expectations
of public market analysts or investors. In such events, or in the event adverse conditions prevail, the market price of our common
stock may decline significantly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>We may be classified as an inadvertent investment company.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are not engaged
in the business of investing, reinvesting, or trading in securities, and we do not hold ourselves out as being engaged in those
activities. Under the Investment Company Act, however, a company may be deemed an investment company under section 3(a)(1)(C) of
the Investment Company Act if the value of its investment securities is more than 40% of its total assets (exclusive of government
securities and cash items) on a consolidated basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our lending subsidiary,
Digital Power Lending, LLC (&ldquo;DP Lending&rdquo;), operates under California Finance Lending License #60DBO-77905. Per the
Investment Company Act of 1940 companies with substantially all their business confined to making small loans, industrial banking
or similar business, such as DP Lending, are excluded from the definition of an investment company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have commenced digital
asset mining, the output of which is cryptocurrencies, which the SEC has indicated it deems a security. In the event that the digital
assets held by us exceed 40% of our total assets, exclusive of cash, we inadvertently become an investment company. An inadvertent
investment company can avoid being classified as an investment company if it can rely on one of the exclusions under the Investment
Company Act. One such exclusion, Rule 3a-2 under the Investment Company Act, allows an inadvertent investment company a grace period
of one year from the earlier of (a) the date on which an issuer owns securities and/or cash having a value exceeding 50% of the
issuer&rsquo;s total assets on either a consolidated or unconsolidated basis and (b) the date on which an issuer owns or proposes
to acquire investment securities having a value exceeding 40% of the value of such issuer&rsquo;s total assets (exclusive of government
securities and cash items) on an unconsolidated basis. We are putting in place policies that we expect will work to keep the investment
securities held by us at less than 40% of our total assets, which may include acquiring assets with our cash, liquidating our investment
securities or seeking a no-action letter from the SEC if we are unable to acquire sufficient assets or liquidate sufficient investment
securities in a timely manner.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As Rule 3a-2 is available
to a company no more than once every three years, and assuming no other exclusion were available to us, we would have to keep within
the 40% limit for at least three years after we cease being an inadvertent investment company. This may limit our ability to make
certain investments or enter into joint ventures that could otherwise have a positive impact on our earnings. In any event, we
do not intend to become an investment company engaged in the business of investing and trading securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Classification as an
investment company under the Investment Company Act requires registration with the SEC. If an investment company fails to register,
it would have to stop doing almost all business, and its contracts would become voidable. Registration is time consuming and restrictive
and would require a restructuring of our operations, and we would be very constrained in the kind of business we could do as a
registered investment company. Further, we would become subject to substantial regulation concerning management, operations, transactions
with affiliated persons and portfolio composition, and would need to file reports under the Investment Company Act regime. The
cost of such compliance would result in our incurring substantial additional expenses, and the failure to register if required
would have a materially adverse impact to conduct our operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We will not be able to successfully
execute our business strategy if we are deemed to be an investment company under the Investment Company Act.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">U.S. companies that
have more than 100 stockholders or are publicly traded in the U.S. and are, or hold themselves out as being, engaged primarily
in the business of investing, reinvesting or trading in securities are subject to regulation under the Investment Company Act.&nbsp;
Unless a substantial part of our assets consists of, and a substantial part of our income is derived from, interests in majority-owned
subsidiaries and companies that we primarily control, we may be required to register and become subject to regulation under the
Investment Company Act.&nbsp; If we were deemed to own but not operate one or more of our other subsidiaries, we would have difficulty
avoiding classification and regulation as an investment company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we were deemed to
be, and were required to register as, an investment company, we would be forced to comply with substantive requirements under the
Investment Company Act, including limitations on our ability to borrow, limitations on our capital structure; restrictions on acquisitions
of interests in associated companies, prohibitions on transactions with affiliates, restrictions on specific investments, and compliance
with reporting, record keeping, voting, proxy disclosure and other rules and regulations.&nbsp; If we were forced to comply with
the rules and regulations of the Investment Company Act, our operations would significantly change, and we would be prevented from
successfully executing our business strategy.&nbsp; To avoid regulation under the Investment Company Act and related rules promulgated
by the SEC, we could need to sell bitcoin and other assets which we would otherwise want to retain and could be unable to sell
assets which we would otherwise want to sell.&nbsp; In addition, we could be forced to acquire additional, or retain existing,
income-generating or loss-generating assets which we would not otherwise have acquired or retained and could need to forgo opportunities
to acquire bitcoin and other assets that would benefit our business.&nbsp; If we were forced to sell, buy or retain assets in this
manner, we could be prevented from successfully executing our business strategy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Securitization of our assets subjects us to various risks</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may securitize assets
to generate cash for funding new investments. We refer to the term securitize to describe a form of leverage under which a company
(sometimes referred to as an &ldquo;originator&rdquo; or &ldquo;sponsor&rdquo;) transfers income producing assets to a single-purpose,
bankruptcy-remote subsidiary (also referred to as a &ldquo;special purpose entity&rdquo; or &ldquo;SPE&rdquo;), which is established
solely for the purpose of holding such assets and entering into a structured finance transaction. The SPE would then issue notes
secured by such assets. The special purpose entity may issue the notes in the capital markets either publicly or privately to a
variety of investors, including banks, non-bank financial institutions and other investors. There may be a single class of notes
or multiple classes of notes, the most senior of which carries less credit risk and the most junior of which may carry substantially
the same credit risk as the equity of the SPE.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">An important aspect
of most debt securitization transactions is that the sale and/or contribution of assets into the SPE be considered a true sale
and/or contribution for accounting purposes and that a reviewing court would not consolidate the SPE with the operations of the
originator in the event of the originator's bankruptcy based on equitable principles. Viewed as a whole, a debt securitization
seeks to lower risk to the note purchasers by isolating the assets collateralizing the securitization in an SPE that is not subject
to the credit and bankruptcy risks of the originator. As a result of this perceived reduction of risk, debt securitization transactions
frequently achieve lower overall leverage costs for originators as compared to traditional secured lending transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In accordance with
the above description, to securitize loans, we may create a wholly owned subsidiary and contribute a pool of our assets to such
subsidiary. The SPE may be funded with, among other things, whole loans or interests from other pools and such loans may or may
not be rated. The SPE would then sell its notes to purchasers whom we would expect to be willing to accept a lower interest rate
and the absence of any recourse against us to invest in a pool of income producing assets to which none of our creditors would
have access. We would retain all or a portion of the equity in the SPE. An inability to successfully securitize portions of our
portfolio or otherwise leverage our portfolio through secured and unsecured borrowings could limit our ability to grow our business
and fully execute our business strategy, and could decrease our earnings, if any. However, the successful securitization of portions
of our portfolio exposes us to a risk of loss for the equity we retain in the SPE and might expose us to greater risk on our remaining
portfolio because the assets we retain may tend to be those that are riskier and more likely to generate losses. A successful securitization
may also impose financial and operating covenants that restrict our business activities and may include limitations that could
hinder our ability to finance additional loans and investments. The Investment Company Act may also impose restrictions on the
structure of any securitizations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Interests we hold in
the SPE, if any, will be subordinated to the other interests issued by the SPE. As such, we will only receive cash distributions
on such interests if the SPE has made all cash interest and other required payments on all other interests it has issued. In addition,
our subordinated interests will likely be unsecured and rank behind all of the secured creditors, known or unknown, of the SPE,
including the holders of the senior interests it has issued. Consequently, to the extent that the value of the SPE's portfolio
of assets has been reduced as a result of conditions in the credit markets, or as a result of defaults, the value of the subordinated
interests we retain would be reduced. Securitization imposes on us the same risks as borrowing except that our risk in a securitization
is limited to the amount of subordinated interests we retain, whereas in a borrowing or debt issuance by us directly we would be
at risk for the entire amount of the borrowing or debt issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may also engage
in transactions utilizing SPEs and securitization techniques where the assets sold or contributed to the SPE remain on our balance
sheet for accounting purposes. If, for example, we sell the assets to the SPE with recourse or provide a guarantee or other credit
support to the SPE, its assets will remain on our balance sheet. Consolidation would also generally result if we, in consultation
with the SEC, determine that consolidation would result in a more accurate reflection of our assets, liabilities and results of
operations. In these structures, the risks will be essentially the same as in other securitization transactions but the assets
will remain our assets for purposes of the limitations described above on investing in assets that are not qualifying assets and
the leverage incurred by the SPE will be treated as borrowings incurred by us for purposes of our limitation on the issuance of
senior securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>We may not be able to utilize our net operating loss carry
forwards.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At December 31, 2019,
we had federal net operating loss carry forwards (&ldquo;NOLs&rdquo;) for income tax purposes of approximately $52,884,756. Approximately
$12,302,381 of NOLs generated prior to 2018 has begun to expire in 2020. The Coronavirus Aid, Relief, and Economic Security Act
signed in to law on March 27, 2020 provided that NOLs generated in a taxable year beginning in 2018, 2019, or 2020, may now be
carried back five years and forward indefinitely. In addition, the 80% taxable income limitation is temporarily removed, allowing
NOLs to fully offset net taxable income. However, we do not know if or when we will have any earnings and capital gains against
which we could apply these carry forwards.&nbsp; Furthermore, as a result of changes in the ownership of our common stock, our
ability to use our federal NOLs will be limited under Internal Revenue Code Section 382.&nbsp; State NOLs are subject to similar
limitations in many cases.&nbsp; As a result, our substantial NOLs may not have any value to us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Changes in the U.S. tax and other laws and regulations may
adversely affect our business.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The U.S. government
may revise tax laws, regulations or official interpretations in ways that could have a significant adverse effect on our business,
including modifications that could reduce the profits that we can effectively realize from our international operations, or that
could require costly changes to those operations, or the way in which they are structured.&nbsp; For example, the effective tax
rates for most U.S. companies reflect the fact that income earned and reinvested outside the U.S. is generally taxed at local rates,
which may be much lower than U.S. tax rates.&nbsp; If we expand abroad and there are changes in tax laws, regulations or interpretations
that significantly increase the tax rates on non-U.S. income, our effective tax rate could increase and our profits could be reduced.&nbsp;
If such increases resulted from our status as a U.S. company, those changes could place us at a disadvantage to our non-U.S. competitors
if those competitors remain subject to lower local tax rates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Risks Related to Related Party Transactions</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There may be conflicts
of interest between our company and certain of our related parties and their respective directors and officers which might not
be resolved in our favor. More importantly, there may be conflicts between certain of our related parties and their respective
directors and officers which might not be resolved in our favor. These risks are set forth below appurtenant to the relevant related
party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Ault &amp; Company</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Our relationship with Ault &amp; Company
may enhance the difficulty inherent in obtaining financing for us as well as expose us to certain conflicts of interest.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of the date of this
prospectus, Ault &amp; Company, of which Milton C. Ault is the chief executive officer, beneficially owned 1,362,795 shares of
our common stock, consisting of 1,078,967 shares owned, 275,862 shares of common stock underlying the 8% Convertible Promissory
Note in the outstanding principal amount of $400,000 sold by us to Ault &amp; Company on February 5, 2020, assuming no conversion
of accrued, unpaid interest on this note, warrants to purchase 94 shares of common stock that are currently exercisable and shares
owned by Philou Ventures, of which Ault &amp; Company, Inc. is the Manager, consisting of: (i) 125,000 shares of Series B Preferred
Stock that are convertible into 2,232 shares of common stock, (ii) warrants to purchase 2,232 shares of common stock that are exercisable
within 60 days of the date hereof and (iii) 3,408 shares of common stock. Assuming Ault &amp; Company converted its note on the
date of this prospectus, Ault &amp; Company would own a number of shares of common stock equal to 4.9% of the number of shares
of common stock on the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Further, Ault &amp;
Company and our company are negotiating the terms of a proposed purchase by Ault &amp; Company of a certain number of shares of
Series C Preferred Stock. Presently, neither the number nor the terms of any such Series C Preferred Stock has been determined,
and any such purchase would have to be approved by our stockholders before Ault &amp; Company would be able to vote or convert
such shares of Series C Preferred Stock. Notwithstanding the presently indeterminate nature of any such acquisition of Series Preferred
Stock, you should be aware that the consummation of such a transaction, assuming the receipt by the Company of its stockholders
approval thereof, could substantially increase Ault &amp; Company&rsquo;s beneficial ownership of our shares of common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Given the close relationship
between Ault &amp; Company on the one hand, and our company on the other, it is far from inconceivable that we could enter into
additional securities purchase agreements with Ault &amp; Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although we have relied
on Philou, which no longer beneficially owns any meaningful number of our shares of common stock, to finance us in the past, and
anticipate that Ault &amp; Company may purchase shares of our Series C Preferred Stock under an agreement providing for the purchase
thereof, we cannot assure you that either Philou or Ault &amp; Company will assist us in the future. We would far prefer to rely
on these entities&rsquo; assistance compared to other sources of financing as the terms they provide us are in general more favorable
to us than we could obtain elsewhere. However, Messrs. Ault, Horne and Nisser could face a conflict of interest in that they serve
on the board of directors of each of Ault &amp; Company and our company. If they determine that an investment in our company is
not in Ault &amp; Company&rsquo;s best interest, we could be forced to seek financing from other sources that would not necessarily
be likely to provide us with equally favorable terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Other conflicts of
interest between us, on the one hand, and Ault &amp; Company, on the other hand, may arise relating to commercial or strategic
opportunities or initiatives. Mr. Ault, as the controlling shareholder of Ault &amp; Company, may not resolve such conflicts in
our favor. For example, we cannot assure you that Ault &amp; Company would not pursue opportunities to provide financing to other
entities whether or not it currently has a relationship with such other entities. Furthermore, our ability to explore alternative
sources of financing other than Ault &amp; Company may be constrained due to Mr. Ault&rsquo;s vision for us and he may not wish
for us to receive any financing at all other than from entities that he controls.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Alzamend Neuro, Inc.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Our relationship with Alzamend Neuro
may expose us to certain conflicts of interest.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1pt; text-align: justify; text-indent: 0.5in">In August 2020,
Alzamend Neuro entered into a securities purchase agreement with our company to sell a convertible promissory note of Alzamend
Neuro, in the aggregate principal amount of $50,000 and issue a 5-year warrant to purchase 16,667 of shares of its common stock.
The convertible promissory note bears interest at 8% per annum, which principal and all accrued and unpaid interest are due six
months after the date of issuance. The principal and interest earned on the convertible promissory note may be converted into shares
of the Alzamend Neuro&rsquo;s common stock at $1.50 per share. The exercise price of the warrant is $3.00 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In December 2020, we
provided Alzamend Neuro $1,000,000 in short-term advances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Messrs. Ault, Horne
and Nisser could face a conflict of interest in that they serve on the board of directors of each of Alzamend Neuro and our company.
Mr. Cragun, our chief financial officer is also the chief financial officer of Alzamend Neuro.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Avalanche International Corp</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We have lent a substantial amount of
funds to Avalanche, a related party, whose ability to repay us is subject to significant doubt and it may not be in our stockholders&rsquo;
best interest to convert the notes into shares of Avalanche common stock even if we had a reasonably viable means of doing so.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On September 6, 2017,
we entered into a Loan and Security Agreement with Avalanche (&ldquo;<B>AVLP Loan Agreement</B>&rdquo;) with an effective date
of August 21, 2017 pursuant to which we will provide Avalanche a non-revolving credit facility of up to $10,000,000 for a period
ending on August 21, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At September 30, 2020,
we had provided Avalanche with $10,153,661 pursuant to the non-revolving credit facility. The warrants issued in conjunction with
the non-revolving credit facility entitles us to purchase up to 20,306,921 shares of Avalanche common stock at an exercise price
of $0.50 per share for a period of five years. The exercise price of $0.50 is subject to adjustment for customary stock splits,
stock dividends, combinations or similar events. The warrants may be exercised for cash or on a cashless basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There is currently
no liquid market for the Avalanche common stock. Consequently, even if we were inclined to convert the debt owed us by Avalanche
into shares of its common stock, our ability to sell such shares is severely limited. Avalanche is not current in its filings with
the SEC and is not required to register the shares of its common stock underlying the amount provided pursuant to the non-revolving
credit facility or any other loan arrangement we have made with Avalanche described above. Further, even if Avalanche were willing
to register such shares, it would not be permitted to do so until it has registered the shares of its common stock underlying the
Third Party Note.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a result, there
is considerable doubt as to whether Avalanche will ever have the ability to repay its debts to us, or if we convert the debt owed
us by Avalanche into shares of its common stock, our ability to convert such shares into cash through the sale of such shares would
be severely limited until such time, if ever, a liquid market for Avalanche&rsquo;s common stock develops. If we are unable to
recoup our investment in Avalanche in the foreseeable future or at all, such failure would have a materially adverse effect on
our financial condition and future prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Originally, the loans we made to Avalanche
were secured by a lien on all of Avalanche&rsquo;s assets. Presently, we only have third priority interest.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Originally, the loans
we made to Avalanche were secured by a lien on all of Avalanche&rsquo;s assets. When Avalanche entered into the Exchange Agreement
with MTIX (see below), the former owners of MTIX were granted a first priority interest in all of MTIX&rsquo;s assets, which constitute
virtually all of Avalanche&rsquo;s assets and reduced our interest to that of a second position, greatly diminishing its value.
When Avalanche issued the Third Party Note referred to above, it granted the third party a first priority security interest in
all its assets, to include those comprised of MTIX. Both we and the former owners of MTIX consented to the subordination of our
respective security interests. Since our security interests have been reduced to a third position, we will have no ability to use
Avalanche&rsquo;s assets to offset any default in Avalanche&rsquo;s debt obligations to us unless and until the two other security
interests are terminated, which would not occur until Avalanche&rsquo;s debts to the senior creditors have been repaid. We do not
anticipate that Avalanche will repay its debts to these creditors within the foreseeable future and will therefore have no recourse
should Avalanche default on its debts to us during this period of time. Any failure by Avalanche to repay us would therefore have
a materially adverse effect on our results of operations, financial condition and future prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Milton C. Ault, III and William Horne,
our Chief Executive Officer and President, respectively, and two of our directors are directors of Avalanche. In addition, Philou
is the controlling stockholder of Avalanche.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Milton C. Ault, III
and William Horne, our Chief Executive Officer and President, respectively, and two of our directors are directors of Avalanche.
In addition, Philou is the controlling stockholder of Avalanche. Certain conflicts of interest between us, on the one hand, and
Avalanche, on the other hand, may arise relating to commercial or strategic opportunities or initiatives, in addition to the conflicts
related to the debt that Avalanche owes us. For example, Messrs. Ault and Horne may find it difficult to determine how to meet
their fiduciary duties to us as well as Avalanche, which could result in a less favorable result for us than would be the case
if they were solely directors of our company. Further, even if Messrs. Ault and Horne were able to successfully meet their fiduciary
obligations to us and Avalanche, the fact that are members of the board of directors of both companies could attenuate their ability
to focus on our business and best interests, possibly to the detriment of both companies. Mr. Ault&rsquo;s control of Philou through
Ault &amp; Company only enhances the risk inherent in having Messrs. Ault and Horne serve as directors of both our company and
Avalanche.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Risks Related to Our Business and Industry - Overview</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Technology changes rapidly in our business,
and if we fail to anticipate new technologies, the quality, timeliness and competitiveness of our products will suffer.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Rapid technology changes
in our industry require us to anticipate, sometimes years in advance, which technologies and/or distribution platforms our products
must take advantage of in order to make them competitive in the market at the time they are released. Therefore, we usually start
our product development with a range of technical development goals that we hope to be able to achieve. We may not be able to achieve
these goals, or our competition may be able to achieve them more quickly than we can. In either case, our products may be technologically
inferior to competitive products, or less appealing to consumers, or both. If we cannot achieve our technology goals within the
original development schedule of our products, then we may delay products until these technology goals can be achieved, which may
delay or reduce revenue and increase our development expenses. Alternatively, we may increase the resources employed in research
and development in an attempt to accelerate our development of new technologies, either to preserve our product launch schedule
or to keep up with our competition, which would increase our development expenses and adversely affect our operations and financial
condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We are dependent upon our ability, and
our contract manufacturers&rsquo; ability, to timely procure electronic components.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Because of the global
economy, many raw material vendors have reduced capacities, closed production lines and, in some cases, even discontinued their
operations. As a result, there is a global shortage of certain electronic or mineral components, which may extend our production
lead-time and our production costs. Some materials are no longer available to support some of our products, thereby requiring us
to search for cross materials or, even worse, redesign some of our products to support currently-available materials. Such redesign
efforts may require certain regulatory and safety agency re-submittals, which may cause further production delays. While we have
initiated actions that we believe will limit our exposure to such problems, the dynamic business conditions in many of our markets
may challenge the solutions that have been put in place, and issues may recur in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, some of
our products are manufactured, assembled and tested by third party subcontractors and contract manufacturers located in Asia. While
we have had relationships with many of these third parties in the past, we cannot predict how or whether these relationships will
continue in the future. In addition, changes in management, financial viability, manufacturing demand or capacity, or other factors,
at these third parties could hurt our ability to manufacture our products.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Our strategic focus on our custom power
supply solution competencies and concurrent cost reduction plans may be ineffective or may limit our ability to compete.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a result of our
strategic focus on custom power supply solutions, we will continue to devote significant resources to developing and manufacturing
custom power supply solutions for a large number of customers, where each product represents a uniquely tailored solution for a
specific customer&rsquo;s requirements. Failure to meet these customer product requirements or a failure to meet production schedules
and/or product quality standards may put us at risk with one or more of these customers. Moreover, changes in market conditions
and strategic changes at the direction of our customers may affect their decision to continue to purchase from us. The loss of
one or more of our significant custom power supply solution customers could have a material adverse impact on our revenues, business
or financial condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have also implemented
a series of initiatives designed to increase efficiency and reduce costs. While we believe that these actions will reduce costs,
they may not be sufficient to achieve the required operational efficiencies that will enable us to respond more quickly to changes
in the market or result in the improvements in our business that we anticipate. In such event, we may be forced to take additional
cost-reducing initiatives, including those involving our personnel, which may negatively impact quarterly earnings and profitability
as we account for severance and other related costs. In addition, there is the risk that such measures could have long-term adverse
effects on our business by reducing our pool of talent, decreasing or slowing improvements in our products or services, making
it more difficult for us to respond to customers, limiting our ability to increase production quickly if and when the demand for
our solutions increases and limiting our ability to hire and retain key personnel. These circumstances could cause our earnings
to be lower than they otherwise might be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We<FONT STYLE="color: red">&nbsp;</FONT>depend
upon a few major customers for a majority of our revenues, and the loss of any of these customers, or the substantial reduction
in the quantity of products that they purchase from us, would significantly reduce our revenues and net income.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We currently depend
upon a few major OEMs and other customers for a significant portion of our revenues. If our major OEM customers will reduce or
cancel their orders scaling back some of their activities, our revenues and net income would be significantly reduced. Furthermore,
diversions in the capital spending of certain of these customers to new network elements have and could continue to lead to their
reduced demand for our products, which could, in turn, have a material adverse effect on our business and results of operations.
If the financial condition of one or more of our major customers should deteriorate, or if they have difficulty acquiring investment
capital due to any of these or other factors, a substantial decrease in our revenues would likely result. We are dependent on the
electronic equipment industry, and accordingly will be affected by the impact on that industry of current economic conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Substantially all of
our existing customers are in the electronic equipment industry, and they manufacture products that are subject to rapid technological
change, obsolescence, and large fluctuations in demand. This industry is further characterized by intense competition and volatility.
The OEMs serving this industry are pressured for increased product performance and lower product prices. OEMs, in turn, make similar
demands on their suppliers, such as us, for increased product performance and lower prices. Such demands may adversely affect our
ability to successfully compete in certain markets or our ability to sustain our gross margins.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Our reliance on subcontract manufacturers
to manufacture certain aspects of our products involves risks, including delays in product shipments and reduced control over product
quality.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Since we do not own
significant manufacturing facilities, we must rely on, and will continue to rely on, a limited number of subcontract manufacturers
to manufacture our power supply products. Our reliance upon such subcontract manufacturers involves several risks, including reduced
control over manufacturing costs, delivery times, reliability and quality of components, unfavorable currency exchange fluctuations,
and continued inflationary pressures on many of the raw materials used in the manufacturing of our power supply products. If we
were to encounter a shortage of key manufacturing components from limited sources of supply, or experience manufacturing delays
caused by reduced manufacturing capacity, inability of our subcontract manufacturers to procure raw materials, the loss of key
assembly subcontractors, difficulties associated with the transition to our new subcontract manufacturers or other factors, we
could experience lost revenues, increased costs, and delays in, or cancellations or rescheduling of, orders or shipments, any of
which would materially harm our business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We outsource, and are dependent upon
developer partners for, the development of some of our custom design products.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We made an operational
decision to outsource some of our custom design products to numerous developer partners. This business structure will remain in
place until the custom design volume justifies expanding our in house capabilities. Incomplete product designs that do not fully
comply with the customer specifications and requirements might affect our ability to transition to a volume production stage of
the custom designed product where the revenue goals are dependent on the high volume of custom product production. Furthermore,
we rely on the design partners&rsquo; ability to provide high quality prototypes of the designed product for our customer approval
as a critical stage to approve production.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We face intense industry competition,
price erosion and product obsolescence, which, in turn, could reduce our profitability.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We operate in an industry
that is generally characterized by intense competition. We believe that the principal bases of competition in our markets are breadth
of product line, quality of products, stability, reliability and reputation of the provider, along with cost. Quantity discounts,
price erosion, and rapid product obsolescence due to technological improvements are therefore common in our industry as competitors
strive to retain or expand market share. Product obsolescence can lead to increases in unsaleable inventory that may need to be
written off and, therefore, could reduce our profitability. Similarly, price erosion can reduce our profitability by decreasing
our revenues and our gross margins. In fact, we have seen price erosion over the last several years on most of the products we
sell, and we expect additional price erosion in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Our future results are dependent on
our ability to establish, maintain and expand our manufacturers&rsquo; representative OEM relationships and our other relationships.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We market and sell
our products through domestic and international OEM relationships and other distribution channels, such as manufacturers&rsquo;
representatives and distributors. Our future results are dependent on our ability to establish, maintain and expand our relationships
with OEMs as well as with manufacturers&rsquo; representatives and distributors to sell our products. If, however, the third parties
with whom we have entered into such OEM and other arrangements should fail to meet their contractual obligations, cease doing,
or reduce the amount of their, business with us or otherwise fail to meet their own performance objectives, customer demand for
our products could be adversely affected, which would have an adverse effect on our revenues.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We may not be able to procure necessary
key components for our products, or we may purchase too much inventory or the wrong inventory.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The power supply industry,
and the electronics industry as a whole, can be subject to business cycles. During periods of growth and high demand for our products,
we may not have adequate supplies of inventory on hand to satisfy our customers' needs. Furthermore, during these periods of growth,
our suppliers may also experience high demand and, therefore, may not have adequate levels of the components and other materials
that we require to build products so that we can meet our customers' needs. Our inability to secure sufficient components to build
products for our customers could negatively impact our sales and operating results. We may choose to mitigate this risk by increasing
the levels of inventory for certain key components. Increased inventory levels can increase the potential risk for excess and obsolescence
should our forecasts fail to materialize or if there are negative factors impacting our customers&rsquo; end markets. If we purchase
too much inventory or the wrong inventory, we may have to record additional inventory reserves or write-off the inventory, which
could have a material adverse effect on our gross margins and on our results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Although we depend on sales of our legacy
products for a meaningful portion of our revenues, these products are mature and their sales will decline.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A relatively large
portion of our sales have historically been attributable to our legacy products. We expect that these products may continue to
account for a meaningful percentage of our revenues for the foreseeable future. However, these sales are declining. Although we
are unable to predict future prices for our legacy products, we expect that prices for these products will continue to be subject
to significant downward pressure in certain markets for the reasons described above. Accordingly, our ability to maintain or increase
revenues will be dependent on our ability to expand our customer base, to increase unit sales volumes of these products and to
successfully, develop, introduce and sell new products such as custom design and value-added products. We cannot assure you that
we will be able to expand our customer base, increase unit sales volumes of existing products or develop, introduce and/or sell
new products.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Failure of our information technology
infrastructure to operate effectively could adversely affect our business.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We depend heavily on
information technology infrastructure to achieve our business objectives. If a problem occurs that impairs this infrastructure,
the resulting disruption could impede our ability to record or process orders, manufacture and ship in a timely manner, or otherwise
carry on business in the normal course. Any such events could cause us to lose customers or revenue and could require us to incur
significant expense to remediate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We are subject to certain governmental
regulatory restrictions relating to our international sales.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Some of our products
are subject to International Traffic in Arms Regulation (&ldquo;ITAR&rdquo;), which are interpreted, enforced and administered
by the U.S. Department of State. ITAR regulation controls not only the export, import and trade of certain products specifically
designed, modified, configured or adapted for military systems, but also the export of related technical data and defense services
as well as foreign production. Any delays in obtaining the required export, import or trade licenses for products subject to ITAR
regulation and rules could have a material adverse effect on our business, financial condition, and/or operating results. In addition,
changes in United States export and import laws that require us to obtain additional export and import licenses or delays in obtaining
export or import licenses currently being sought could cause significant shipment delays and, if such delays are too great, could
result in the cancellation of orders. Any future restrictions or charges imposed by the United States or any other country on our
international sales or foreign subsidiary could have a materially adverse effect on our business, financial condition, and/or operating
results. In addition, from time to time, we have entered into contracts with the Israeli Ministry of Defense which were governed
by the U.S. Foreign Military Financing program (&ldquo;FMF&rdquo;). Any such future sales would be subject to these regulations.
Failure to comply with ITAR or FMF rules could have a material adverse effect on our financial condition, and/or operating results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We depend on international operations
for a substantial majority of our components and products.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We purchase a substantial
majority of our components from foreign manufacturers and have a substantial majority of our commercial products assembled, packaged,
and tested by subcontractors located outside the United States. These activities are subject to the uncertainties associated with
international business operations, including trade barriers and other restrictions, changes in trade policies, governmental regulations,
currency exchange fluctuations, reduced protection for intellectual property, war and other military activities, terrorism, changes
in social, political, or economic conditions, and other disruptions or delays in production or shipments, any of which could have
a materially adverse effect on our business, financial condition, and/or operating results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>We depend on international sales for a portion of our revenues.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Sales to customers
outside of North America accounted for 56.9% and 29.9% of net revenues for the years ended December 31, 2019 and 2018, and we expect
that international sales will continue to represent a material portion of our total revenues. International sales are subject to
the risks of international business operations as described above, as well as generally longer payment cycles, greater difficulty
collecting accounts receivable, and currency restrictions. In addition, Gresham, our wholly-owned subsidiary in the United Kingdom,
supports our European and other international customers, distributors, and sales representatives, and therefore is also subject
to local regulation. International sales are also subject to the export laws and regulations of the United States and other countries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Our sales and profitability may be affected
by changes in economic, business and industry conditions</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the economic climate
in the United States or abroad deteriorates, customers or potential customers could reduce or delay their technology and entertainment
investments. Reduced or delayed technology and entertainment investments could decrease our sales and profitability. In this environment,
our customers may experience financial difficulty, cease operations and fail to budget or reduce budgets for the purchase of our
products and professional services. This may lead to longer sales cycles, delays in purchase decisions, payment and collection,
and can also result in downward price pressures, causing our sales and profitability to decline. In addition, general economic
uncertainty and general declines in capital spending in the information technology sector make it difficult to predict changes
in the purchasing requirements of our customers and the markets we serve. There are many other factors which could affect our business,
including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">The introduction and market acceptance of new technologies, products and services;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.15pt"></TD><TD STYLE="width: 35.85pt">&bull;</TD><TD STYLE="text-align: justify">New competitors and new forms of competition;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.15pt"></TD><TD STYLE="width: 35.85pt">&bull;</TD><TD STYLE="text-align: justify">The size and timing of customer orders (for retail distributed physical product);&nbsp;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.15pt"></TD><TD STYLE="width: 35.85pt">&bull;</TD><TD>The size and timing of capital expenditures by our customers;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.15pt"></TD><TD STYLE="width: 35.85pt">&bull;</TD><TD STYLE="text-align: justify">Adverse changes in the credit quality of our customers and suppliers;&nbsp;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.15pt"></TD><TD STYLE="width: 35.85pt">&bull;</TD><TD STYLE="text-align: justify">Changes in the pricing policies of, or the introduction of, new products and services by us or
our competitors;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.15pt"></TD><TD STYLE="width: 35.85pt">&bull;</TD><TD STYLE="text-align: justify">Changes in the terms of our contracts with our customers or suppliers;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.15pt"></TD><TD STYLE="width: 35.85pt">&bull;</TD><TD STYLE="text-align: justify">The availability of products from our suppliers; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>
<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.15pt"></TD><TD STYLE="width: 35.85pt">&bull;</TD><TD STYLE="text-align: justify">Variations in product costs and the mix of products sold.&nbsp;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">These trends and factors
could adversely affect our business, profitability and financial condition and diminish our ability to achieve our strategic objectives.</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The sale of our products is dependent
upon our ability to satisfy the proprietary requirements of our customers.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We depend upon a relatively
narrow range of products for the majority of our revenue. Our success in marketing our products is dependent upon their continued
acceptance by our customers. In some cases, our customers require that our products meet their own proprietary requirements. If
we are unable to satisfy such requirements, or forecast and adapt to changes in such requirements, our business could be materially
harmed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The sale of our products is dependent
on our ability to respond to rapid technological change, including evolving industry-wide standards, and may be adversely affected
by the development, and acceptance by our customers, of new technologies which may compete with, or reduce the demand for, our
products.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Rapid technological
change, including evolving industry standards, could render our products obsolete. To the extent our customers adopt such new technology
in place of our products, the sales of our products may be adversely affected. Such competition may also increase pricing pressure
for our products and adversely affect the revenues from such products.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Our limited ability to protect our proprietary
information and technology may adversely affect our ability to compete, and our products could infringe upon the intellectual property
rights of others, resulting in claims against us, the results of which could be costly.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Many of our products
consist entirely or partly of proprietary technology owned by us. Although we seek to protect our technology through a combination
of copyrights, trade secret laws and contractual obligations, these protections may not be sufficient to prevent the wrongful appropriation
of our intellectual property, nor will they prevent our competitors from independently developing technologies that are substantially
equivalent or superior to our proprietary technology. In addition, the laws of some foreign countries do not protect our proprietary
rights to the same extent as the laws of the United States. In order to defend our proprietary rights in the technology utilized
in our products from third party infringement, we may be required to institute legal proceedings, which would be costly and would
divert our resources from the development of our business. If we are unable to successfully assert and defend our proprietary rights
in the technology utilized in our products, our future results could be adversely affected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although we attempt
to avoid infringing known proprietary rights of third parties in our product development efforts, we may become subject to legal
proceedings and claims for alleged infringement from time to time in the ordinary course of business. Any claims relating to the
infringement of third-party proprietary rights, even if not meritorious, could result in costly litigation, divert management&rsquo;s
attention and resources, require us to reengineer or cease sales of our products or require us to enter into royalty or license
agreements which are not advantageous to us. In addition, parties making claims may be able to obtain an injunction, which could
prevent us from selling our products in the United States or abroad.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>If we are unable to satisfy our customers&rsquo;
specific product quality, certification or network requirements, our business could be disrupted and our financial condition could
be harmed.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our customers demand
that our products meet stringent quality, performance and reliability standards. We have, from time to time, experienced problems
in satisfying such standards. Defects or failures have occurred in the past, and may in the future occur, relating to our product
quality, performance and reliability. From time to time, our customers also require us to implement specific changes to our products
to allow these products to operate within their specific network configurations. If we are unable to remedy these failures or defects
or if we cannot effect such required product modifications, we could experience lost revenues, increased costs, including inventory
write-offs, warranty expense and costs associated with customer support, delays in, or cancellations or rescheduling of, orders
or shipments and product returns or discounts, any of which would harm our business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>If we ship products that contain defects,
the market acceptance of our products and our reputation will be harmed and our customers could seek to recover their damages from
us.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our products are complex,
and despite extensive testing, may contain defects or undetected errors or failures that may become apparent only after our products
have been shipped to our customers and installed in their network or after product features or new versions are released. Any such
defect, error or failure could result in failure of market acceptance of our products or damage to our reputation or relations
with our customers, resulting in substantial costs for us and our customers as well as the cancellation of orders, warranty costs
and product returns. In addition, any defects, errors, misuse of our products or other potential problems within or out of our
control that may arise from the use of our products could result in financial or other damages to our customers. Our customers
could seek to have us pay for these losses. Although we maintain product liability insurance, it may not be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="background-color: white"><B>Some
of our business is subject to U.S. government procurement laws and regulations</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="background-color: white">We
must comply with certain laws and regulations relating to the formation, administration and performance of federal government contracts.
These laws and regulations affect how we conduct business with our federal government contracts, including the business that we
do as a subcontractor. In complying with these laws and regulations, we may incur additional costs, and non-compliance may lead
to the assessment of fines and penalties, including contractual damages, or the loss of business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Risks Related to Our Business and Industry - Microphase</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Microphase has a history of losses and
our future profitability on a quarterly or annual basis is uncertain, which could have a harmful effect on our business and the
value of our company.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the past three
fiscal years Microphase has incurred losses from operations. These losses are attributable to lower volumes of its products sold
to major defense contractors partially as a result of the overall reduction in defense spending and sequestration by the U.S. Congress.
Since the financial crisis of 2008, Microphase has been significantly short of capital needed to acquire parts for production of
its products to complete orders for such products. At times, Microphase has not had the cash available to make advance payments
for the purchase of parts, and then, as a consequence, Microphase would not receive the parts from its vendors required to finish
a customer order. This would then delay the delivery of products to customers, and would also delay recognition of the resulting
revenues and the receipt of cash from the customer. Sometimes after experiencing a delay in delivery of an order from Microphase,
the customer would not place its next order with Microphase, resulting in a loss of business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Microphase&rsquo;s
future profitability depends upon many factors, including several that are beyond its control. These factors include, without limitation:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">changes in the demand for ITS products and services;</P></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">loss of key customers or contracts;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">the introduction of competitive products;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">the failure to gain market acceptance of ITS new and existing products; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">the failure to successfully and cost effectively develop, introduce and market new products, services
and product enhancements in a timely manner.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, Microphase
is incurring significant legal, accounting, and other expenses related to being a reporting company without there being a trading
market for any of its securities. As a result of these expenditures, Microphase will have to generate and sustain increased revenue
to achieve and maintain future profitability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>A large percentage of Microphase&rsquo;s
current revenue is derived from prime defense contractors to the U.S. government and its allies, and the loss of these relationships,
a reduction in U.S. government funding or a change in U.S. government spending priorities or bidding processes could have an adverse
impact on its business, financial condition, results of operations and cash flows.&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Microphase is highly
dependent on sales to major defense contractors of the U.S. military and its allies, including Lockheed Martin, Raytheon, BAE Systems
and SAAB. The percentages of its revenue that were derived from sales to these named major defense contractors and directly to
the U.S. Government were 51.5% in fiscal 2019 and 55.6% in fiscal 2018. Therefore, any significant disruption or deterioration
of Microphase&rsquo;s relationship with any such major defense contractors or the U.S. Government could materially reduce its revenue.&nbsp;
During the year ended December 31, 2019 there were three customers that accounted for more than 10% of sales:&nbsp; BAE Systems,
Raytheon Company and Lockheed Martin.&nbsp; During the year ended December 31, 2018 there were four customers that accounted for
more than 10% of sales: BAE Systems, Raytheon Company, Saab and Lockheed Martin. Microphase&rsquo;s competitors continuously engage
in efforts to expand their business relationships with the same major defense contractors and the U.S. Government and will continue
these efforts in the future, and the U.S. Government may choose to use other contractors. Microphase expects that a majority of
the business that it seeks will be awarded through competitive bidding. Microphase operates in highly competitive markets and its
competitors have more extensive or more specialized engineering, manufacturing and marketing capabilities than Microphase does
in many areas, and Microphase may not be able to continue to win competitively awarded contracts or to obtain task orders under
multi-award contracts. Further, the competitive bidding process involves significant cost and managerial time to prepare bids and
proposals for contracts that may not be awarded to Microphase, as well as the risk that Microphase may fail to accurately estimate
the resources and costs required to fulfill any contract awarded to us. Following any contract award, Microphase may experience
significant expense or delay, contract modification or contract rescission as a result of its competitors protesting or challenging
contracts awarded to it in competitive bidding. Major defense contractors to whom Microphase supplies components for systems must
compete with other major defense contractors (to which Microphase may not supply components) for military orders from the U.S.
Government.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, Microphase
competes with other policy needs, which may be viewed as more necessary, for limited resources and an ever-changing amount of available
funding in the budget and appropriation process. Budget and appropriations decisions made by the U.S. Government are outside of
Microphase control and have long-term consequences for its business. U.S. Government spending priorities and levels remain uncertain
and difficult to predict and are affected by numerous factors, including until recently sequestration (automatic, across-the-board
U.S. Government budgetary spending cuts), and the purchase of our products could be superseded by alternate arrangements. While
the US defense budget was recently increased, there can be no assurance that this increase will be maintained for the foreseeable
future, particularly in light of the recent federal expenditures the federal government has made with a view to ameliorating the
economic damage suffered as a result of COVID-19. A change in U.S. Government spending priorities or an increase in non-procurement
spending at the expense of our programs, or a reduction in total U.S. Government spending, could have material adverse consequences
on Microphase&rsquo;s future business.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Microphase&rsquo;s U.S. government contracts
may be terminated by the federal government at any time prior to their completion, which could lead to unexpected loss of sales
and reduction in Microphase&rsquo;s backlog.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Under the terms of Microphase&rsquo;s U.S.
government contracts, the U.S. government may unilaterally:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD>terminate or modify existing contracts;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD>reduce the value of existing contracts through partial termination; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD>delay the payment of Microphase&rsquo;s invoices by government payment offices.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The federal government
can terminate or modify any of its contracts with Microphase or its prime contractors either for the federal government&rsquo;s
convenience, or if Microphase or its prime contractors default, by failing to perform under the terms of the applicable contract.
A termination arising out of Microphase&rsquo;s default could expose it to liability and have a material adverse effect on its
ability to compete for future federal government contracts and subcontracts. If the federal government or its prime contractors
terminate and/or materially modify any of Microphase&rsquo;s contracts or if any applicable options are not exercised, Microphase&rsquo;s
failure to replace sales generated from such contracts would result in lower sales and would adversely affect its earnings, which
could have a material adverse effect on Microphase&rsquo;s business, results of operations and financial condition. Microphase&rsquo;s
backlog as of December 31, 2019 was approximately $6.4 million. Microphase&rsquo;s backlog could be adversely affected if contracts
are modified or terminated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Microphase&rsquo;s products with military
applications are subject to export regulations, and compliance with these regulations may be costly.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Microphase is required
to obtain export licenses before filling foreign orders for many of its products that have military or other governmental applications.
United States Export Administration regulations control technology exports like its products for reasons of national security and
compliance with foreign policy, to guarantee domestic reserves of products in short supply and, under certain circumstances, for
the security of a destination country. Thus, any foreign sales of its products requiring export licenses must comply with these
general policies. Compliance with these regulations is costly, and these regulations are subject to change, and any such change
may require Microphase to improve its technologies, incur expenses or both in order to comply with such regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Microphase depends on U.S. government
contracts issued to major defense contractors, which often are only partially funded, subject to immediate termination, and heavily
regulated and audited. The termination or failure to fund, or negative audit findings for, one or more of these contracts could
have an adverse impact on Microphase&rsquo;s business.&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Over its lifetime,
a U.S. Government program awarded to a major defense contractor may be implemented by the award of many different individual contracts
and subcontracts. The funding of U.S. Government programs is subject to Congressional appropriations. Although multi-year contracts
may be authorized and appropriated in connection with major procurements, Congress generally appropriates funds on a fiscal year
basis. Procurement funds are typically made available for obligations over the course of one to three years. Consequently, programs
often receive only partial funding initially, and additional funds are designated only as Congress authorizes further appropriations.
The termination of funding for a U.S. Government program with respect to major defense contractors for which Microphase is a subcontractor
would result in a loss of anticipated future revenue attributable to that program, which could have an adverse impact on its operations.
In addition, the termination of, or failure to commit additional funds to, a program for which Microphase is a subcontractor could
result in lost revenue and increase its overall costs of doing business.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Generally, U.S. Government
contracts are subject to oversight audits by U.S. Government representatives. Such audits could result in adjustments to Microphase&rsquo;s
contract costs. Any costs found to be improperly allocated to a specific contract will not be reimbursed, and such costs already
reimbursed must be refunded. Microphase has recorded contract revenues based on costs Microphase expect to realize upon final audit.
However, Microphase does not know the outcome of any future audits and adjustments, and Microphase may be required to materially
reduce its revenues or profits upon completion and final negotiation of audits. Negative audit findings could also result in termination
of a contract, forfeiture of profits, suspension of payments, fines and suspension or debarment from U.S. Government contracting
or subcontracting for a period of time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, U.S. Government
contracts generally contain provisions permitting termination, in whole or in part, without prior notice at the U.S. Government&rsquo;s
convenience upon the payment only for work done and commitments made at the time of termination. Microphase can give no assurance
that one or more of the U.S. Government contracts with a major defense contractor under which Microphase provides component products
will not be terminated under these circumstances. Also, Microphase can give no assurance that it will be able to procure new contracts
to offset the revenue or backlog lost as a result of any termination of its U.S. Government contracts. Because a significant portion
of Microphase&rsquo;s revenue is dependent on its performance and payment under its U.S. Government contracts, the loss of one
or more large contracts could have a material adverse impact on its business, financial condition, results of operations and cash
flows.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Microphase&rsquo;s
government business also is subject to specific procurement regulations and other requirements. These requirements, though customary
in U.S. Government contracts, increase its performance and compliance costs. In addition, these costs might increase in the future,
thereby reducing Microphase&rsquo;s margins, which could have an adverse effect on its business, financial condition, results of
operations and cash flows. Failure to comply with these regulations and requirements could lead to fines, penalties, repayments,
or compensatory or treble damages, or suspension or debarment from U.S. Government contracting or subcontracting for a period of
time. Among the causes for debarment are violations of various laws, including those related to procurement integrity, export control,
U.S. Government security regulations, employment practices, protection of the environment, accuracy of records, proper recording
of costs and foreign corruption. The termination of a U.S. Government contract or relationship as a result of any of these acts
would have an adverse impact on Microphase&rsquo;s operations and could have an adverse effect on its standing and eligibility
for future U.S. Government contracts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Microphase&rsquo;s business could be
negatively impacted by cybersecurity threats and other security threats and disruptions.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a U.S. Government
defense contractor, Microphase faces certain security threats, including threats to its information technology infrastructure,
attempts to gain access to its proprietary or classified information, threats to physical security, and domestic terrorism events.
Microphase&rsquo;s information technology networks and related systems are critical to the operation of its business and essential
to its ability to successfully perform day-to-day operations. Microphase is also involved with information technology systems for
certain customers and other third parties, which generally face similar security threats. Cybersecurity threats in particular,
are persistent, evolve quickly and include, but are not limited to, computer viruses, attempts to access information, denial of
service and other electronic security breaches. Microphase believes that it has implemented appropriate measures and controls and
has invested in skilled information technology resources to appropriately identify threats and mitigate potential risks, but there
can be no assurance that such actions will be sufficient to prevent disruptions to mission critical systems, the unauthorized release
of confidential information or corruption of data. A security breach or other significant disruption involving these types of information
and information technology networks and related systems could:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">disrupt the proper functioning of these networks and systems and therefore its operations and/or
those of certain of its customers;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">result in the unauthorized access to, and destruction, loss, theft, misappropriation or release
of, proprietary, confidential, sensitive or otherwise valuable information of Microphase or its customers, including trade secrets,
which others could use to compete against Microphase or for disruptive, destructive or otherwise harmful purposes and outcomes;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">compromise national security and other sensitive government functions;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">require significant management attention and resources to remedy the damages that result;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">subject Microphase to claims for breach of contract, damages, credits, penalties or termination;
and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">damage Microphase&rsquo;s reputation with its customers (particularly agencies of the U.S. Government)
and the public generally.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Any or all of the foregoing could have a
negative impact on its business, financial condition, results of operations and cash flows.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Microphase enters into fixed-price contracts
that could subject it to losses in the event of cost overruns or a significant increase in inflation.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Microphase has a number
of fixed-price contracts which allow it to benefit from cost savings but subject it to the risk of potential cost overruns, particularly
for firm fixed-price contracts, because Microphase assumes the entire cost burden. If its initial estimates are incorrect, Microphase
can lose money on these contracts. U.S. Government contracts can expose Microphase to potentially large losses because the U.S.
Government can hold Microphase responsible for completing a project or, in certain circumstances, paying the entire cost of its
replacement by another provider regardless of the size or foreseeability of any cost overruns that occur over the life of the contract.
Because many of these contracts involve new technologies and applications, unforeseen events such as technological difficulties,
fluctuations in the price of raw materials, problems with its suppliers and cost overruns, can result in the contractual price
becoming less favorable or even unprofitable to Microphase. The U.S. and other countries also may experience a significant increase
in inflation. A significant increase in inflation rates could have a significant adverse impact on the profitability of these contracts.
Furthermore, if Microphase does not meet contract deadlines or specifications, Microphase may need to renegotiate contracts on
less favorable terms, be forced to pay penalties or liquidated damages or suffer major losses if the customer exercises its right
to terminate. In addition, some of its contracts have provisions relating to cost controls and audit rights, and if Microphase
fails to meet the terms specified in those contracts Microphase may not realize their full benefits. Microphase&rsquo;s results
of operations are dependent on its ability to maximize its earnings from its contracts. Cost overruns could have an adverse impact
on its financial results.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Risks Related to Our Business and Industry - Enertec</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;<B>Potential political, economic and military instability
in Israel could adversely affect our operations.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1pt; text-align: justify; text-indent: 35.9pt">Enertec&rsquo;s
operating facilities are located in Israel. Accordingly, political, economic and military conditions in Israel directly affect
Enertec&rsquo;s operations. Since the establishment of the State of Israel in 1948, a number of armed conflicts have taken place
between Israel and its Arab neighbors. A state of hostility, varying in degree and intensity, has led to security and economic
problems for Israel. Since October 2000, there has been an increase in hostilities between Israel and the Palestinian Arabs, which
has adversely affected the peace process and has negatively influenced Israel&rsquo;s relationship with its Arab citizens and several
Arab countries, including the Israel-Gaza conflict. Such ongoing hostilities may hinder Israel&rsquo;s international trade relations
and may limit the geographic markets where Enertec can sell its products and solutions. Hostilities involving or threatening Israel,
or the interruption or curtailment of trade between Israel and its present trading partners, could materially and adversely affect
Enertec&rsquo;s operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, Israel-based
companies and companies doing business with Israel have been the subject of an economic boycott by members of the Arab League and
certain other predominantly Muslim countries since Israel&rsquo;s establishment. Although Israel has entered into various agreements
with certain Arab countries and the Palestinian Authority, and various declarations have been signed in connection with efforts
to resolve some of the economic and political problems in the Middle East, we cannot predict whether or in what manner these problems
will be resolved. Wars and acts of terrorism have resulted in significant damage to the Israeli economy, including reducing the
level of foreign and local investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Furthermore, certain
of our officers and employees may be obligated to perform annual reserve duty in the Israel Defense Forces and are subject to being
called up for active military duty at any time. All Israeli male citizens who have served in the army are subject to an obligation
to perform reserve duty until they are between 40 and 49 years old, depending upon the nature of their military service.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Enertec may become subject to claims
for remuneration or royalties for assigned service invention rights by its employees, which could result in litigation and harm
our business.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A significant portion
of the intellectual property covered by Enertec&rsquo;s products has been developed by Enertec&rsquo;s employees in the course
of their employment for Enertec. Under the Israeli Patent Law, 5727-1967, or the Patent Law, and recent decisions by the Israeli
Supreme Court and the Israeli Compensation and Royalties Committee, a body constituted under the Patent Law, Israeli employees
may be entitled to remuneration for intellectual property that they develop for us unless they explicitly waive any such rights.
To the extent that Enertec is unable to enter into agreements with its future employees pursuant to which they agree that any
inventions created in the scope of their employment or engagement are owned exclusively by Enertec (as it has done in the past),
Enertec may face claims demanding remuneration. As a consequence of such claims, Enertec could be required to pay additional remuneration
or royalties to its current and former employees, or be forced to litigate such claims, which could negatively affect its business.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;<B><U>Risks Related to Ownership
of Our Common Stock and this Offering</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>If we do not
continue to satisfy the NYSE American continued listing requirements, our common stock could be delisted from NYSE American.</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
listing of our common stock on the NYSE American is contingent on our compliance with the NYSE American&rsquo;s conditions for
continued listing. On July 24, 2020, we were notified by the NYSE American that we were no longer in compliance with the NYSE American
continued listing standards because our reported stockholders' equity was below continued listing standards. The NYSE American
requires that a listed company's stockholders' equity be $6.0 million or more if it has reported losses from continuing operations
and/or net losses in its five most recent fiscal years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Following
submission of our compliance plan demonstrating how we intend to regain compliance with the continued listing standards, we were
notified on October 8, 2020, that the NYSE American granted us a listing extension on the basis of our plan until January 24, 2022.
We are subject to periodic review by NYSE American staff during the extension period. Failure to make progress consistent with
the plan or to regain compliance with the continued listing standards by the end of the extension period could result in our common
stock being delisted from the NYSE American.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">On
January 4, 2021, we were notified by the NYSE American we failed to comply with the NYSE American continued listing standards because
of our inability to hold an annual meeting of stockholders no later than one year after the end of our last fiscal year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">In
light of our continued losses and inability to obtain quorum for our annual meeting, there is no assurance that we will be able
to regain compliance with the NYSE American continued listing standards. If we fail to meet the NYSE American listing requirement,
we may be subject to delisting by the NYSE American. In the event our common stock is no longer listed for trading on the NYSE
American, our trading volume and share price may decrease and we may experience further difficulties in raising capital which could
materially affect our operations and financial results. Further, delisting from the NYSE American could also have other negative
effects, including potential loss of confidence by partners, lenders, suppliers and employees and could also trigger various defaults
under our lending agreements and other outstanding agreements. Finally, delisting could make it harder for us to raise capital
and sell securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>You may experience future dilution as a result of future
equity offerings.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In order to raise additional
capital, we may in the future offer additional shares of our common stock or other securities convertible into or exchangeable
for our common stock at prices that may not be the same as the price per share in this offering. We may sell shares or other securities
in any other offering at a price per share that is less than the price per share paid by investors in this offering, and investors
purchasing shares or other securities in the future could have rights superior to existing stockholders. The price per share at
which we sell additional shares of our common stock, or securities convertible or exchangeable into common stock, in future transactions
may be higher or lower than the price per share paid by investors in this offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Our common stock price is volatile.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our common stock is
listed on the NYSE American. In the past, our trading price has fluctuated widely, depending on many factors that may have little
to do with our operations or business prospects. The exercise of outstanding options and warrants may adversely affect our stock
price and a stockholder&rsquo;s percentage of ownership. As of December 31, 2020, we had outstanding options to purchase an aggregate
of 950 shares of common stock, with a weighted average exercise price of $564.32 per share, exercisable at prices ranging from
$480 to $1,352 per share and warrants to purchase up to 3,316,034 shares of common stock, with a weighted average exercise price
of $6.31 per share, at exercise prices ranging from $0.88 to $2,000 per share.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On April 2, 2019, pursuant
to the underwriting agreement with A.G.P./Alliance Global Partners entered into on March 29, 2019, as referenced above, we issued
an aggregate of 793,325 shares of common stock, including shares of common stock underlying warrants. The sale of these shares
of our common stock, including those underlying the warrants (assuming exercise thereof), has had a material and adverse effect
on the market price of our common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, we have
previously agreed to register shares of common stock, and common stock underlying outstanding warrants and convertible debt in
connection with private placement of our securities that are not being registered in this prospectus. Our shares of common stock
are thinly traded. Therefore, the resale of a large number of shares of common stock and common stock underlying warrants and convertible
debt by the selling stockholders may adversely affect the market price of our common stock.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Volatility in our common stock price may subject us to securities
litigation.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Stock markets, in general,
have experienced, and continue to experience, significant price and volume volatility, and the market price of our common stock
may continue to be subject to similar market fluctuations unrelated to our operating performance or prospects. This increased volatility,
coupled with depressed economic conditions, could continue to have a depressing effect on the market price of our common stock.
The following factors, many of which are beyond our control, may influence our stock price:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">the status of our growth strategy including the development of new products with any proceeds we
may be able to raise in the future;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">announcements of technological or competitive developments;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">regulatory developments affecting us, our customers or our competitors;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">announcements regarding patent or other intellectual property litigation or the issuance of patents
to us or our competitors or updates with respect to the enforceability of patents or other intellectual property rights generally
in the US or internationally;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">actual or anticipated fluctuations in our quarterly operating results;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">changes in financial estimates by securities research analysts;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">changes in the economic performance or market valuations of our competitors;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">additions or departures of our executive officers; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">sales or perceived sales of additional shares of our common stock.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, the securities
markets have, from time to time, experienced significant price and volume fluctuations that are not related to the operating performance
of particular companies. Any of these factors could result in large and sudden changes in the volume and trading price of our common
stock and could cause our stockholders to incur substantial losses. In the past, following periods of volatility in the market
price of a company&rsquo;s securities, stockholders have often instituted securities class action litigation against that company.
If we were involved in a class action suit or other securities litigation, it would divert the attention of our senior management,
require us to incur significant expense and, whether or not adversely determined, have a material adverse effect on our business,
financial condition, results of operations and prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>We have a substantial
number of convertible notes, warrants, options and preferred stock outstanding that could affect our price.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Due
to a number of financings, we have a substantial number of shares that are subject to issuance pursuant to outstanding convertible
debt, warrants and options. These conversion prices and exercise prices range from $0.88 to $2,000 per share of common stock. As
of&nbsp;the date of this prospectus, the number of shares of common stock subject to convertible notes, warrants, options and preferred
stock were 440,862, 3,316,034, 950 and 2,232,&nbsp;respectively. The issuance of common stock pursuant to convertible notes, warrants,
options and preferred stock at conversion or exercise prices less than market prices may have the effect of limiting an increase
in market price of our common stock until all of these underling shares have been issued.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The issuance of shares of our Class
B Common Stock to our management or others could provide such persons with voting control leaving our other stockholders unable
to elect our directors and the holders of our shares of common stock will have little influence over our Management.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although there are
currently no shares of our Class B Common Stock issued and outstanding, our certificate of incorporation authorizes the issuance
of 25,000,000 shares of Class B Common Stock. Each share of Class B Common Stock provides the holder thereof with ten (10) votes
on all matters submitted to a stockholder vote. Our certificate of incorporation does not provide for cumulative voting for the
election of directors. Any person or group who controls or can obtain more than 50% of the votes cast for the election of each
director will control the election of directors and the other stockholders will not be able to elect any directors or exert any
influence over management decisions. As a result of the super-voting rights of our shares of Class B Common Stock, the issuance
of such shares to our management or others could provide such persons with voting control and our other stockholders will not
be able to elect our directors and will have little influence over our management. While we are listed on the NYSE American or
any other national securities exchange it is highly unlikely that we would issue any shares of Class B Common Stock as doing so
would jeopardize our continued listing any such exchange. However, if were to be delisted for some other reason and our shares
of Class A Common Stock trade on an over-the-counter market, then we would face no restriction on issuing shares of Class B Common
Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>We have a number
of shares of common stock subject to registration rights.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Due
to a number of financings, we have contractually agreed to register with the SEC shares of common stock, and common stock underlying
outstanding warrants and convertible debt in connection with private placements of our securities. The potential resale at the
same time of a large number of shares of common stock and common stock underlying warrants and convertible debt by the selling
stockholders may adversely affect the market price of our common stock.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The rights of the holders of common
stock may be impaired by the potential issuance of preferred stock.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our certificate of
incorporation gives our board of directors the right to create new series of preferred stock. As a result, the board of directors
may, without stockholder approval, issue preferred stock with voting, dividend, conversion, liquidation or other rights which could
adversely affect the voting power and equity interest of the holders of common stock. Preferred stock, which could be issued with
the right to more than one vote per share, could be utilized as a method of discouraging, delaying or preventing a change of control.
The possible impact on takeover attempts could adversely affect the price of our common stock. Although we have no present intention
to issue any shares of preferred stock or to create a series of preferred stock, we may issue such shares in the future.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The requirements of being a public company
may strain our resources, divert management&rsquo;s attention and affect our ability to attract and retain qualified board members.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are a public company
and subject to the reporting requirements of the Exchange Act, and the Sarbanes-Oxley Act of 2002. The Exchange Act requires, among
other things, that we file annual, quarterly and current reports with respect to our business and financial condition. The Sarbanes-Oxley
Act requires, among other things, that we maintain effective disclosure controls and procedures and internal controls for financial
reporting. For example, Section&nbsp;404 of the Sarbanes-Oxley Act requires that our management report on the effectiveness of
our internal controls structure and procedures for financial reporting. Section&nbsp;404 compliance may divert internal resources
and will take a significant amount of time and effort to complete.&nbsp;If we fail to maintain compliance under Section 404, or
if in the future management&nbsp;determines that our internal control over financial reporting are not effective as defined under
Section&nbsp;404, we could be subject to sanctions or investigations by the NYSE American should we in the future be listed on
this market, the SEC, or other regulatory authorities. Furthermore, investor perceptions of our company may suffer, and this could
cause a decline in the market price of our common stock. Any failure of our internal controls could have a material adverse effect
on our stated results of operations and harm our reputation. If we are unable to implement these changes effectively or efficiently,
it could harm our operations, financial reporting or financial results and could result in an adverse opinion on internal controls
from our independent auditors. We may need to hire a number of additional employees with public accounting and disclosure experience
in order to meet our ongoing obligations as a public company, particularly if we become fully subject to Section 404 and its auditor
attestation requirements, which will increase costs. Our management team and other personnel will need to devote a substantial
amount of time to new compliance initiatives and to meeting the obligations that are associated with being a public company, which
may divert attention from other business concerns, which could have a material adverse effect on our business, financial condition
and results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>If we fail to comply with the rules&nbsp;under
the Sarbanes-Oxley Act of 2002 related to accounting controls and procedures, or if we discover material weaknesses and deficiencies
in our internal control and accounting procedures, our stock price could decline significantly and raising capital could be more
difficult.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we fail to comply
with the rules&nbsp;under the Sarbanes-Oxley Act of 2002 related to disclosure controls and procedures, or, if we discover material
weaknesses and other deficiencies in our internal control and accounting procedures, our stock price could decline significantly
and raising capital could be more difficult. Section&nbsp;404 of the Sarbanes-Oxley Act requires annual management assessments
of the effectiveness of our internal control over financial reporting. If material weaknesses or significant deficiencies are discovered
or if we otherwise fail to achieve and maintain the adequacy of our internal control, we may not be able to ensure that we can
conclude on an ongoing basis that we have effective internal controls over financial reporting in accordance with Section&nbsp;404
of the Sarbanes-Oxley Act. Moreover, effective internal controls are necessary for us to produce reliable financial reports and
are important to helping prevent financial fraud. If we cannot provide reliable financial reports or prevent fraud, our business
and operating results could be harmed, investors could lose confidence in our reported financial information, and the trading price
of our common stock could drop significantly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>If securities or industry analysts do
not publish research or reports about our business, or if they change their recommendations regarding our stock adversely, our
stock price and trading volume could decline.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The trading market
for our common stock will be influenced by the research and reports that industry or securities analysts publish about us or our
business. Our research coverage by industry and financial analysts is currently limited. Even if our analyst coverage increases,
if one or more of the analysts who cover us downgrade our stock, our stock price would likely decline. If one or more of these
analysts cease coverage of our company or fail to regularly publish reports on us, we could lose visibility in the financial markets,
which in turn could cause our stock price or trading volume to decline.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The elimination of monetary liability
against our directors, officers and employees under law and the existence of indemnification rights for or obligations to our directors,
officers and employees may result in substantial expenditures by us and may discourage lawsuits against our directors, officers
and employees.&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our certificate of
incorporation contains a provision permitting us to eliminate the personal liability of our directors to us and our stockholders
for damages for the breach of a fiduciary duty as a director or officer to the extent provided by Delaware law. We may also have
contractual indemnification obligations under any future employment agreements with our officers. The foregoing indemnification
obligations could result in us incurring substantial expenditures to cover the cost of settlement or damage awards against directors
and officers, which we may be unable to recoup. These provisions and the resulting costs may also discourage us from bringing a
lawsuit against directors and officers for breaches of their fiduciary duties, and may similarly discourage the filing of derivative
litigation by our stockholders against our directors and officers even though such actions, if successful, might otherwise benefit
us and our stockholders.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We do not anticipate paying dividends
on our common stock and, accordingly, stockholders must rely on stock appreciation for any return on their investment.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have never declared
or paid cash dividends on our common stock and do not expect to do so in the foreseeable future. The declaration of dividends is
subject to the discretion of our board of directors and will depend on various factors, including our operating results, financial
condition, future prospects and any other factors deemed relevant by our board of directors. You should not rely on an investment
in our company if you require dividend income from your investment in our company. The success of your investment will likely depend
entirely upon any future appreciation of the market price of our common stock, which is uncertain and unpredictable. There is no
guarantee that our common stock will appreciate in value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>USE OF PROCEEDS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Except as otherwise
provided in the applicable prospectus supplement, we intend to use the net proceeds from the sale of the securities offered by
this prospectus for general corporate purposes, which may include working capital, capital expenditures, research and development
expenditures, regulatory affairs expenditures, clinical trial expenditures, acquisitions of new technologies and investments, the
financing of possible acquisitions or business expansions, and the repayment, refinancing, redemption or repurchase of future indebtedness
or capital stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The intended application
of proceeds from the sale of any particular offering of securities using this prospectus will be described in the accompanying
prospectus supplement relating to such offering. The precise amount and timing of the application of these proceeds will depend
on our funding requirements and the availability and costs of other funds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>THE SECURITIES WE MAY&nbsp;OFFER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The descriptions of
the securities contained in this prospectus, together with the applicable prospectus supplements, summarize all the material terms
and provisions of the various types of securities that we may offer. We will describe in the applicable prospectus supplement relating
to any securities the particular terms of the securities offered by that prospectus supplement. If we indicate in the applicable
prospectus supplement, the terms of the securities may differ from the terms we have summarized below. We will also include in
the prospectus supplement information, where applicable, about material United States federal income tax considerations relating
to the securities, and the securities exchange, if any, on which the securities will be listed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may sell from time
to time, in one or more offerings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">shares of our common stock;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">shares of our preferred stock;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">debt securities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">warrants to purchase shares of our common stock or preferred stock;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">rights to purchase shares of our common stock; and/or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify"></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">units consisting of any of the securities listed above.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The terms of any securities
we offer will be determined at the time of sale. We may issue securities that are exchangeable for or convertible into common stock
or any of the other securities that may be sold under this prospectus. When particular securities are offered, a supplement to
this prospectus will be filed with the Commission, which will describe the terms of the offering and sale of the offered securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>DESCRIPTION OF CAPITAL STOCK</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">The
following is a summary of all material characteristics of our capital stock as set forth in our articles of incorporation and bylaws.
The summary does not purport to be complete and is qualified in its entirety by reference to our certificate of incorporation and
bylaws, and to the provisions of the General Corporation Law of the State of Delaware, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are authorized to
issue 500,000,000 shares of Class A Common Stock and 25,000,000 shares of Class B Common Stock, par value $0.001 per share.&nbsp;
As of the date of this prospectus, there were 27,753,562 shares of our Class A Common Stock issued and outstanding but no shares
of Class B common stock issued or outstanding. The outstanding shares of our common stock are validly issued, fully paid and nonassessable.
In this prospectus, all references solely to &ldquo;common stock&rdquo; shall refer to the Class A Common Stock except where otherwise
indicated.&nbsp; In this prospectus, all references solely to &ldquo;common stock&rdquo; shall refer to both the Class A Common
Stock and the Class B Common Stock except where otherwise indicated. We are authorized to issue up to 25,000,000 shares of preferred
stock, par value $0.001 per share.&nbsp; Of these shares of preferred stock, 1,000,000 are designated as Series A Convertible Preferred
Stock, 500,000 are designated as Series B Convertible Preferred Stock, and 2,500 are designated as Series C Convertible Redeemable
Preferred Stock. As of the date of this prospectus, there were 7,040 shares of Series A Convertible Preferred Stock outstanding,
125,000 shares of Series B Convertible Preferred Stock and no shares of Series C Convertible Redeemable Preferred Stock outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Holders of our shares
of Class A Common Stock are entitled to one vote for each share on all matters submitted to a shareholder vote. Holders of our
shares Class B common stock are entitled to ten votes for each share on all matters submitted to a shareholder vote. Holders of
our common stock do not have cumulative voting rights. Therefore, holders of a majority of the shares of our common stock voting
for the election of directors can elect all of the directors. Holders of our common stock representing a majority of the voting
power of our capital stock issued, outstanding and entitled to vote, represented in person or by proxy, are necessary to constitute
a quorum at any meeting of shareholders. A vote by the holders of a majority of our outstanding shares is required to effectuate
certain fundamental corporate changes such as liquidation, merger or an amendment to our certificate of incorporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Holders of our common
stock are entitled to share in all dividends that our Board of Directors, in its discretion, declares from legally available funds.
In the event of a liquidation, dissolution or winding up, each outstanding share entitles its holder to participate pro rata in
all assets that remain after payment of liabilities and after providing for each class of stock, if any, having preference over
our common stock. Our common stock has no preemptive, subscription or conversion rights and there are no redemption provisions
applicable to our common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Preferred Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are authorized to
issue up to 25,000,000 shares of preferred stock, par value $0.001 per share. Of these shares of preferred stock, 1,000,000 are
designated as Series A Redeemable Convertible Preferred Stock; 500,000 are designated as Series B Redeemable Convertible Preferred
Stock; 2,500 shares are designated as Series C Redeemable Convertible Preferred Stock. As of December 31, 2020, there were 7,040
shares of Series A Redeemable Convertible Preferred Stock outstanding; 125,000 shares of Series B Redeemable Convertible Preferred
Stock outstanding and no shares of Series C Redeemable Convertible Preferred Stock outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The shares of preferred
stock may be issued in series, and shall have such voting powers, full or limited, or no voting powers, and such designations,
preferences and relative participating, optional or other special rights, and qualifications, limitations or restrictions thereof,
as shall be stated and expressed in the resolution or resolutions providing for the issuance of such stock adopted from time to
time by the board of directors. The board of directors is expressly vested with the authority to determine and fix in the resolution
or resolutions providing for the issuances of preferred stock the voting powers, designations, preferences and rights, and the
qualifications, limitations or restrictions thereof, of each such series to the full extent now or hereafter permitted by the laws
of the State of Delaware.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1pt; text-align: justify; text-indent: 0.5in">The authorized
shares of preferred stock will be available for issuance without further action by our stockholders unless such action is required
by applicable law or the rules of any stock exchange or automated quotation system on which our securities may be listed or traded.
The NYSE American currently requires stockholder approval as a prerequisite to listing shares in several circumstances, including,
in certain circumstances, where the issuance of shares could result in an increase in the number of shares of common stock outstanding,
or in the amount of voting securities outstanding, of at least 20%.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Transfer Agent and Registrar</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Transfer Agent
and Registrar for our common stock is Computershare, 8742 Lucent Blvd., Suite 225, Highlands Ranch, CO 80129.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>DESCRIPTION OF DEBT SECURITIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2pt; text-align: justify; text-indent: 35.8pt">As used
in this prospectus, debt securities means the debentures, notes, bonds and other evidences of indebtedness that DPW may issue from
time to time. Debt securities offered by this prospectus will be either senior debt securities or subordinated debt securities.
Senior debt securities will be issued under a &ldquo;Senior Indenture&rdquo; and subordinated debt securities will be issued under
a &ldquo;Subordinated Indenture.&rdquo; This prospectus sometimes refers to the Senior Indenture and the Subordinated Indenture
collectively as the &ldquo;Indentures.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1pt; text-align: justify; text-indent: 35.9pt">The form
of Senior Indenture and the form of the Subordinated Indenture are filed as exhibits to the registration statement. The statements
and descriptions in this prospectus or in any prospectus supplement regarding provisions of the Indentures and debt securities
are summaries thereof, do not purport to be complete and are subject to, and are qualified in their entirety by reference to, all
of the provisions of the Indentures and debt securities, including the definitions therein of certain terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>General</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3pt; text-align: justify; text-indent: 35.7pt">Debt securities
will be direct unsecured obligations of DPW Senior debt securities will rank equally with all of DPW&rsquo;s other senior and unsubordinated
debt. The subordinated debt securities will be subordinate and junior in right of payment to all of DPW&rsquo;s present and future
senior indebtedness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2pt; text-align: justify; text-indent: 35.8pt">Because
DPW is principally a holding company, its right to participate in any distribution of assets of any subsidiary, upon the subsidiary&rsquo;s
liquidation or reorganization or otherwise, is subject to the prior claims of creditors of the subsidiary, except to the extent
DPW may be recognized as a creditor of that subsidiary. Accordingly, DPW&rsquo;s obligations under debt securities will be structurally
subordinated to all existing and future indebtedness and liabilities of its subsidiaries, and holders of debt securities should
look only to DPW&rsquo;s assets for payment thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2pt; text-align: justify; text-indent: 35.8pt">The Indentures
do not limit the aggregate principal amount of debt securities that DPW may issue and provide that DPW may issue debt securities
from time to time in one or more series, in each case with the same or various maturities, at par or at a discount. DPW may issue
additional debt securities of a particular series without the consent of the holders of debt securities of such series outstanding
at the time of the issuance. Any such additional debt securities, together with all other outstanding debt securities of that series,
will constitute a single series of debt securities under the applicable Indenture. The Indentures also do not limit our ability
to incur other debt, except as described under &ldquo;Restrictive Covenants&rdquo; herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1pt; text-align: justify; text-indent: 35.9pt">Each prospectus
supplement will describe the terms relating to the specific series of debt securities being offered. These terms will include some
or all of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">the title of debt securities and whether they are subordinated debt securities or senior debt securities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">any limit on the aggregate principal amount of such debt securities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">the price or prices at which DPW will sell such debt securities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">the maturity date or dates of such debt securities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">the rate or rates of interest, if any, which may be fixed or variable, at which such debt securities
will bear interest, or the method of determining such rate or rates, if any;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">the date or dates from which any interest will accrue or the method by which such date or dates
will be determined;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">the right, if any, to extend the interest payment periods and the duration of any such deferral
period, including the maximum consecutive period during which interest payment periods may be extended;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">whether the amount of payments of principal of (and premium, if any) or interest on such debt securities
may be determined with reference to any index, formula or other method, such as one or more currencies, commodities, equity indices
or other indices, and the manner of determining the amount of such payments;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">the dates on which DPW will pay interest on such debt securities and the regular record date for
determining who is entitled to the interest payable on any interest payment date;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">whether the debt securities will be secured or unsecured;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">the place or places where the principal of (and premium, if any) and interest on such debt securities
will be payable;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">if DPW possesses the option to do so, the periods within which and the prices at which DPW may
redeem such debt securities, in whole or in part, pursuant to optional redemption provisions, and the other terms and conditions
of any such provisions;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">DPW&rsquo;s obligation, if any, to redeem, repay or purchase such debt securities by making periodic
payments to a sinking fund or through an analogous provision or at the option of holders of the debt securities, and the period
or periods within which and the price or prices at which DPW will redeem, repay or purchase such debt securities, in whole or in
part, pursuant to such obligation, and the other terms and conditions of such obligation;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">the denominations in which such debt securities will be issued, if other than denominations of
$1,000 and integral multiples of $1,000;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">the portion, or methods of determining the portion, of the principal amount of such debt securities
which DPW must pay upon the acceleration of the maturity of the debt securities in connection with an Event of Default (as described
below), if other than the full principal amount;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">the currency, currencies or currency unit in which DPW will pay the principal of (and premium,
if any) or interest, if any, on such debt securities, if not United States dollars;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">provisions, if any, granting special rights to holders of such debt securities upon the occurrence
of specified events;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">any deletions from, modifications of or additions to the Events of Default or DPW&rsquo;s covenants
with respect to the applicable series of debt securities, and whether or not such Events of Default or covenants are consistent
with those contained in the applicable Indenture;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">the application, if any, of the terms of the Indentures relating to defeasance and covenant defeasance
(which terms are described below) to such debt securities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">whether the subordination provisions summarized below or different subordination provisions will
apply to such debt securities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">the terms, if any, upon which the holders may convert or exchange such debt securities into or
for DPW&rsquo;s common stock, preferred stock or other securities or property;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">whether any of such debt securities will be issued in global form and, if so, the terms and conditions
upon which global debt securities may be exchanged for certificated debt securities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">any change in the right of the trustee or the requisite holders of such debt securities to declare
the principal amount thereof due and payable because of an Event of Default;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">the depositary for global or certificated debt securities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">any special tax implications of such debt securities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">any trustees, authenticating or paying agents, transfer agents or registrars or other agents with
respect to such debt securities; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">any other terms of such debt securities.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2pt; text-align: justify; text-indent: 35.8pt">Unless otherwise
specified in the applicable prospectus supplement, debt securities will not be listed on any securities exchange.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2pt; text-align: justify; text-indent: 35.8pt">Unless otherwise
specified in the applicable prospectus supplement, debt securities will be issued in fully-registered form without coupons.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1pt; text-align: justify; text-indent: 35.9pt">Debt securities
may be sold at a substantial discount below their stated principal amount, bearing no interest or interest at a rate which at the
time of issuance is below market rates. The applicable prospectus supplement will describe the federal income tax consequences
and special considerations applicable to any such debt securities. Debt securities may also be issued as indexed securities or
securities denominated in foreign currencies, currency units or composite currencies, as described in more detail in the prospectus
supplement relating to any of the particular debt securities. The prospectus supplement relating to specific debt securities will
also describe any special considerations and certain additional tax considerations applicable to such debt securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Subordination</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1pt; text-align: justify; text-indent: 35.9pt">The prospectus
supplement relating to any offering of subordinated debt securities will describe the specific subordination provisions. However,
unless otherwise noted in the prospectus supplement, subordinated debt securities will be subordinate and junior in right of payment
to all of DPW&rsquo;s Senior Indebtedness, to the extent and in the manner set forth in the Subordinated Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2pt; text-align: justify; text-indent: 35.8pt">Under the
Subordinated Indenture, &ldquo;Senior Indebtedness&rdquo; means all obligations of DPW in respect of any of the following, whether
outstanding at the date of execution of the Subordinated Indenture or thereafter incurred or created:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">the principal of (and premium, if any) and interest due on indebtedness of DPW for borrowed money;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">all obligations guaranteed by DPW for the repayment of borrowed money, whether or not evidenced
by bonds, debentures, notes or other written instruments;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">all obligations guaranteed by DPW evidenced by bonds, debentures, notes or similar written instruments,
including obligations assumed or incurred in connection with the acquisition of property, assets or businesses (provided, however,
that the deferred purchase price of any other business or property or assets shall not be considered indebtedness if the purchase
price thereof is payable in full within 90 days from the date on which such indebtedness was created);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">any obligations of DPW as lessee under leases required to be capitalized on the balance sheet of
the lessee under generally accepted accounting principles;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">all obligations of DPW for the reimbursement on any letter of credit, banker&rsquo;s acceptance,
security purchase facility or similar credit transaction;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">all obligations of DPW in respect of interest rate swap, cap or other agreements, interest rate
future or options contracts, currency swap agreements, currency future or option contracts and other similar agreements;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">all obligations of the types referred to above of other persons for the payment of which DPW is
responsible or liable as obligor, guarantor or otherwise; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">all obligations of the types referred to above of other persons secured by any lien on any property
or asset of DPW (whether or not such obligation is assumed by DPW).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1pt; text-align: justify; text-indent: 35.9pt">Senior Indebtedness
does not include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">indebtedness or monetary obligations to trade creditors created or assumed by DPW in the ordinary
course of business in connection with the obtaining of materials or services;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">indebtedness that is by its terms subordinated to or ranks equal with the subordinated debt securities;
and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">any indebtedness of DPW to its affiliates (including all debt securities and guarantees in respect
of those debt securities issued to any trust, partnership or other entity affiliated with DPW that is a financing vehicle of DPW
in connection with the issuance by such financing entity of preferred securities or other securities guaranteed by DPW) unless
otherwise expressly provided in the terms of any such indebtedness.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1pt; text-align: justify; text-indent: 35.9pt">Senior Indebtedness
shall continue to be Senior Indebtedness and be entitled to the benefits of the subordination provisions irrespective of any amendment,
modification or waiver of any term of such Senior Indebtedness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2pt; text-align: justify; text-indent: 35.8pt">Unless otherwise
noted in the accompanying prospectus supplement, if DPW defaults in the payment of any principal of (or premium, if any) or interest
on any Senior Indebtedness when it becomes due and payable, whether at maturity or at a date fixed for prepayment or by declaration
or otherwise, then, unless and until such default is cured or waived or ceases to exist, DPW will make no direct or indirect payment
(in cash, property, securities, by set-off or otherwise) in respect of the principal of or interest on the subordinated debt securities
or in respect of any redemption, retirement, purchase or other requisition of any of the subordinated debt securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2pt; text-align: justify; text-indent: 35.8pt">In the event
of the acceleration of the maturity of any subordinated debt securities, the holders of all senior debt securities outstanding
at the time of such acceleration will first be entitled to receive payment in full of all amounts due on senior debt securities
before the holders of subordinated debt securities will be entitled to receive any payment of principal (and premium, if any) or
interest on the subordinated debt securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1pt; text-align: justify; text-indent: 35.9pt">If any of
the following events occurs, DPW will pay in full all Senior Indebtedness before it makes any payment or distribution under subordinated
debt securities, whether in cash, securities or other property, to any holder of subordinated debt securities:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">any dissolution or winding-up or liquidation or reorganization of DPW, whether voluntary or involuntary
or in bankruptcy, insolvency or receivership;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">any general assignment by DPW for the benefit of creditors; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">any other marshaling of DPW&rsquo;s assets or liabilities.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2pt; text-align: justify; text-indent: 35.8pt">In such
event, any payment or distribution under subordinated debt securities, whether in cash, securities or other property, which would
otherwise (but for the subordination provisions) be payable or deliverable in respect of such subordinated debt securities, will
be paid or delivered directly to the holders of Senior Indebtedness in accordance with the priorities then existing among such
holders until all Senior Indebtedness has been paid in full. If any payment or distribution under subordinated debt securities
is received by the trustee of any subordinated debt securities in contravention of any of the terms of the Subordinated Indenture
and before all the Senior Indebtedness has been paid in full, such payment or distribution or security will be received in trust
for the benefit of, and paid over or delivered and transferred to, the holders of Senior Indebtedness at the time outstanding in
accordance with the priorities then existing among such holders for application to the payment of all Senior Indebtedness remaining
unpaid to the extent necessary to pay all such Senior Indebtedness in full.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1pt; text-align: justify; text-indent: 0.1pt">The Subordinated
Indenture does not limit the issuance of additional Senior Indebtedness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1pt; text-align: justify; text-indent: 35.9pt">If subordinated
debt securities are issued to a trust in connection with the issuance of trust preferred securities, such subordinated debt securities
may thereafter be distributed pro rata to the holders of such trust securities in connection with the dissolution of such trust
upon the occurrence of certain events described in the applicable prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Restrictive Covenants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2pt; text-align: justify; text-indent: 35.8pt">Unless an
accompanying prospectus supplement states otherwise, the following restrictive covenant shall apply to each series of senior debt
securities:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2pt; text-align: justify; text-indent: 35.8pt"><I>Limitation
on Liens</I>. So long as any senior debt securities are outstanding, neither DPW nor any of its subsidiaries will create, assume,
incur or guarantee any indebtedness for money borrowed which is secured by any pledge of, lien on or security interest in any capital
stock of its Designated Subsidiaries, other than specified types of permitted liens.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2pt; text-align: justify; text-indent: 35.8pt">However,
this restriction will not apply if all debt securities then outstanding and, at our option, any other senior indebtedness ranking
equally with such debt securities, are secured at least equally and ratably with the otherwise prohibited secured debt so long
as it is outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2pt; text-align: justify; text-indent: 35.8pt">This limitation
shall not apply to debt secured by a pledge of, lien on or security interest in any shares of stock of any subsidiary at the time
it becomes a Designated Subsidiary, including any renewals or extensions of such secured debt. &ldquo;Designated Subsidiary&rdquo;
means any subsidiary of DPW, the consolidated net worth of which represents at least 10% of the consolidated net worth of DPW</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1pt; text-align: justify; text-indent: 35.9pt">The Subordinated
Indenture does not contain a similar limitation on liens.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 37 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Consolidation, Merger, Sale of Assets
and Other Transactions</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1pt; text-align: justify; text-indent: 35.9pt">DPW may
not (i) merge with or into or consolidate with another person or sell, assign, transfer, lease or convey all or substantially all
of its properties and assets to, any other person other than a direct or indirect wholly-owned subsidiary of DPW, and (ii) no person
may merge with or into or consolidate with DPW or, except for any direct or indirect wholly-owned subsidiary of DPW, sell, assign,
transfer, lease or convey all or substantially all of its properties and assets to DPW unless:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">DPW is the surviving corporation or the person formed by or surviving such merger or consolidation
or to which such sale, assignment, transfer, lease or conveyance has been made, if other than DPW, has expressly assumed by supplemental
indenture all the obligations of DPW under such debt securities, the Indentures and any guarantees of preferred securities or common
securities issued by certain trusts;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">immediately after giving effect to such transaction, no default or Event of Default has occurred
and is continuing; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">DPW delivers to the trustee an officers&rsquo; certificate and an opinion of counsel, each stating
that the supplemental indenture complies with the applicable Indenture.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Events of Default, Notice and Waiver</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1pt; text-align: justify; text-indent: 35.9pt">Unless an
accompanying prospectus supplement states otherwise, the following shall constitute &ldquo;Events of Default&rdquo; under the Indentures
with respect to each series of debt securities:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">DPW&rsquo;s failure to pay any interest on any debt security of such series when due and payable,
continued for 30 days;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">DPW&rsquo;s failure to pay principal (or premium, if any) on any debt security of such series when
due, regardless of whether such payment became due because of maturity, redemption, acceleration or otherwise, or is required by
any sinking fund established with respect to such series;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">DPW&rsquo;s failure to observe or perform any other of its covenants or agreements with respect
to such debt securities for 90 days after it receives notice of such failure;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">certain defaults with respect to DPW&rsquo;s debt (other than such debt securities or non-recourse
debt) in any aggregate principal amount in excess of $25,000,000 consisting of the failure to make any payment at maturity or that
results in acceleration of the maturity of such debt; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">certain events of bankruptcy, insolvency or reorganization of DPW</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1pt; text-align: justify; text-indent: 35.9pt">If an Event
of Default with respect to any debt securities of any series outstanding under either of the Indentures shall occur and be continuing,
the trustee under such Indenture or the holders of at least 25% in aggregate principal amount of the debt securities of that series
outstanding may declare, by notice as provided in the applicable Indenture, the principal amount (or such lesser amount as may
be provided for in the debt securities of that series) of the debt securities of that series outstanding to be due and payable
immediately; provided that, in the case of an Event of Default involving certain events in bankruptcy, insolvency or reorganization,
acceleration is automatic; and, provided further, that after such acceleration, but before a judgment or decree based on acceleration,
the holders of a majority in aggregate principal amount of the outstanding debt securities of that series may, under certain circumstances,
rescind and annul such acceleration if all Events of Default, other than the nonpayment of accelerated principal, have been cured
or waived.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2pt; text-align: justify; text-indent: 35.8pt">Upon the
acceleration of the maturity of original issue discount securities, an amount less than the principal amount thereof will become
due and payable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2pt; text-align: justify; text-indent: 35.8pt">Reference
is made to the prospectus supplement relating to any original issue discount securities for the particular provisions relating
to acceleration of maturity thereof. Any past default under either Indenture with respect to debt securities of any series, and
any Event of Default arising therefrom, may be waived by the holders of a majority in principal amount of all debt securities of
such series outstanding under such Indenture, except in the case of (i) default in the payment of the principal of (or premium,
if any) or interest on any debt securities of such series or (ii) default in respect of a covenant or provision which may not be
amended or modified without the consent of the holder of each outstanding debt security of such series affected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2pt; text-align: justify; text-indent: 35.8pt">The trustee
is required, within 90 days after the occurrence of a default (which is known to the trustee and is continuing), with respect to
the debt securities of any series (without regard to any grace period or notice requirements), to give to the holders of debt securities
of such series notice of such default; provided, however, that, except in the case of a default in the payment of the principal
of (and premium, if any) or interest, or in the payment of any sinking fund installment, on any debt securities of such series,
the trustee shall be protected in withholding such notice if it in good faith determines that the withholding of such notice is
in the interests of the holders of debt securities of such series.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 38 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2pt; text-align: justify; text-indent: 35.8pt">The trustee,
subject to its duties during default to act with the required standard of care, may require indemnification by the holders of debt
securities of any series with respect to which a default has occurred before proceeding to exercise any right or power under the
Indentures at the request of the holders of debt securities of such series. Subject to such right of indemnification and to certain
other limitations, the holders of a majority in principal amount of the outstanding debt securities of any series under either
Indenture may direct the time, method and place of conducting any proceeding for any remedy available to the trustee, or exercising
any trust or power conferred on the trustee with respect to debt securities of such series.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2pt; text-align: justify; text-indent: 35.8pt">No holder
of a debt security of any series may institute any action against DPW under either of the Indentures (except actions for payment
of overdue principal of (and premium, if any) or interest on such debt security or for the conversion or exchange of such debt
security in accordance with its terms) unless (i) the holder has given to the trustee written notice of an Event of Default and
of the continuance thereof with respect to debt securities of such series specifying an Event of Default, as required under the
applicable Indenture, (ii) the holders of at least 25% in aggregate principal amount of debt securities of that series then outstanding
under such Indenture shall have requested the trustee to institute such action and offered to the trustee indemnity reasonably
satisfactory to it against the costs, expenses and liabilities to be incurred in compliance with such request and (iii) the trustee
shall not have instituted such action within 60 days of such request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1pt; text-align: justify; text-indent: 35.9pt">DPW is required
to furnish annually to the trustee statements as to its compliance with all conditions and covenants under each Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Discharge, Defeasance and Covenant Defeasance</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1pt; text-align: justify; text-indent: 35.9pt">If indicated
in the applicable prospectus supplement, DPW may discharge or defease its obligations under each Indenture as set forth below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2pt; text-align: justify; text-indent: 35.8pt">DPW may
discharge certain obligations to holders of any series of debt securities issued under either the Senior Indenture or the Subordinated
Indenture which have not already been delivered to the trustee for cancellation and which have either become due and payable or
are by their terms due and payable within one year (or scheduled for redemption within one year) by irrevocably depositing with
the trustee cash or, in the case of debt securities payable only in U.S. dollars, U.S. Government Obligations (as defined in either
Indenture), as trust funds in an amount certified to be sufficient to pay when due, whether at maturity, upon redemption or otherwise,
the principal of (and premium, if any) and interest on such debt securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1pt; text-align: justify; text-indent: 35.9pt">If indicated
in the applicable prospectus supplement, DPW may elect either (i) to defease and be discharged from any and all obligations with
respect to debt securities of or within any series (except as otherwise provided in the relevant Indenture) (&ldquo;defeasance&rdquo;)
or (ii) to be released from its obligations with respect to certain covenants applicable to debt securities of or within any series
(&ldquo;covenant defeasance&rdquo;), upon the deposit with the relevant Indenture trustee, in trust for such purpose, of money
and/or government obligations which through the payment of principal and interest in accordance with their terms will provide money
in an amount sufficient, without reinvestment, to pay the principal of (and premium, if any) or interest on such debt securities
to maturity or redemption, as the case may be, and any mandatory sinking fund or analogous payments thereon. As a condition to
defeasance or covenant defeasance, DPW must deliver to the trustee an opinion of counsel to the effect that the holders of such
debt securities will not recognize income, gain or loss for federal income tax purposes as a result of such defeasance or covenant
defeasance and will be subject to federal income tax on the same amounts and in the same manner and at the same times as would
have been the case if such defeasance or covenant defeasance had not occurred. Such opinion of counsel, in the case of defeasance
under clause (i) above, must refer to and be based upon a ruling of the Internal Revenue Service or a change in applicable federal
income tax law occurring after the date of the relevant Indenture. In addition, in the case of either defeasance or covenant defeasance,
DPW shall have delivered to the trustee (i) an officers&rsquo; certificate to the effect that the relevant debt securities exchange(s)
have informed it that neither such debt securities nor any other debt securities of the same series, if then listed on any securities
exchange, will be delisted as a result of such deposit and (ii) an officers&rsquo; certificate and an opinion of counsel, each
stating that all conditions precedent with respect to such defeasance or covenant defeasance have been complied with. DPW may exercise
its defeasance option with respect to such debt securities notwithstanding its prior exercise of its covenant defeasance option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Modification and Waiver</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1pt; text-align: justify; text-indent: 35.9pt">Under the
Indentures, DPW and the applicable trustee may supplement the Indentures for certain purposes which would not materially adversely
affect the interests or rights of the holders of debt securities of a series without the consent of those holders. DPW and the
applicable trustee may also modify the Indentures or any supplemental indenture in a manner that affects the interests or rights
of the holders of debt securities with the consent of the holders of at least a majority in aggregate principal amount of the outstanding
debt securities of each affected series issued under the Indenture. However, the Indentures require the consent of each holder
of debt securities that would be affected by any modification which would:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 39 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">extend the fixed maturity of any debt securities of any series, or reduce the principal amount
thereof, or reduce the rate or extend the time of payment of interest thereon, or reduce any premium payable upon the redemption
thereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">reduce the amount of principal of an original issue discount debt security or any other debt security
payable upon acceleration of the maturity thereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">change the currency in which any debt security or any premium or interest is payable;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">impair the right to institute suit for any payment on or with respect to any debt security;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">reduce the percentage in principal amount of outstanding debt securities of any series, the consent
of whose holders is required for modification or amendment of the Indentures or for waiver of compliance with certain provisions
of the Indentures or for waiver of certain defaults;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">reduce the requirements contained in the Indentures for quorum or voting; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">modify any of the above provisions.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2pt; text-align: justify; text-indent: 35.8pt">If subordinated
debt securities are held by a trust or a trustee of a trust, a supplemental indenture that affects the interests or rights of the
holders of debt securities will not be effective until the holders of not less than a majority in liquidation preference of the
preferred securities and common securities of the applicable trust, collectively, have consented to the supplemental indenture;
provided, further, that if the consent of the holder of each outstanding debt security is required, the supplemental indenture
will not be effective until each holder of the preferred securities and the common securities of the applicable trust has consented
to the supplemental indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1pt; text-align: justify; text-indent: 35.9pt">The Indentures
permit the holders of at least a majority in aggregate principal amount of the outstanding debt securities of any series issued
under the Indentures which is affected by the modification or amendment to waive DPW&rsquo;s compliance with certain covenants
contained in the Indentures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Payment and Paying Agents</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1pt; text-align: justify; text-indent: 35.9pt">Unless otherwise
indicated in the applicable prospectus supplement, payment of interest on a debt security on any interest payment date will be
made to the person in whose name a debt security is registered at the close of business on the record date for the interest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2pt; text-align: justify; text-indent: 35.8pt">Unless otherwise
indicated in the applicable prospectus supplement, principal, interest and premium on the debt securities of a particular series
will be payable at the office of such paying agent or paying agents as DPW may designate for such purpose from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2pt; text-align: justify; text-indent: 35.8pt">Notwithstanding
the foregoing, at DPW&rsquo;s option, payment of any interest may be made by check mailed to the address of the person entitled
thereto as such address appears in the security register.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2pt; text-align: justify; text-indent: 35.8pt">Unless otherwise
indicated in the applicable prospectus supplement, a paying agent designated by DPW and located in the Borough of Manhattan, The
City of New York will act as paying agent for payments with respect to debt securities of each series. All paying agents initially
designated by DPW for debt securities of a particular series will be named in the applicable prospectus supplement. DPW may at
any time designate additional paying agents or rescind the designation of any paying agent or approve a change in the office through
which any paying agent acts, except that DPW will be required to maintain a paying agent in each place of payment for debt securities
of a particular series.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1pt; text-align: justify; text-indent: 35.9pt">All moneys
paid by DPW to a paying agent for the payment of the principal, interest or premium on any debt security which remain unclaimed
at the end of two years after such principal, interest or premium has become due and payable will be repaid to DPW upon request,
and the holder of such debt security thereafter may look only to DPW for payment thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Denominations, Registrations and Transfer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1pt; text-align: justify; text-indent: 35.9pt">Unless an
accompanying prospectus supplement states otherwise, debt securities will be represented by one or more global certificates registered
in the name of a nominee for The Depository Trust Company, or DTC. In such case, each holder&rsquo;s beneficial interest in the
global securities will be shown on the records of DTC and transfers of beneficial interests will only be effected through DTC&rsquo;s
records.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 40 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2pt; text-align: justify; text-indent: 35.8pt">A holder
of debt securities may only exchange a beneficial interest in a global security for certificated securities registered in the holder&rsquo;s
name if:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">DTC notifies DPW that it is unwilling or unable to continue serving as the depositary for the relevant
global securities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">DTC ceases to maintain certain qualifications under the Exchange Act and no successor depositary
has been appointed for 90 days; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">DPW determines, in its sole discretion, that the global security shall be exchangeable.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1pt; text-align: justify; text-indent: 35.9pt">If debt
securities are issued in certificated form, they will only be issued in the minimum denomination specified in the accompanying
prospectus supplement and integral multiples of such denomination. Transfers and exchanges of such debt securities will only be
permitted in such minimum denomination. Transfers of debt securities in certificated form may be registered at the trustee&rsquo;s
corporate office or at the offices of any paying agent or trustee appointed by DPW under the Indentures. Exchanges of debt securities
for an equal aggregate principal amount of debt securities in different denominations may also be made at such locations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Governing Law</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1pt; text-align: justify; text-indent: 35.9pt">The Senior
Indenture, the Subordinated Indenture and debt securities will be governed by, and construed in accordance with, the internal laws
of the State of New York, without regard to its principles of conflicts of laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Conversion or Exchange Rights</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1pt; text-align: justify; text-indent: 35.9pt">The prospectus
supplement will describe the terms, if any, on which a series of debt securities may be convertible into or exchangeable for DPW&rsquo;s
Class A Common Stock, preferred stock or other debt securities. These terms will include provisions as to whether conversion or
exchange is mandatory, at the option of the holder or at DPW&rsquo;s option. These provisions may allow or require the number of
shares of DPW&rsquo;s Class A Common Stock or other securities to be received by the holders of such series of debt securities
to be adjusted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>DESCRIPTION OF WARRANTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following description,
together with the additional information we may include in any applicable prospectus supplements, summarizes the material terms
and provisions of the warrants that we may offer under this prospectus and the related warrant agreements and warrant certificates.
While the terms summarized below will apply generally to any warrants that we may offer, we will describe the particular terms
of any series of warrants in more detail in the applicable prospectus supplement. If we indicate in the prospectus supplement,
the terms of any warrants offered under that prospectus supplement may differ from the terms described below.&nbsp; If there are
differences between that prospectus supplement and this prospectus, the prospectus supplement will control.&nbsp; Thus, the statements
we make in this section may not apply to a particular series of warrants.&nbsp; Specific warrant agreements will contain additional
important terms and provisions and will be incorporated by reference as an exhibit to the registration statement which includes
this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>General</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -10pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may issue warrants
for the purchase of common stock and/or preferred stock in one or more series. We may issue warrants independently or together
with common stock and/or preferred stock, and the warrants may be attached to or separate from these securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will evidence each
series of warrants by warrant certificates that we may issue under a separate agreement. We may enter into the warrant agreement
with a warrant agent. Each warrant agent may be a bank that we select which has its principal office in the United States and a
combined capital and surplus of at least $50,000,000.&nbsp; We may also choose to act as our own warrant agent.&nbsp; We will indicate
the name and address of any such warrant agent in the applicable prospectus supplement relating to a particular series of warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will describe in
the applicable prospectus supplement the terms of the series of warrants, including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">the offering price and aggregate number of warrants offered;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 41 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">the currency for which the warrants may be purchased;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">if applicable, the designation and terms of the securities with which the warrants are issued and
the number of warrants issued with each such security or each principal amount of such security;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">if applicable, the date on and after which the warrants and the related securities will be separately
transferable;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">in the case of warrants to purchase common stock or preferred stock, the number of shares of common
stock or preferred stock, as the case may be, purchasable upon the exercise of one warrant and the price at which these shares
may be purchased upon such exercise;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">the warrant agreement under which the warrants will be issued;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">the effect of any merger, consolidation, sale or other disposition of our business on the warrant
agreement and the warrants;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">anti-dilution provisions of the warrants, if any;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">the terms of any rights to redeem or call the warrants;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">any provisions for changes to or adjustments in the exercise price or number of securities issuable
upon exercise of the warrants;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">the dates on which the right to exercise the warrants will commence and expire or, if the warrants
are not continuously exercisable during that period, the specific date or dates on which the warrants will be exercisable;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">the manner in which the warrant agreement and warrants may be modified;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">the identities of the warrant agent and any calculation or other agent for the warrants;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">federal income tax consequences of holding or exercising the warrants;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">the terms of the securities issuable upon exercise of the warrants;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">any securities exchange or quotation system on which the warrants or any securities deliverable
upon exercise of the warrants may be listed; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">any other specific terms, preferences, rights or limitations of or restrictions on the warrants.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Before exercising their
warrants, holders of warrants will not have any of the rights of holders of the securities purchasable upon such exercise, including
in the case of warrants to purchase common stock or preferred stock, the right to receive dividends, if any, or, payments upon
our liquidation, dissolution or winding up or to exercise voting rights, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Exercise of Warrants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each warrant will entitle
the holder to purchase the securities that we specify in the applicable prospectus supplement at the exercise price that we describe
in the applicable prospectus supplement. Unless we otherwise specify in the applicable prospectus supplement, holders of the warrants
may exercise the warrants at any time up to 5:00&nbsp;p.m. Eastern Time on the expiration date that we set forth in the applicable
prospectus supplement. After the close of business on the expiration date, unexercised warrants will become void.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Holders of the warrants
may exercise the warrants by delivering the warrant certificate representing the warrants to be exercised together with specified
information, and paying the required amount to the warrant agent in immediately available funds, as provided in the applicable
prospectus supplement. We will set forth on the reverse side of the warrant certificate, and in the applicable prospectus supplement,
the information that the holder of the warrant will be required to deliver to the warrant agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Until the warrant is
properly exercised, no holder of any warrant will be entitled to any rights of a holder of the securities purchasable upon exercise
of the warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 42 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Upon receipt of the
required payment and the warrant certificate properly completed and duly executed at the corporate trust office of the warrant
agent or any other office indicated in the applicable prospectus supplement, we will issue and deliver the securities purchasable
upon such exercise. If fewer than all of the warrants represented by the warrant certificate are exercised, then we will issue
a new warrant certificate for the remaining amount of warrants. If we so indicate in the applicable prospectus supplement, holders
of the warrants may surrender securities as all or part of the exercise price for warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Enforceability of Rights by Holders
of Warrants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any warrant agent will
act solely as our agent under the applicable warrant agreement and will not assume any obligation or relationship of agency or
trust with any holder of any warrant. A single bank or trust company may act as warrant agent for more than one issue of warrants.
A warrant agent will have no duty or responsibility in case of any default by us under the applicable warrant agreement or warrant,
including any duty or responsibility to initiate any proceedings at law or otherwise, or to make any demand upon us. Any holder
of a warrant may, without the consent of the related warrant agent or the holder of any other warrant, enforce by appropriate legal
action its right to exercise, and receive the securities purchasable upon exercise of, its warrants in accordance with their terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Warrant Agreement Will Not Be Qualified
Under the Trust Indenture Act</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No warrant agreement
will be qualified as an indenture, and no warrant agent will be required to qualify as a trustee, under the Trust Indenture Act.
Therefore, holders of warrants issued under a warrant agreement will not have the protection of the Trust Indenture Act with respect
to their warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Governing Law</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each warrant agreement
and any warrants issued under the warrant agreements will be governed by New York law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Calculation Agent</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Calculations relating
to warrants may be made by a calculation agent, an institution that we appoint as our agent for this purpose.&nbsp; The prospectus
supplement for a particular warrant will name the institution that we have appointed to act as the calculation agent for that warrant
as of the original issue date for that warrant. We may appoint a different institution to serve as calculation agent from time
to time after the original issue date without the consent or notification of the holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The calculation agent&rsquo;s
determination of any amount of money payable or securities deliverable with respect to a warrant will be final and binding in the
absence of manifest error.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>DESCRIPTION OF RIGHTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1pt 0pt 0.2pt; text-align: justify; text-indent: 35.8pt">This
section describes the general terms of the rights that we may offer and sell by this prospectus. This prospectus and any accompanying
prospectus supplement will contain the material terms and conditions for each right. The accompanying prospectus supplement may
add, update or change the terms and conditions of the rights as described in this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1pt 0pt 0.3pt; text-align: justify; text-indent: 35.7pt">The
particular terms of each issue of rights, the rights agreement relating to the rights and the rights certificates representing
rights will be described in the applicable prospectus supplement, including, as applicable:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">the title of the rights;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1pt 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">the date of determining the stockholders entitled to the rights distribution;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1pt 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">the title, aggregate number of shares of Class A common stock or preferred stock purchasable upon
exercise of the rights;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1pt 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">the exercise price;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1pt 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">the aggregate number of rights issued;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1pt 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">the date, if any, on and after which the rights will be separately transferable;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1pt 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">the date on which the right to exercise the rights will commence and the date on which the right
will expire; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1pt 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">any other terms of the rights, including terms, procedures and limitations relating to the distribution,
exchange and exercise of the rights.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 43 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>DESCRIPTION OF UNITS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may issue units
comprised of one or more of the other securities described in this prospectus in any combination. Each unit will be issued so that
the holder of the unit is also the holder of each security included in the unit. Thus, the holder of a unit will have the rights
and obligations of a holder of each included security. The unit agreement under which a unit is issued may provide that the securities
included in the unit may not be held or transferred separately, at any time or at any time before a specified date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The applicable prospectus
supplement will describe:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 27pt">&bull;</TD><TD STYLE="text-align: justify">the designation and terms of the units and of the securities comprising the units, including whether
and under what circumstances those securities may be held or transferred separately;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -27pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 27pt">&bull;</TD><TD STYLE="text-align: justify">any unit agreement under which the units will be issued;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -27pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 27pt">&bull;</TD><TD STYLE="text-align: justify">any provisions for the issuance, payment, settlement, transfer or exchange of the units or of the
securities comprising the units; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -27pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 27pt">&bull;</TD><TD STYLE="text-align: justify">whether the units will be issued in fully registered or global form.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The applicable prospectus
supplement will describe the terms of any units. The preceding description and any description of units in the applicable prospectus
supplement does not purport to be complete and is subject to and is qualified in its entirety by reference to the unit agreement
and, if applicable, collateral arrangements and depositary arrangements relating to such units.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PLAN OF DISTRIBUTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may sell the securities
being offered pursuant to this prospectus through underwriters or dealers, through agents, or directly to one or more purchasers
or through a combination of these methods.&nbsp; The applicable prospectus supplement will describe the terms of the offering of
the securities, including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">the name or names of any underwriters, if any, and if required, any dealers or agents;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">the purchase price of the securities and the proceeds we will receive from the sale;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">any underwriting discounts and other items constituting underwriters&rsquo; compensation;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">any discounts or concessions allowed or reallowed or paid to dealers; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">any securities exchange or market on which the securities may be listed.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may distribute the
securities from time to time in one or more transactions at:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">a fixed price or prices, which may be changed;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">market prices prevailing at the time of sale;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">prices related to such prevailing market prices; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">negotiated prices.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Only underwriters named
in the prospectus supplement are underwriters of the securities offered by the prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If underwriters are
used in an offering, we will execute an underwriting agreement with such underwriters and will specify the name of each underwriter
and the terms of the transaction (including any underwriting discounts and other terms constituting compensation of the underwriters
and any dealers) in a prospectus supplement. The securities may be offered to the public either through underwriting syndicates
represented by managing underwriters or directly by one or more investment banking firms or others, as designated. If an underwriting
syndicate is used, the managing underwriter(s)&nbsp;will be specified on the cover of the prospectus supplement. If underwriters
are used in the sale, the offered securities will be acquired by the underwriters for their own accounts and may be resold from
time to time in one or more transactions, including negotiated transactions, at a fixed public offering price or at varying prices
determined at the time of sale. Any public offering price and any discounts or concessions allowed or reallowed or paid to dealers
may be changed from time to time. Unless otherwise set forth in the prospectus supplement, the obligations of the underwriters
to purchase the offered securities will be subject to conditions precedent and the underwriters will be obligated to purchase all
of the offered securities if any are purchased.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 44 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may grant to the
underwriters options to purchase additional securities to cover over-allotments, if any, at the public offering price, with additional
underwriting commissions or discounts, as may be set forth in a related prospectus supplement. The terms of any over-allotment
option will be set forth in the prospectus supplement for those securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we use a dealer
in the sale of the securities being offered pursuant to this prospectus or any prospectus supplement, we will sell the securities
to the dealer, as principal.&nbsp; The dealer may then resell the securities to the public at varying prices to be determined by
the dealer at the time of resale.&nbsp; The names of the dealers and the terms of the transaction will be specified in a prospectus
supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may sell the securities
directly or through agents we designate from time to time.&nbsp; We will name any agent involved in the offering and sale of securities
and we will describe any commissions we will pay the agent in the prospectus supplement. Unless the prospectus supplement states
otherwise, any agent will act on a best-efforts basis for the period of its appointment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may authorize agents
or underwriters to solicit offers by institutional investors to purchase securities from us at the public offering price set forth
in the prospectus supplement pursuant to delayed delivery contracts providing for payment and delivery on a specified date in the
future. We will describe the conditions to these contracts and the commissions we must pay for solicitation of these contracts
in the prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with
the sale of the securities, underwriters, dealers or agents may receive compensation from us or from purchasers of the securities
for whom they act as agents in the form of discounts, concessions or commissions. Underwriters may sell the securities to or through
dealers, and those dealers may receive compensation in the form of discounts, concessions or commissions from the underwriters
or commissions from the purchasers for whom they may act as agents. Underwriters, dealers and agents that participate in the distribution
of the securities, and any institutional investors or others that purchase securities directly and then resell the securities,
may be deemed to be underwriters, and any discounts or commissions received by them from us and any profit on the resale of the
securities by them may be deemed to be underwriting discounts and commissions under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may provide agents
and underwriters with indemnification against particular civil liabilities, including liabilities under the Securities Act, or
contribution with respect to payments that the agents or underwriters may make with respect to such liabilities. Agents and underwriters
may engage in transactions with, or perform services for, us in the ordinary course of business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, we may
enter into derivative transactions with third parties (including the writing of options), or sell securities not covered by this
prospectus to third parties in privately negotiated transactions. If the applicable prospectus supplement indicates, in connection
with such a transaction, the third parties may, pursuant to this prospectus and the applicable prospectus supplement, sell securities
covered by this prospectus and the applicable prospectus supplement. If so, the third party may use securities borrowed from us
or others to settle such sales and may use securities received from us to close out any related short positions. We may also loan
or pledge securities covered by this prospectus and the applicable prospectus supplement to third parties, who may sell the loaned
securities or, in an event of default in the case of a pledge, sell the pledged securities pursuant to this prospectus and the
applicable prospectus supplement. The third party in such sale transactions will be an underwriter and will be identified in the
applicable prospectus supplement or in a post-effective amendment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To facilitate an offering
of a series of securities, persons participating in the offering may engage in transactions that stabilize, maintain, or otherwise
affect the market price of the securities. This may include over-allotments or short sales of the securities, which involves the
sale by persons participating in the offering of more securities than have been sold to them by us. In those circumstances, such
persons would cover such over-allotments or short positions by purchasing in the open market or by exercising the over-allotment
option granted to those persons. In addition, those persons may stabilize or maintain the price of the securities by bidding for
or purchasing securities in the open market or by imposing penalty bids, whereby selling concessions allowed to underwriters or
dealers participating in any such offering may be reclaimed if securities sold by them are repurchased in connection with stabilization
transactions. The effect of these transactions may be to stabilize or maintain the market price of the securities at a level above
that which might otherwise prevail in the open market. Such transactions, if commenced, may be discontinued at any time. We make
no representation or prediction as to the direction or magnitude of any effect that the transactions described above, if implemented,
may have on the price of our securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any common stock sold
pursuant to a prospectus supplement will be eligible for quotation and trading on the NYSE American. Any underwriters to whom securities
are sold by us for public offering and sale may make a market in the securities, but such underwriters will not be obligated to
do so and may discontinue any market making at any time without notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 45 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In order to comply
with the securities laws of some states, if applicable, the securities offered pursuant to this prospectus will be sold in those
states only through registered or licensed brokers or dealers. In addition, in some states securities may not be sold unless they
have been registered or qualified for sale in the applicable state or an exemption from the registration or qualification requirement
is available and complied with.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>LEGAL MATTERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The validity of the
securities offered by this prospectus is being passed upon for us by Olshan Frome Wolosky LLP, New York, New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXPERTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The consolidated financial
statements incorporated in this prospectus by reference from our Annual Report on&nbsp;Form&nbsp;10-K&nbsp;for&nbsp;the years ended
December&nbsp;31, 2019 and 2018, and for each of the years in the period ended December 31,2019, have been so incorporated in reliance
on the report of Marcum, LLP, an independent registered public accounting firm, incorporated herein by reference, given on the
authority of said firm as experts in auditing and accounting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The consolidated financial
statements of Enertec Systems 2001 LTD., as of December 31, 2019 and December 31, 2018, and for the year ended December 31, 2019
and for the period from May 22, 2018 to December 31, 2018 incorporated by reference in this prospectus have been so incorporated
in reliance on the report of BDO ZIV HAFT, an independent registered public accounting firm, incorporated herein by reference,
given on the authority of said firm as experts in auditing and accounting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>WHERE YOU CAN FIND MORE INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1pt; text-align: justify; text-indent: 35.9pt; background-color: white">We
have filed with the Commission a registration statement on Form S-3 under the Securities Act, with respect to the securities covered
by this prospectus. This prospectus and any prospectus supplement which form a part of the registration statement, does not contain
all of the information set forth in the registration statement or the exhibits and schedules filed therewith. For further information
with respect to us and the securities covered by this prospectus, please see the registration statement and the exhibits filed
with the registration statement. Any statements made in this prospectus or any prospectus supplement concerning legal documents
are not necessarily complete and you should read the documents that are filed as exhibits to the registration statement or otherwise
filed with the Commission for a more complete understanding of the document or matter. A copy of the registration statement and
the exhibits filed with the registration statement may be inspected without charge at the Public Reference Room maintained by the
Commission, located at 100 F Street, N.E., Washington, D.C. 20549. Please call the Commission at 1-800-SEC-0330 for more information
about the operation of the Public Reference Room. The Commission also maintains an internet website that contains reports, proxy
and information statements and other information regarding registrants that file electronically with the Commission. The address
of the website is http://www.sec.gov.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We
file annual, quarterly and current reports, proxy statements and other information with the Commission. You may read, without charge,
and copy the documents we file at the Commission&rsquo;s public reference room in Washington, D.C. at 100 F Street, N.E., Washington,
D.C. 20549. You can request copies of these documents by writing to the Commission and paying a fee for the copying cost. Please
call the Commission at 1-800-SEC-0330 for further information on the public reference rooms. Our filings with the Commission are
also available to the public at no cost from the SEC&rsquo;s website at <FONT STYLE="color: blue"><U>http://www.sec.gov</U></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INCORPORATION OF DOCUMENTS BY REFERENCE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have filed a registration
statement on Form S-3 with the Commission under the Securities Act. This prospectus is part of the registration statement but the
registration statement includes and incorporates by reference additional information and exhibits. The Commission permits us to
&ldquo;incorporate by reference&rdquo; the information contained in documents we file with the Commission, which means that we
can disclose important information to you by referring you to those documents rather than by including them in this prospectus.
Information that is incorporated by reference is considered to be part of this prospectus and you should read it with the same
care that you read this prospectus. Information that we file later with the Commission will automatically update and supersede
the information that is either contained, or incorporated by reference, in this prospectus, and will be considered to be a part
of this prospectus from the date those documents are filed. We have filed with the Commission, and incorporate by reference in
this prospectus:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">Our Annual Report on Form 10-K for the period ended December 31, 2019, filed with the SEC on May
29, 2020, as amended by the Annual Report on Form 10-K/A filed with the SEC on June 1, 2020;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">Quarterly Reports on Form 10-Q for the quarters ended March 31, 2020, June 30, 2020 and September
30, 2020;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 46 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">Current Reports on Form 8-K filed with the SEC on January 2, 2020; January 16, 2020; January 22,
2020; February 6, 2020; February 10, 2020; an amendment filed on February 25, 2020; February 25, 2020; February 25, 2020; February
28, 2020; March 26, 2020; March 27, 2020; an amendment filed on April 9, 2020; April 14, 2020; April 20, 2020; May 1, 2020; May
13, 2020; May 29, 2020; June 29, 2020; July 8, 2020; July 17, 2020; an amendment filed on July 22, 2020; July 24, 2020; August
14, 2020; August 20, 2020; September 17, 2020; September 18, 2020; an amendment filed on September 30, 2020; October 2, 2020; October
13, 2020; October 23, 2020; October 27, 2020; November 11, 2020; November 20, 2020; November 30, 2020; December 1, 2020; December
3, 2020; December 21, 2020; December 30, 2020; and January 4, 2021;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">Our Definitive Proxy Statements filed with the SEC on each of May 18, 2020 and November 13, 2020,
and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&bull;</TD><TD STYLE="text-align: justify">The description of our common stock contained in our Form 8-A filed with the SEC on January 30,
1997.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We also incorporate
by reference all additional documents that we file with the Securities and Exchange Commission under the terms of Sections 13(a),
13(c), 14 or 15(d) of the Exchange Act that are made after the initial filing date of the registration statement of which this
prospectus is a part until the offering of the particular securities covered by a prospectus supplement or term sheet has been
completed. We are not, however, incorporating, in each case, any documents or information that we are deemed to furnish and not
file in accordance with Securities and Exchange Commission rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will provide you,
without charge upon written or oral request, a copy of any and all of the information that has been incorporated by reference in
this prospectus and that has not been delivered with this prospectus. Requests should be directed to DPW Holdings, Inc., 48430
Lakeview Blvd., Fremont, California, 94538-3158; Tel.: (510) 657-2635; Attention: Milton C. Ault III, Chief Executive Office.</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 47 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right"></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Up to $50,000,000</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;<IMG SRC="aultglobal_biglogo.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>DPW Holdings, Inc.&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Shares of Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PROSPECTUS SUPPLEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;<IMG SRC="acmsm_logo.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>January 25, 2021</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="border-top: Black 2px solid; font-size: 1pt; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>acmsm_logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 acmsm_logo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!F17AI9@  34T *@    @ ! $:  4
M   !    /@$;  4    !    1@$H  ,    !  (   $Q  (    0    3@
M      !@     0   &     !<&%I;G0N;F5T(#0N,BXU /_; $,  @$! 0$!
M @$! 0(" @("! ," @("!00$ P0&!08&!@4&!@8'"0@&!PD'!@8("P@)"@H*
M"@H&" L,"PH,"0H*"O_; $,! @(" @("!0,#!0H'!@<*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"O_  !$( '@
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MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$
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M6WTZQMUPL: =3ZL>I8\DG->QF5L)3A@H_9UE_B:U7R6A%/6[-NBO'-"UHO\
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MTVI%H]JB*O0*(E KA=2^+?C&UU"XM8IK?;',RKFW[ _6OD*U1QD7"/-H0_\
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M"MNK7EOHV@#E=W !%FO?WK..(X>H_!"4GYFKYK:E"T_X)K_\%#?%8\CXK?\
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MXFGG,,>GP3%MDB-(&7<%PH1SN(&:&ET%&6MA_P (_CA^UW\.?^"B?A_]FO\
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MK^%BH\NEM-==--5V:=P+7AC_ ()]?M0_"GXZ^)/VY_AMX.O)/',?QBN[W3?
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M@USXATY24HRNWJ_+R 6BN< HH ** "B@ HQ0 8HH *,9X- !BC'O0 =*,=J
6#I10 4A4$Y- "XHQ0 =** "B@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>aultglobal_biglogo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aultglobal_biglogo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!F17AI9@  34T *@    @ ! $:  4
M   !    /@$;  4    !    1@$H  ,    !  (   $Q  (    0    3@
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MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$
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M7[">C3>'RMYXXU6'Q.]OE;BVTZVET2VNBF0IL'>&^O+9),;BNHV<LJ@X,1;
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MRQ_96Y^ G@\>NH^/O_5D>+J_3C1K]=4TBSNT^8S0KY@&.)57RYOIB0,0#U!
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M[.RN_;JY3D']F5<>\O=&"PE2M3]O.M"I'W+TE*/MFH2E)Q:C=ZSBFF]'G?\
M!0K_ ).MT[_LW_PE_P"K#^(]7_\ @GO_ ,G S?\ 8D:__P"E>FU1_P""A7_)
MUNG?]D \)?\ JP_B/5+]A;Q-X=\*?'.74_$^N:3X?TT^#M;MA?ZS?VNFV9N)
M+G3VC@^TW<L4/G2*KLD6_>RH[*I"L1T8R<*?BM&I4G&G"&>X*4ISDHPBE2H7
M<I2:22ZMM(UH1E+@I1C%RD\JJ)1BFVVTDDDKMM^1^\I.!^?\C7\W'BBZN+_X
MK_'74+R1I;Z[^/?QCCNRYRT8TCX@:WX>TVV)X.VTT31M*M8L@?N88^O4_OU'
M\:O@_*RI'\4/ ,CNRHBIXLT-F9G8*JJ!>DEF8A0!R2<"OQ-_:6\%7GPV_:>^
M*.FW%E-;:%\2[^'XL>#=0:)TLM2.L66G:?XYTZWE9%BEU+1_%EI+J>I01,TD
M-GXITB>95^T*S_7^+#ACN'L+7P=>EB:6"S*E+$^PJQJJE&O1K4Z52I[.4E%.
M?N1<K7<_=>]_G."U+#YE7I5Z<Z4Z^%?L?:0E!U'2K4IU(PYDFVH/G:5[*+;V
M/N7]@'2M-:S^(6M&.-]52?1=-65@IE@L76]N71#]]([J>-#( 0LC6B9!,?'Z
M-CCCTK\0_P!G#XU2?!KQ7/<WL$U[X8U^&"SU^TMU5KE/L\DK6>HVBLR*]U9-
M+(!#(ZQSV\\\6Z.1DF3]68OC]\'GT3^W?^%@^&ULQ%'(83=_\3%=Z[A#_8X7
M^U6N>J"W6S\UI $5"2!77X:<0Y+_ *M8;+IXS"83&9?+$QQ5'$5:>'E-5<56
MK0KQ=5P56$H58QE*+ER3BX2M:-^;BK+<=_:U7$1H5JU#$QHNE.G"511<:-.G
M*G+E3Y)*<6TFE>,DTWJ?)/\ P48TC3;7P?\ !KQS;VD9\7:)\:_"_AG2KI5'
MVFYT'QO9ZIIGBO1F8 R26,MA;0Z]+!S$MWX>L[UE#VJNOROH<DD-_8RPEEEB
MN[:2-E)5E=)$965ARI! ((Z8K;^/OQ7N_C]\0_#NI6UMJ&D?#3X=3:A<>$-(
MU2!+;4?$OB_4+:YTJX\>:E9AI+C3+.QT*\N](\*:7=,E^BZGJ^K:O:6=S-I]
MI:=%\&/!]QXV\>Z%I$43/:P74.I:JX!V0Z99NCW)=@1M\X8MHR2!YTT?)^Z?
MR;CO&X7B?C:E2R.U=U/J66QQ-"SCBL3SN+JPE&_/"E[2-/VNJ<:3E%N"BSZ?
M)J%3*\E7UZ]-PCB,34A-6=&E)QDJ;3>C:3DXNUI5'%ZW/$?VK6+?\%1O"K,,
M,W[)=JQ'7!/C;Q22,^QKWGP]K&IZ#J-MJFCSM:ZC;,YMIT17:-I(Y(V*AE8;
MMCL%.,J2".17A/[6 Q_P5)\,#T_9.MQ^7C?Q57U;\&(K&;XB>&X]22VDLFN9
MQ.EXD3VS+]DN0/-6=6BP"01N'W@*X^,:%7$^(-7"T<1+"5Z^<86A2Q:<E+#5
M:N*I4Z>(C*,HR4J,Y*I%QE&2E%-2B[-:X&I&GP[A*DZ:J0AEW/*DTFJD8TIR
ME3::::FDXM---/5-:'$6.F6UOJ6L:PT4CZUXCO\ ^T_$&K74\UYJFLWHB2"*
MXU*^NYIKNZ:VM88;6TBGF:&QM8(;6RCM[:*.)?N'X!Z_X0M;"3P_9RW,6OWK
M&]O/MB1HEX\48'EV3I*^4MH]Y5)5CE8&20*5!"?.O[4L'@BQ\5?"K_A6SVR^
M,I_&5TGC>P\+2!]'_P"$"E\*^(IM0NO&%I8[M&L[M?$$/AIM O;M(=?FNS+;
M:=++ILNL0O2\&W,UKXGT&>V=HYDU>R\MEY);SD &,<AVPI&/NL1P>1="IC/#
MSC>E*IB<#GU:2I?6<2G.M4]GCIJ.)Y9RFYT,>X<]YRE5TJ+FYH5))\E:-//,
MF;C"MA(\LO9TG:*4J*7LTXI<LJ/,ERZ+17BDTCZR_:@^-.F?L^? ?XE?%C46
M!F\+>';E]"M"ID;5/%6I;=+\*Z2D2G>[:CK]YI]L^T?)#))*?EC?'YU_LR?#
MO5?AE\&?!WA[Q'*;KQAJ$5YXM\<7TDCRW%]XT\8W]QXB\13W<T@#RW$5]J#6
M+2L272TC.< $]Q^W9KUC\5OC5\ /V9+>X-WINAWTW[1/Q7L;>8*$T/P:[:7\
M.M(U) &\RUU[QE?27<MK+Q+;Z*DHC90)8_0(22(SSNPK>I! !SSG)!^N3ZYK
MU?&?/?KN=X;)J4TZ&54N>LHO3ZWB8PG.[VO"E[.%FG9J7F<W#.$^K9=[>4;5
M,;4]K=[^QI<U.BOG)UI^<90^7@_QL@U;X1_';]ESXBW%Q,WA+XRZ5XR^!OB*
MW8R&VTWQ#?7%EXR^'5^B$^5%<ZK=Z?J>ERR_*YMWCCV2>7D?8?@O5_[$U_3M
M0)(A23RI\ D^3.HA<A<]521FQSDA<@D CSOX@:7IOQ;\-:/X2\?VBZWH6@:]
MH/BC1+13<:7-I6O^%YS/H6J6%_I,EC?VUS8,6"F*Z598GDAG62*21&Z&#/)Y
MW8!XZ@C!!QZYY&>O':OS;'9IEN'S3*<QX=IXK#2RVAEDI_6H4H2GF& A2=7$
M15&M73AB*U-UI7<7>;7*E:_J*G6JX6=#&\DI5/K-.3IN3BZ%:HY0C>48/FA"
MI[.UMHQ:D[Z?2WQT</\  [XON#N#?"KXA,&'0@^$=7((QP01R".#U%?E_P#\
M$[/^3-O@?_V!M>_]3+Q%7Z&>.-9.L?LV_%5W*&6S^%/Q$L90N<_Z/X1U58B<
MD\F$IO\ ]O<!TK\\_P#@G9_R9M\#_P#L#:]_ZF7B*OU'Q@S*CG&5\(YIAOX.
M/PD\5!7NX^UITY2IRU?O4Y.5.6KM*+1XO#=&6'H9K0G\5'&T:;\^6%5)KRDK
M27DT?J[\-_\ D7%_Z_+C^4==]7F7P_U33;70%AN;ZU@E^USMY<L\:. VS!*L
MP(!P<$CGJ.*[^#4]/NG,5M>VT\@7<4AF21@HP"Q"$D $CGW'J*_8. \PP'^J
M?#.%^O8/ZS_9."I_5_K-'V_M/917)[+G]ISWTY>7FOT/DLUI5?[0QL_9U.7Z
MQ4?-R2Y;7WO:WXEZBBBON3RPHHI&.%8^@)_(4 ?RB?\ !R1K=U)XO_9>\.$X
MLK/PQ\3-:49.6NM2U/PE8R$CT6'2H@I]6;WS^,/_  2Y\9?#3P/^W/\ "O5_
MB?>C2[*^M_%/AKPIK%Q=K9Z7I?CCQ7H-WX=T6;69)'2+[%J-MJ.HZ!"TK"&/
M4]8TZXG*0P22Q_?W_!<7XVW'QZ^-%A?Z!86[?#GX,:KXD^#FG>(K<M-_;GBZ
M!-/UGQ5*;E?W)MK>[!T^PBC)$EOIW]H*S+?;8_YWO$)(9V'!4A@?0AU((]""
M,@CD'D<U^\Y#E^!XS\)*F2T\57PV#SS*^(<DJXO#656E[?'9CEV(K4DVXU%S
M.I**;4*]-V?[N9^'<1XG%\.^(L\PG1I5<1EN-R?,J>'K:TYJ."P&+H4ZC2O!
M\C@FTG*E-73YHH_H*_X+=_LM_M#_ !S_ &C?V9-!^&7P_P#%/BGP;K/A>Y\(
MV^MZ+H.K:KH/A7Q?J_C-EU_4/%U[86L\.@:='H;^&;Q[_47MH)+/3+]K>262
MRN5B_FB_:O\ @=/^S1\<_'_P3G\;^'O'^H?#S5+73+_Q/X66[@TV34WTRPU"
M\L/*NU2>TU71+JZ?2M6MQ).EIJME=017$RQAZ_;3]A[_ (+3_$O]GFYF\#_M
M-7'C'XX_"DZ?I-CX;U!;W3[CQWX!;3&%MFVU&_CMKKQ1HL^G/BXT[6-6>^M9
MM/M'TN[C6XOH9?EK_@M#^R)\#/V4_BK\-[GX2>.?'?BK6_CCH/B_XN>,]/\
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M1C_>_P#"4Z8XT[5(@-EOJ*Q*9!L8V]Y&KS6S866*'^\/_@FS\=]._9^_9_\
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M"',]O)(C*FXA5EBYQR?E=1CKOQ7@?Q"^#?BCPQX]\4_%+X;PMXATOQR=.O\
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MT87BK%X7"T,)##8:5/#THTHRE[7F:C?65JB5VG;1)'YKVWPG^(\CHC>%-5!
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H@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>chart2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 chart2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!F17AI9@  34T *@    @ ! $:  4
M   !    /@$;  4    !    1@$H  ,    !  (   $Q  (    0    3@
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MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$
M A$#$0 _ /W\HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B
M@ HH ** "B@ S10 44 %% !10 44 &:* "B@ HH ** "B@ HH ** "B@ HH
M** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH
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ML^+?Q!^&7[56C:A>?$C6=2\.Z3H]M\3/#JZS97MO#!9RVVD6)MX[XM*CB3;
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MWKY9_P""@!_XRG_8Z_[. U#_ -0KQ)0!]344 %% !10 44 %% !10 44 %%
M!10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %%
M!10 44 %% !10 44 %% !10 44 % (/2@ HH ^4?&G[.?[:/[-WQ_P#%WQQ_
M8.NO _BCPU\2M035/&OPI^)&N7>DP66M"&.%]6TS4+6UNVC,\<40GM9(2C.G
MFHZ,762Q_P +;_X+)]/^&(/V?_\ Q(75O_F:H #\6O\ @LF.O[$'[/\ _P")
M"ZM_\S5'_"VO^"R?_1D'[/\ _P")"ZM_\S5 !_PMK_@LG_T9!^S_ /\ B0NK
M?_,U1_PMK_@LG_T9!^S_ /\ B0NK?_,U0 ?\+:_X+)_]&0?L_P#_ (D+JW_S
M-4?\+:_X+)_]&0?L_P#_ (D+JW_S-4 '_"VO^"R?_1D'[/\ _P")"ZM_\S5<
ME\?OVP/^"L_[.'P(\;?M#^/?V%_@;-H7@/PCJ7B+6H=-^/\ JDER]I96LES,
ML2MX=56D*1,%4LH+8!('- !\ ?VP?^"L_P"T?\"/!/[0W@+]A?X&PZ%X\\(Z
M;XBT6'4OC_JD=REI>VL=S"LJKX=95D"2J&4,P#9 )'-=;_PMK_@LG_T9!^S_
M /\ B0NK?_,U0 ?\+9_X+)?]&0? #_Q(35O_ )FJ/^%L_P#!9/&/^&(/@!_X
MD+JW_P S5 !_PMK_ (+)_P#1D'[/_P#XD+JW_P S5'_"V?\ @LG_ -&0?L__
M /B0FK?_ #-4 '_"VO\ @LG_ -&0?L__ /B0NK?_ #-4?\+9_P""R?\ T9!\
M /\ Q(35O_F:H /^%M?\%D_^C(/V?_\ Q(35O_F:J;X0_LS?M3?%S]I7P_\
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M[T9_X.F_3]@'_P O>@ _XZF_^K /_+WHS_P=-?\ 5@'_ )>] !G_ (.FO^K
M/_+WKC_V>OC7_P './[2GP"\#_M%^!=/_80M-$\?>#],\2:/:ZM#XTCNH;6^
MM8[J))EC=T64)*H8*[J&! 9A@D [#_CJ;_ZL _\ +WH_XZF_^K /_+WH /\
MCJ;_ .K /_+WH_XZFO\ JP#_ ,O>@ _XZFO^K /_ "]Z/^.IO_JP#_R]Z #_
M (ZF_P#JP#_R]Z,_\'37_5@'_E[T (/^(IKM_P , _\ E[TO_'4W_P!6 ?\
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M8JB*6)PJC '8?\=37_5@'_E[T '_ !U-_P#5@'_E[TA/_!TU_P!6 ?\ E[T
M+_QU-_\ 5@'_ )>]'_'4W_U8!_Y>] !_QU-?]6 ?^7O7'ZU\:_\ @YQT+X^^
M&?V=+O3_ -A!M;\5>#]<\2:?=1P^-#:QVNE76DVMPDC%PXE9]9M2@5&4K',6
M9"JAP#L/^.IK_JP#_P O>@_\137_ %8!_P"7O0 ?\=3?_5@'_E[T9_X.FO\
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M6^M8[J))EC=T64)*H8*[J&!PS#!(!V&?^#IK./\ C #_ ,O>C_CJ;_ZL _\
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M*7BFB62-O^&79QN4C@X/B3(KD_B7:_\ !3+X/_#/Q-\8/B'_ ,%0/ -CX?\
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MZ6]^D4X,,K6LDJQ2?)(5;Y:OEEIINKKT5B?:PLWV:3]6['-?&WXS_P#!2O\
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M% 'RK^W1&MY^W3^Q?I]ROF6[?%[Q+,T+\H9(_ ^OM&^.FY3R#U!Z5]54 %%
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M;>TA&I%OHFGYO2S^]ZBH.-&I!QVNF_G?F7R5K>9ZQ_P3_P#A-_P4@\.?M?\
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MTZQ_X>)_LSZW]DC^V1V?C:T6ZVCS!!)IMM(\6[KL9X86*]"T2'JHQ](4 %%
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M&;2#XK:IK'QZN[Y=3DO-&O;>[B^RKXA^RV4MK>_9)3):6DK.&WP3HR/&V?\
M$B[];+\[O\C;FC[126RB_F[*WZGG_P"S_P#LG?\ !17X)_#*W^%.@?"#XY6?
MAZ+X8>![?Q1I-U\?H;B:^OM/N;M-=LM%N7U^632);B"6T,+0-9P%+9H_-M6V
M-5ZR^"/_  5*\%^+8O&$OPS_ &A/$:Z9;Z#=^%K'3_CGIC1P0P>*+J>6PU"*
MZU^&&^NUT&6&UFDD26&>:/<TLSHER=O:4W6YGMS7^5O^'%)TVY+R@OGIS?\
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M&*WEU33=>GMDM]02%C&]S;/*DQW/B(R%*+:I]@-S7_C%JOBSXB6?Q?\ %/\
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M(;A[B4,T>WRA&$2.JD8RHNFGI9K[W=_@5+EG6=5]9<UNETDE^*+_ ,,?#/\
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M,.NPZ9K%IKD5K#:?VKI4MTRVL_GV]O;I/;3209:!9$D+,R&Y_P -_P#[4_\
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MKX9_#+1]6&H1^$]-N;B.>]N+J[4+'<ZA=FWLU?R@8H4M5CC:3<\C?3E !10
M5\ ?\'1W_*"CXY_]RS_ZD^DT ??]% !10 =!1D8S0 9HH ,T4 %&: #-% !1
M0 44 %% !UKX _X-<?\ E!1\#/\ N9O_ %)]6H ^_P#'>B@ HH .<T4 %% '
MP!_P3Q_Y3K_\%%?^Z1_^HQ<U]_\ 2@ H- "8.<TH&!TH ;C-.Q[U( ,]Z*H
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M+=?:]2NKXYB7P^P7:;DH,,<A >,XH ]V_P"$P_X+<?\ 1N_[*_\ X>;Q)_\
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MXK^/WQ.\=:/\/?%?AJ^\*_\ ""^&_$?PVUN/P[=)((]4BOQF\22Y4W*A[-9
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M%% !10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44
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M$$J;E4C[.RWY5?\ Q77Z?F81YG"G%])3?R<7;\?R.9^!WQ+^-OCK_@HK\/\
MX??M!_$[XK:;XG\+Z/H<?BCX=Z3\7M/9VOH]'A26:_TZR\51^=8F[F,\ABT>
M]#N$:2_$7G6D'ZP@8%.HXRBG';4S@I*23Z1BGZVU/FW_ (+'_P#*)[]I#/\
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MX#"CL'DE4)M;["\$^$-"^'O@S2/ /A:T^SZ9H>EV^GZ=!G/EP0QK'&OX*H%
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MLK?>O^"8\O[ET7LVI?-'T@ %YI:#0^5_^"2?_)(?BY_V=1\4_P#U+=1KZHH
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MAZZJ;IQFM-O\K?FSHJRHSIQ5OY6_DVW^"5O,ROCI^QK_ ,%'/&>F^(/@O>^
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M6_\ #J>!?_EW1_PV_P#MZ_\ 2%[XK?\ AT_ O_RZH /^&W_V]?\ I"[\5O\
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MJZ\6? [X'Z7I?B"^MEM]0\67\T^I:U>0@Y$<VHWLDUW*N></*03R>: /7:*
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M ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HY]: #FB@ HH !GO10 44
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MSK]K_P#Y-+^*/_9.M;_]()JDU#]D#_DTOX7?]DZT3_T@AKT6@ HH ** "B@
MHH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@
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MC5Y>MCILUYU^U_\ \FE_%'_LG6M_^D$U!H'[('_)I?PN_P"R=:)_Z00UZ+0
M44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %% !10
M44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %% !10
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M 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 ? '_  3P_P"4Z_\
MP45_[I'_ .HQ<U]_T (Z)*C1R(&5AAE8<$5F_P#"%>#?^A2TS_P C_PH /\
MA"O!W_0I:9_X 1__ !-'_"%^#?\ H4M,_P# "/\ PH /^$+\'?\ 0I:9_P"
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MYV0/3<]$/_!0\=?^&&_VB?\ PV?_ -T4'_@H>/\ HQK]HK_PV?\ ]T47 /\
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M$SXH>)]*;4[C+R:9H.B:Y?:/IVE0%B?*@1+$SLB85Y[F:0C+<>J?\% _AO\
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MP?\ @K'\#)?B?^QMXJ^*G@&T6V^)WPFTFZ\;?"?Q#;[([K3M;TZ![F*-)6(
MAN!&;6:-F$<D,[J_!XJLHQJM1V+6Q[U\*_&\'Q,^&'ASXD6L(CB\0:#9ZG'&
MN<*L\*2@<@'@-W -;U9C"B@ HH ** "B@ HH ** "B@ HH ** "B@ HH **
M"B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH **
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MKSO]L#/_  R7\4,?]$ZUO_T@FJC1;"_L?_\ )I?PN_[)UHG_ *00UZ+0 44
M%% !10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44
M%% !10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44
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MM(H** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@
MHH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@
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M5T>GZ=I^DV<>G:58PVMO$N(H+>((B#T"C@4 344 %% !10 44 %% !10 44
M%% !10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44
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M7PMJ.JPH,R26<6IV\/VP(/F<0EV1<,X4$$@'OU% !10 44 %% !10 44 %%
M!10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %%
M!10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 ? '_!/#_E.O\
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M%9A&B("1D*BCH *R/VP/^32_BC_V3K6__2":INV]11BHZ(/V0/\ DTOX7?\
M9.M$_P#2"&O1:!A10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44
M %% !10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44
M %% !10 44 %% !10 44 ? '_!/#_E.O_P %%?\ ND?_ *C%S7W_ $ ?*_\
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M.M>KZH/(P: "@\]J ([L7'V63[*D;S;#Y:R,54MV!(!P/?!^AKX/\+?L9_\
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M_H@?_EU:K_\ )5 !_P .G?V /^B!_P#EU:K_ /)5'_#IW]@#_H@?_EU:K_\
M)5 !_P .G?V /^B!_P#EU:K_ /)5'_#IW]@#_H@?_EU:K_\ )5 !_P .G?V
M/^B!_P#EU:K_ /)5'_#IW]@#_H@?_EU:K_\ )5 !_P .G?V /^B!_P#EU:K_
M /)5=I\ ?V&OV0_V6_$.I>,O@'^SYX:\-Z[K,:QZOXBM;'S-2O8U^ZDMW*6G
MD08&%9RH &!P* /5J* "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "
JB@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>chart_s2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 chart_s2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!F17AI9@  34T *@    @ ! $:  4
M   !    /@$;  4    !    1@$H  ,    !  (   $Q  (    0    3@
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MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$
M A$#$0 _ /[^**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MX6O3J4^;GBHPJ.*IUJ,ZG[_45^ /_#@O_K-1_P %_O\ Q8W_ /B;H_X<%_\
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MVO'1I=5N@#]*:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M!=Z9:>"O!'[0/[.&LVFLW5VMG<VFO2^.KZQM+2PU&TE\.7TMY%?:7^>_Q/\
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M-C]3^N_VFOVDOVH/A?\ 'KX'_!+X"?L[? ;XOCXV>%OB/K5AXE^+G[57Q ^
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M1KK_ ()[?M;7,&IZ7=1_LY:C%\-?'7[:WQJ^"/C,_%GXEZ;XY^(OB_\ ;/\
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M&EW>_"[XC:)\/+_Q+X?\<WW@_P -Z[X#\5>,?&>EW/PS\66GBF;Q#I?GT_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]&@#]HZ*_%S_ (<0_L;?]%8_;_\ _%A?[6W_ ,]&C_AQ#^QM_P!%8_;_ /\
MQ87^UM_\]&@#]HZ*_%S_ (<0_L;?]%8_;_\ _%A?[6W_ ,]&OGK]K/\ X(I_
MLH?#S]F;XZ>.?#OQ8_;P_MWPI\,_%>N:3_:O[?/[5.L::;ZPTN>: 7VE:C\3
M)['4+8NH$UI=PRP3)E)$9210!_1117X2?\0Z?_!.W_H+?MC_ /B;_P"TO_\
M/"H_XAT_^"=O_06_;'_\3?\ VE__ )X5 '[MT5^$G_$.G_P3M_Z"W[8__B;_
M .TO_P#/"H_XAT_^"=O_ $%OVQ__ !-_]I?_ .>%0!^P'QP^ GP4_:7^'&N?
M"#]H+X5> _C+\,/$9MWUCP-\1O#.E^*O#MU<V4OGZ=J*6&JV]Q'::OI5R%O-
M(UFR^S:KI%ZD=[IMY:W<4<R_C-??\&OO_!"W4+V\OY_V%[6.>^NKB\FCL?VC
M/VMM,LDEN97FD2STW3?CU::=I]JKN1;V-A:VUE:1!(+6WA@CCC79_P"(=/\
MX)V_]!;]L?\ \3?_ &E__GA4?\0Z?_!.W_H+?MC_ /B;_P"TO_\ /"H YS_B
M%Q_X(4?]&-?^;,_MA_\ T05'_$+C_P $*/\ HQK_ ,V9_;#_ /H@JZ/_ (AT
M_P#@G;_T%OVQ_P#Q-_\ :7_^>%1_Q#I_\$[?^@M^V/\ ^)O_ +2__P \*@#G
M/^(7'_@A1_T8U_YLS^V'_P#1!4?\0N/_  0H_P"C&O\ S9G]L/\ ^B"KH_\
MB'3_ ."=O_06_;'_ /$W_P!I?_YX5'_$.G_P3M_Z"W[8_P#XF_\ M+__ #PJ
M .<_XA<?^"%'_1C7_FS/[8?_ -$%1_Q"X_\ !"C_ *,:_P#-F?VP_P#Z(*NC
M_P"(=/\ X)V_]!;]L?\ \3?_ &E__GA4?\0Z?_!.W_H+?MC_ /B;_P"TO_\
M/"H YS_B%Q_X(4?]&-?^;,_MA_\ T05'_$+C_P $*/\ HQK_ ,V9_;#_ /H@
MJZ/_ (AT_P#@G;_T%OVQ_P#Q-_\ :7_^>%1_Q#I_\$[?^@M^V/\ ^)O_ +2_
M_P \*@#G/^(7'_@A1_T8U_YLS^V'_P#1!4?\0N/_  0H_P"C&O\ S9G]L/\
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M_P 0N/\ P0H_Z,:_\V9_;#_^B"H_XA<?^"%'_1C7_FS/[8?_ -$%7SW^S?\
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MT8U_YLS^V'_]$%1_Q"X_\$*/^C&O_-F?VP__ *(*@#]_J*_ '_B%Q_X(4?\
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M1\'-6O&M-.T-8_"_Q+^+?@FSUN^GTW4OB%9WRZ%:>)/;M%_X(:_\&M_B2_\
M .E>'? '[.6OZI\5O$'B+PG\+M-T7_@H1\=]5O\ XD^*O",OD>+/#/@&SL?V
MJ9[CQCX@\,3?N?$6C>'8]1U'19?W>I6UL_%?2GQT_P""?O[8_P"U(W@;Q/\
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MO#^D^$M5^#_C:7XQ+XT^(_B_0?$6B26R?2'Q]_;[USQ5X>^)G@^S^%6M:#\
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MTL'6G.FH8B3DXQI?\$\/^4Z__!Q5_P!XC?\ UCSQM7[_ %?@#_P3P_Y3K_\
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M:%%1E-XG%87 XC$X3"*G3E&K4>+Q-*EAE3H/ZQ4=7DPZE6E3B_6/''[1FG^
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MXOGPF&]G.I'"5:TG44,31HO$5Z%>C7JTZ:JY77P.,A2FLSA#"_MUX3\(^%/
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MP!X5\'Z/XE\->(/%/CCQM\/?#_@OP]X:\2^&_$NKZ_9Z#K^D:C>>0Z1^P/\
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M^+^LV5DD?BCXUVWAZ'XN>+I;G5+KQ3XUUBZUG5Y[WDO^'L7_  2R_P"DEG[
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M?I%S#?Q^*=97PC:?#6G?$+_@V6TGQ=X&\<Z9^W)X.L/$OPVL?A-IG@J[M/\
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M@^'/QZ^&MI\)OVC_ (9Z%XH\<^"[?XK>$] .L3>$;C3_ !O\-/&G@+QY\/\
MQ%ICZ[JF@>(]2\/Z[-I_C_X>ZC>^!?%FC7]FFCW^C_/_ /P5T_9)^)G[6/[*
M_A^;X"6^@WO[2_[+/Q]^"_[:/[,VF^)G:#1-=^-/[.OB23Q+HGA.\OO[0TV'
M3#XW\/WGB?P5;:K>7*V&G7?B&"[O3#;127,'D'PG_P""]O\ P3J\0^'SIW[1
MGQAL/V(?CYX96QTSXL?LV_M7VNK_  C^)7PZ\6R6<<^H:5!_PE>DZ3IGCC0(
MY_-&D>,_"%QJ6AZQ9""Z+6-Q.UC#QRA":<:D(U(.-2$J=2*J4IQJTIT9QJ4I
MJ5.I%PJ2<54C)0J*%:'+6I4YPZ(5*E*<*E*I4HU:=2C6I5:4YTJU*KAZU/$4
M:E*K3<:E*<*U*G)2IRBVDX-N$IQE]E>+_P#@GA^RIX\^"_A?]G_Q5X7^*.H_
M#3PAX^\"?%'1X(OVF?VGM+\;S^/OAA::-9?#SQ'XC^+>D?&.P^+?C&Z\&Q^&
MO#,_AZW\7^.-=L=-U'PQX9U:WM%U3P[HMY8]'H/["_[+_AGX1_$7X%:/\/=7
M@^%_Q4T_5=(\7^'[GXH?%O4[X:1JOB7Q1XQ.D^$_%>J>.[WQA\.M+T;Q1XT\
M3:YX0T[X>:_X6L_ M_J9E\%PZ#]DL!:_,O\ P_"_X)#?])%?V4O_  Z^@?\
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MYAB,10Q.*Q<)1G3<,5.I1CF%65*=/$YABL'0H1K1Q-2C6I_M;^PSH/P@\&_
MA/@3\)?A-\;/@KX0^"-[!\-KWX-_M">-?$WQ,\:^ )=0\(^&_&L?@V'QUXF^
M+7QSMO$_A71M#\9:9I.BR^#_ (I>+_A[IT%K/H/@O4GT+2[95Z'X:?L+?LH_
M!Z\^ 6H?#;X0:9X6O/V7_"WQ!\%? RXM?$/C.[?P/X:^*D]M=>/-._XF?B2^
M7Q*VNW%K'-]N\8+X@U'2Y)+QM&N].^WWWVC^0/3/VS/^";7Q)_:Z^#OQO^/'
MQ#\!?$_X>>*_VL_C5XZF\._M0?MQ? G]IYOV5?V>/$W[-NE>"="\">(/!WQ4
M_:S^+'A70M(\2_M(:CXA^+-QX _9CE^)OAVU\/Z%X,&KB.\\!_#OPEX?X7Q)
M^TC^P;XY\ ^/K:_^-'[&VD?&?PS\&_B!I?QD^(NI_M#?LXW&G?\ !1CX^Z-\
M9OA=\3_V?OC)I,^F^.]1U:W\9>!+'P-XN/ASQI^T=HOPN\2?"K5O&\'P^\$7
M$OP\6_URQ]"I4=3$8;%UL1*%?&8"GC\SJTIU<35P^)645JF+PT)U*KKXJO1^
MOX[+%0J5Y5:E3,*N#R^MFV'EF6+I<//4E''X>E2]I"ABH4\#'$N5"&93JXBN
MZ>(J..&E0PD9UL)"K+$U(*-)SP^)QL,!"I1O_;#X^_97^#OQ,^.'PJ_:*\6P
M?$R3XJ?!6TU&P^'5[X>^/GQ[\$^#-)M=9D9]<BU?X3>"?B7X>^$OC+^WD,-K
MKTGC7P/XBDUS3K'2M,U9[S3M'TJUL_C_ ,=_L9?L-?M)?M/_ !H'Q/\ !/Q[
ML/CU=P_ OQIXIB?]I_\ :L^&OAKX@^$_@UKB^(/@CX[^'_AGX:?'S1OAU/X5
M^&GQ%_M.:"RT;0="U/PO\2#?Z_XF\.VFH>+-*UWQ+_*?XH_;J_X)>7/[2?B?
MXJ?$#X4_LV?$OP3\1OVL?VA?B<_PLT?XQ_L/:K=^(OAA\?\ ]B[X/>#_ !)9
M^,=4U'XX:)\-M/N)_CKX+UKQ!\4O"GC?QA8Z%KGCV&V\9^ M1^*>M66AZY=?
MJ-^RU_P4X_X)X?#[XB_L,:5\0O\ @HW^SA?ZG^RO^P9XW^$OQ@\<3?&H:SX>
M\6_$'XG:W\ Y-"\':1XH\0SQ77C\^$[?X0^)-0U/Q(+66ZM,Z ;VZL[CQ!/I
MYSP="G3J8"?MHX><,-A\>XT/9I8#-LPX>Q_$N)6'Q$:U)QQ67YOEV6Y1BL9&
MFJ>)QN.G3M3S2C@J,]YU8UX9DW.:IO$2P$:F(I5I3S++<OS/"X'!K$X10J36
M&Q%.O4KX;#5:B^INGA<=2GB,LACJE/\ 9:#_ ()-_L,0+KJGX>?%2\'B?6?B
M!XAU\ZI^UA^UUK#:IJ_Q.\6:+\0/%UW<OJWQUO6/F?$+P_IGQ#\/0(4M?!'Q
M!6]\<^"(?#OBO5M6U>^@N?\ @DC^PCJ-SY^O?#GXJ^+;>3Q3\8?&=YHOCC]K
M3]K_ ,=^%M7\1?'[2+?0OB_=Z_X0\8_'C7/"WB&V\;:;;)%?:3KFCZAH]A<2
M75_HUAINH7MY=3\E_P /PO\ @D-_TD5_92_\.OH'_P >H_X?A?\ !(;_ *2*
M_LI?^'7T#_X]7+%\L:<8^[&EAYX.E&.D:>$G.G4GA::6D,/.I1HSG0C:E*=*
MG)Q<H1:TDW.I4JS;E5K8B.,JU)/FJ5<7"-2,,54F[RGB(1JU8QKR;JQC4J)2
M2G*_K-[_ ,$R_P!C[6(_AW%XD\*?%_QF/A?I_P 2=)\,/X__ &L?VMOB!/?:
M7\7/"W_"#>/M-\>W/C7XXZ]<_%:QUCP3CP=96GQ2E\90>&_"J1>'O"\>C:1%
M'9I#I?\ P3#_ &-]%U?P5KVF>#_BW::SX!^)O@;XRZ#J*_M7_M:R7-Y\4OAQ
MX&L?AEX2\<>,GF^.,G_"QM>L_AYIMGX*U.Y^(0\4+XF\,QOHWB>/6;&>XAE\
ML_X?A?\ !(;_ *2*_LI?^'7T#_X]7%^/O^"]W_!)[P;X;N=6\-?M@?#SXX^*
MI9H--\*_"/\ 9X.I_&GXP_$'Q'?%HM(\+^"? '@>RU/5]4U;5KH):03W2V&B
MV<DBS:OJVG68>Y76-:M"I[:%6K&K[6C7]K&<HU/;X?%?7</6YTU+VM#&I8NC
M4OSTL5_M$'&K[Y*C%0=-12INCB,.X))0=#%T8X?%4''X71Q.'A"AB*=N2M1C
M&E4C*$5%>#?\$\/^4Z__  <5?]XC?_6//&U?O]7X[_\ !)WX!_&O3=7_ &Q_
MV]?VG_APGP<_:$_X**_&/PE\1+[X/7,D%YXH^$/P'^#'@*Q^$_[.GPY\>ZG:
MSW%K>>.M/\'VFJ^)_$L-G)':Z5?>+FTM[2QU*TU*TB_8BLAGX _\$\/^4Z__
M  <5?]XC?_6//&U<98?%?]I^\_;G^+GQ0^*FA:O<^!OA]_P4+^&7[&?@+PG\
M-_\ @H9^T-X0^'MIX1\=?!GX5>-?!^J^,_V;-/\ V>-+^%WCB]TOQ)XETCQQ
MX@U*7Q1HOB'5KWQ_XT^&OB+6O&WPZ^''A6#QYW?[6FJ?%?\ X)O_ /!1O5?^
M"C-A\-/'OQE_8M_:I^"7PR^ ?[9&G?"/P9XA^(/Q2_9_^(/P3UWQ9=_!K]H0
M>#_#RZIKWBKX57'AGQWK_@GQKI7AG0WO_#=PB>)I7O[B]L=)O?!Y?V@_^#;/
MQCJ_B'XB3?MX^&X]6^)/QM\,_M3:\\W_  4<_;-\)-<?&WP]826GACQW_P (
M<_[06B0>$-6T/2);+1;7PS9Z#H6DZ9I&@^%?#TWA^"P\%^%[#1;PLE1Q]/$U
M+NE3HX>FE#E]K"I_K'PWB\95H2E&^'KU.'<%Q!EV'Q=&<*]#$9C2BOW%;$5*
M2Q*=7+,?A*3C#$XJG6ITZE2'/15\KS6GAE7CS<M:A2SFKD^.K8:I1JTL11P5
M2,N6481J?8=I_P %.?VE3\'/ OQB\1_LD_ [P5X=\9?$KXC^ ;GQ!KG[7_CE
MOAWX7/P<^(7BCX;^-D\6?$JY_8ZT;PQX+UOQEX@\,R1?!$_$*X\%^!/&%LVI
M?\)UX_\ A?XALM!\*^+_ %[]F[]MSXIR_LC?M4?M2_M7>$? ^BZ/\!_C7^U[
MHFC6/P=\6ZOXWN]<^'?[/OQ8\>> ["QFL]?^'?PWBTKQ )_"$N@Z?(VH>(;;
MQ';I9^,-6U3PM)K%WX3\.?!^F?M-_P#!N-I7PCT3X%0?MO?!B\^&&@:UXVUJ
MTT'7/VZOC[XDU"_'Q+\1Z?XM^(_ASQ+XM\0_&C5/&7C'X?\ Q \0:9!?^-OA
MEXM\0:W\.O%8N-4L]=\+W]AK>LVM_P"Q>'/^"B/_  0%\+?#[XR?"?3?VUOV
M4;SX8?'[Q'\1_%/Q5^'OB;X_ZKXT\&:_JOQ=>[G^)<.E^&_&/BG7=(\&:#XR
MOM1U35M9\*>![3PWX6FUW5]9U^/1HM:UC4[^[TE*A[#&J$)_6*M'$0PC3Y84
M)2GE$Z/OU'B%&I'V&9Q^LRP]=4X5H1>$Q"Q,E@KPUHT<%3Q4N>I#-,'B,94A
M35IX"A#B.EB*<8PJ8>K5EB8X_)9O"JOA**EESOB95Z4<7B?4M&_X*4?M$?\
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M0/$&K>%)O$F@65]=7US::)K%A;S:AJ#QF]N/I2O$/V=O@Q;_  $^%6D_#_\
MMD>)M<EUSQKXZ\<>*QIR:.OBOXC_ !/\9Z]\1?B)XD@TB.YO1I%CJ_C+Q/K-
MUI6D&^U!](TIK'3'U"^:T-W-I_'+X]_!G]FGX:>)OC#\>_B5X0^%'PT\(:=<
M:GKWB[QGK-IH^F6T%M$TGV>V^T2"?4]4NBH@T[1M,AO-6U2\DALM.LKJ[GBA
M<Q#BZTW!QDFUS2IP5.E.IRKVLZ--1A[.A.KSRH4W%.G2<(27-%CCR7J>RC6C
M0=?$/"PQ,U4Q5/!.O4>"IXNI%N-3&4\(Z,,74@W"IB8U9P;A)'Y6?\$Y/^4E
M7_!=G_LYO]DO_P!8N^&%?M?7XG?\$9-)\>?$^S_;<_X*">._!&H?#K3_ /@H
M=^U(?BY\$?"FNI?VGBK_ (9A^&GPT\%_!OX%>*_%^C7MCIO_  C^O^/]"\):
MGXV71TM9Y(M"UW0[N?5;]KQ4M/VQK$H_%#_@G)_RDJ_X+L_]G-_LE_\ K%WP
MPK]KZ_GT^/GB+Q1_P2B_X*)_'+]NWQ%X&^(?CK]@3]O'P5\(-._:C\3?#'PS
MXL^(^O?LK_M#? 3POJ?@?PA\8=<^&?A:WUG7)OA%\1OAB-*\.^.O$G@S0;S4
M['Q1X=TB\UZSNF.D)J7UG:_\%RO^"05W;6]W%_P43_992*Z@BN(TNOB;I-E<
MK'/&LB+<65[]GO+2=58"6UNX(;FWD#13Q1RHZ* ?JQ17Y7?\/PO^"0W_ $D5
M_92_\.OH'_QZC_A^%_P2&_Z2*_LI?^'7T#_X]0!^J-%?E=_P_"_X)#?])%?V
M4O\ PZ^@?_'J/^'X7_!(;_I(K^RE_P"'7T#_ ./4 ?JC17Y7?\/PO^"0W_21
M7]E+_P .OH'_ ,>H_P"'X7_!(;_I(K^RE_X=?0/_ (]0!^J-%?E=_P /PO\
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M*<JRL-)!# @$$'(/(KXJ_P"'QW_!)W_I)#^Q-_XDI\)__FIKL_A]_P %2O\
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M1OP4_P"B/?"W_P -]X3_ /E17J5% 'EO_"C?@I_T1[X6_P#AOO"?_P J*/\
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M)9B22:].HH \M_X4;\%/^B/?"W_PWWA/_P"5%'_"C?@I_P!$>^%O_AOO"?\
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M+HR0^)+C3])GGM-/1Z^-_P!ISX;+_P %/O\ @J%K_P"PM\7=>\11?L-?L/\
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MQ%6I-VC"%'"X:O6:NZE:4(X;"TZ^,K8?#UJY7[*O7=HTL-"E.M-W:C[?%8?
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M32E!N%>,;224YQG[)U*:4Y>Q?\,@?LE_]&N_LZ_^&2^&G_S,T?\ #('[)?\
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MG*_X*U?]FR?\$VO_ $T_M%U^U] !1110!^.W_!OW_P H9_\ @GS_ -D*MO\
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MPS&=&G.+E'&5L%@H8K#Y?04/WGUO,*SCE^&5*.)JRQ6+PD:6$Q%1QH5_Z/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% 'XN?'#_E/+^P+_ -F ?MQ?^K+_ &;Z_7WQK_R)OBW_ +%G7O\
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M[]HOXF:YX;\-?\%&+[]G6+]GW]H3X.3>$?'?@W_@H)\=[7Q58W7[,_PU\1?
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MM=^,/&UM?:O\)Y/VY[7Q/H&B:9\+_&/B#X=ZYX>\*U^XG_!.;0-7T?\ 8O\
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M_$'Q[-X'UR*^T3XE^)1XEUB"&^^?_%O[8?\ P4#\??&#]H;PU\.]*_9[\.?
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M?[!PE;$5(0YKK$TN(I8[!-*I4G# 4,-6JX6$,=AL95_0*OQV_P""M?\ R/\
M_P $=_\ M,3\!O\ UF;]K^OV)K\=O^"M?_(__P#!'?\ [3$_ ;_UF;]K^L30
M_8FBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MXOB-\/\ ]GZ?]F">Y7PW:?LXVWPXM=$\<_!N9/#OB[0-.\#V.FV=[;PZ_P"
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M(VG%;F</^</_  _-^!W_ $9-_P %8_\ Q7#^T)_\HZ/^'YOP._Z,F_X*Q_\
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M,U;Q)X-TOQ_XH\1:WX-\<^#[R^&FZ!<W3^)8I"9QH'>?\/\ 3_K"O_P7^_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MM]0ETZ^@]_\ "_\ P4<\+O9WFG^'O@A^V3\:?&EO\4OCEH_CCP!X>\%_L_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/\)[/X,?%75?%_A*_2V^&VK>(OA-^VA^RI?>(?!GPQU[XA?#SQ3\1[.Q\'^
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M>K_&&Z\2:YXI^&_@/X,&]UE?&^BVOC+3O#&I:?I>N?-^BZS^T1>PMXNTB?\
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M:/>>-/#<-[=+$8+<ZG!YTD>]=TE_^U;_ ,%J)[2>'2?^"0O[/>FZC(H2UO\
M5/\ @J#X?U;3K60NO[Z[TZR_90TJ[NX57=NBM]0M93P5<D;&O?L5_L'_ +2$
M/[2_B3_@H=_P47^*O@KXF?M<:SX!O?A+\'_A)\&(_$5E^S9^R#\']8U&RU3Q
M)X1^&">)Y$U[QQX\\>:AI>FW_P 0/BIXET^RUF[2$^&-)C7PW;VP< _8:BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\$4O^ST_CE_ZPA^TY7$6?KO1110 4444 %%%% !1110 4444 %%%% !1110
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MTYXW^)7_ &HHHHJ30**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+QM^47P9_;U_:DU?X=^!Y_CQ^WG^SQH_P<^+OQRT_0+K]K/X ^,_AM\=]:^
MUY=_"?Q'XEM?V=/BCXJ\2_L/_L^_ 'X;^*?&?Q:T#3_!F@^&?'/PD\1?%;PQ
MH.N)\._$?B>[^)OB7P)X\O/>_P#@F%XH\.:SX+_X)*>)/A3XF\,>*M3\9_L3
M?&#P7\<M0\+7=N%U;PQ\)KGX=6VGW'BFSTZ[NEA\0?#+XQZG<>#;'0]?0ZQX
M-O/'7C[0Q-I]V=;L+O7#+%X>,,'?EP^2SRM8"E1I1KK"U<1E_$/$DXSBZ<Z=
M>E&J_P#;,/5J03^M5<QJPQV#PV#<\*5>E7I8O,8.M#$X]9OA<9*M2G3EC*>=
M4\%PWCW4G*U1^VRO)YX;#8FC3Q4:2P\,'1Q&4XB&/:^\OCS^P5XC^,7QA^(?
MBO2?CA8>$_@S^T'H'P?\/_M,?"+5?A6WB[Q'XRA^!OB#4=<\'7_PE^*,/Q%\
M+1?"'4=<MM0_X1KQ]-KO@#XLQ:KH%G:3>#H/ /BA)/$TGEGC?_@D]X;\9?'&
M3XU_\+HUC2+C3?VH5^/7@SP[:>"+"2'PK\/_ !WX.3P_^TS\!%U0^(H;C4O"
MO[27B!Y?&?C#6&MK,:;JECX:4>']8N?#T>I7GZYT5P4)O#5:->CRPK4(U84Z
MO)"53V5?&8''5Z%2<XRE6P]:MEV$IU<-6=2A/!0J9=*F\OQ.)PM9U*=.K3KT
M9TX.EB8QC6IQA&$)2A@\;@85HQ@HJGBH4,PQCABZ:ABH8FL\;&LL;"GB(?@?
M\4/^"(6DZY?_ +4UW\'O&7[(_P -=5_:1\1_$[Q?:?%_QI_P3]\,_%']JKP1
MJ_QOUZ[UOXL>'[S]I/2OCO\ ##Q3XP^'.I'6_$</@[PV-&\,^)/"<-UHVDZA
MXZ\5^#M%F\):O[+^WA;ZM:?MC?\ !#NUUZ^T[5-<MOVO_C%;ZSJ>D:5<Z'I.
MHZM#^P+^TO'J-]I>B7NL>(;S1]/N[Q9KBRTN[U_7+G3[:2.TGUC4I8FO9OV+
MK\2OVR/&L?Q9_P""N_\ P2G_ &:_AZ;+7O%'[/UW^T?^VK\?/L\WFR?#7X63
M? CQK^SS\-Y]9^SRRM9WOQ%\?_%:YL-!L;NVC>\M_#U_?I<P6]NJ7I"<J>%H
M8.,F\/AJ=&CAX3?M)4J5"$H4X0JU.:JH\LGSKG_>RM.KSSC&256$:V.Q.9U5
MS8[&U:];%XB[4L15Q-6-:M5K1BU"I4E4CS*4HN5/FJ*FX*K44OVUHHHJ2PHH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** /R(_X*9_\G'_ /!&G_M)6?\
MUC+]K>OUWK\B/^"F?_)Q_P#P1I_[25G_ -8R_:WK]=Z /.?B[\(_AI\>_AEX
MW^#7QD\%Z%\1/A=\2/#U_P"%?&_@KQ):_;-&\0:%J4>RYL[J-7CFBD5A'<V5
M]9S6VH:;?06VHZ==6M_:V]S%^.GA/_@G5_P4H_95@D\!?L/?\%/--N_V=K*U
ML].^'_P4_;@_9WM?VB-=^#FEVESJDL6A^!_CEX1\??"_X@>(/"MGI]QI'A_1
M/#WQ"M_$UQH>DZ);&WU^>XGNVG_=&B@#\7/^%'_\%Y?^C^OV /\ Q!WXE_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7]O^!M6UK]O#4? WQ-_:#_;)^*'[+GP9T7X :58_LI?"WQ+\'-1\4>,O"W[
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MC/X>_!']L[5=%^$/QI^$GQ:U[]IW]J?X*7'QL_8G\3K9?\-1^$/BMI%A\)O
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@#\B/^"F?_)Q_P#P1I_[25G_ -8R_:WK]=Z_(C_@IG_R<?\ \$:?^TE9
M_P#6,OVMZ_7>@#\4/^"C?_*2K_@A-_V<W^UI_P"L7?$^OVOK\.O^"PVMV/P(
M^+G_  2U_;G\:QWL7P/_ &3_ -LC7=/^/?B.UM_/L_AK\/OVCO@A\0?@C9?%
MCQ.X826G@KP7XTU[PM%XHOH8[B2QLM;2\:$P6\[I^W&F:GIVM:;I^L:/J%EJ
MVD:M96FIZ5JNF74%_INIZ;?P1W5CJ&GWUK)+:WEE>6LL5S:7=M+)!<021S0R
M/&ZL0"[1110!\:_'KX*_M0_$?XL?#CQ7\,/C[\"? GPP\#_9]1O/AO\ $S]E
M[Q[\7]?O_%_VN6.?QKHOC;PW^UG\&/#^EZWIF@S36'@NW\4?#'QYHWA?6[F?
MQ3<:9KVH0Z5#I?S)XT_X)6^'_B1=^,O"'C;XOW=U^S\VO?M"?$GX+_"_0_A_
M8:1XO^#_ ,;/VFT\52?$3XDO\2[_ ,3:[IGC"/PQJGCGQKKGPB\/+\-_"TG@
MS4O&7B)?$.O>.]/_ .$=L?#GZRT4Z;E2A[.G.I"-L9>U2?,WCI4Y5IRFY<\J
MM/V-)8*K*3JY="G"&7SPL(J(ZEJO\6-.I%RP<G2G3ISH2>!IXFEAU/#RBZ$X
M.GC,7#$TY4W3QJQ6(^N1Q#K5.;\KO'G_  3_ /C7X]_9\_:0\#ZK^T[\/[K]
MHK]J3Q%X O/B/\<M5_9NUN\^'VE^$OAG9^'M%\*>#?!/P/TK]HG0-=T:WMM(
M\/2:A<ZAJWQP\0I-XX\5^-?$L&F6ND:MI?A+0?>OVR?V<?C?^TW\ /#WPB\#
M?&SX5?"OQ=%XW^$'C?QKXY\5_L_^+OBKX<UZ[^$GC3PU\3+6Q\+^ M'_ &C?
MA-J?A&WUKQ[X/T*6XDU;X@^-Y++PB=6\.Q_:-9OK/Q?I?VO10W=J6D7&O@<3
M!TXJDZ=;+HT(X25+V:C[*,/JU&56G3Y:>*JQ=7%0K59U)RFDE0K0KTERU84Z
MM*,MURUJE2K+FA*\)SA.I/V%2<95,-%\F'E2@HQ7YE^+/V.OVL/C#K/P?\6?
M'C]K/X*^)?$GP5^.F@?%3PGI7PQ_9"\5?#/X<MX7/PK^+_P@^(?AB^T#Q'^U
MK\5/'L_C/QKX6^,>JRZ5X[?XJ/X8\':IX8\*W47PKUN(>);?Q)Q_[-__  3]
M_:,_9P\<_#K7])_:W^&?C7PG\'OV<!^RE\-?#'BG]E/6+;6=/^$>A^/?#?B?
MP+<>)O%?AS]IG1;;Q'X_T7POH1\'>)/$EIX8\/Z#XIFCT3Q)8>#O"EU8:[I_
MBK]9**UA7JTYQG"2@XRG-*,(*'//*\9DKG*GR\DIQRW,<QPU.<HN5%YCF%>D
MX8G&XJM5>)7URA2P^)O6HT:>%I48R;O3I8/.'G]"E"::J1I+-^3&U*:DH8BI
M0PL,1&K1PF%IT2BBBL0"OR(_X*&?\GP_\$4O^ST_CE_ZPA^TY7Z[U^&'[5WQ
M+A^/G_!8[_@F=^S'\(GTSQ=J?[(=U^T/^V'^U?JEC=7-RGP=\,^(/@-XG^ W
MP5\-:S)9V-SIL/B?XG>)?BOK-[9Z%J&J:;JUIH7AU-;6QO+"]26( _<^BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** /R(_X*9_\G'_\$:?^TE9_
M]8R_:WK]=Z_(C_@IG_R<?_P1I_[25G_UC+]K>OUWH Y/QWX#\$_%'P7XI^''
MQ)\)>'?'G@#QQH6I^%_&/@OQ=H]AX@\,>*/#FLVLECJNB:]HFJ07.G:II>H6
MDTMO=V5Y;RP31.RNA!K\=M!_X(<?"GX5W][;?LL_MT_\%./V._AE<6RP:?\
M 3X"?M3:1J'P/\+R?VCJ.I37/@KP7\=_A;\;)_!C7,FHFWFLO#6L:9I(L[.Q
M@@TZ$0NTO[:T4 ?CM_PZ4\?_ /28C_@L3_X?G]F;_P"A H_X=*>/_P#I,1_P
M6)_\/S^S-_\ 0@5^Q-% 'X[?\.E/'_\ TF(_X+$_^'Y_9F_^A H_X=*>/_\
MI,1_P6)_\/S^S-_]"!7[$T4 ?CM_PZ4\?_\ 28C_ (+$_P#A^?V9O_H0*/\
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M)]3U)[+3S=W4>E65C#<2QO\ 85% !1110 4444 %%%% !1110 4444 %%%%
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M):MO1+5C2<FHQ3;;222;;;T226K;>B2W/Q5_X=%?''_I--_P5C_\.9^SW_\
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M.;J*:BX*$W*W*[?E+_PZ*^./_2:;_@K'_P"',_9[_P#H=*/^'17QQ_Z33?\
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M]A?]HNYU"UB?JL-Y/I&F2SH.'>QMR?\ 5BD(_8.BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ML[M+)%I7AWP[9:=I-BLTSO/.;>UC:>>22>8O+([MWU% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
=44 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>dpwlogo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 dpwlogo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!F17AI9@  34T *@    @ ! $:  4
M   !    /@$;  4    !    1@$H  ,    !  (   $Q  (    0    3@
M      !@     0   &     !<&%I;G0N;F5T(#0N,"XU /_; $,  @$! @$!
M @(" @(" @(#!0,# P,#!@0$ P4'!@<'!P8'!P@)"PD(" H(!P<*#0H*"PP,
M# P'"0X/#0P."PP,#/_; $,! @(" P,#!@,#!@P(!P@,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#/_  !$( #(
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MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$
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M]/?^#5+]@QM3U_Q'^T%KUHPM]/$GA_POYB\22L!]KN%]E&V('IEI!U6OR5^
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MYXFOYM2OKA_$T!,DLKEFZ]AG '8 "O0?AY\)_B1_P0$_8=^,VN>/-,\+:/\
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L:J"V !D\X KT_.:**\;&?QY>I[&#_@1] HHHKE.H**** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>acmsm_smlogo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 acmsm_smlogo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!F17AI9@  34T *@    @ ! $:  4
M   !    /@$;  4    !    1@$H  ,    !  (   $Q  (    0    3@
M      !@     0   &     !<&%I;G0N;F5T(#0N,BXU /_; $,  @$! 0$!
M @$! 0(" @("! ," @("!00$ P0&!08&!@4&!@8'"0@&!PD'!@8("P@)"@H*
M"@H&" L,"PH,"0H*"O_; $,! @(" @("!0,#!0H'!@<*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"O_  !$( $D
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MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$
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M;-'L;7X<@W5XZDY\F.]U/=+]UA\H/;C)&?']M@Z=2\4WY,V4?W=SD/&'[/\
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MB-/%GC7PE]NU!=%FTE;C[?/%BSED222/;'(J\M&AW8W#& 0":T[3X8>"]/\
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7"B@ HH ** "B@ HH ** "B@ HH __]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
